{
  "category": "Clinical Pathology",
  "subject": {
    "name": "Immunology",
    "url": "https://app.pathprimer.com/curriculum/c01a3e35-50b2-44c8-be40-7cb129b659f1",
    "lessons": {
      "Normal Immune System": {
        "name": "Normal Immune System",
        "url": "https://app.pathprimer.com/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
        "topics": {
          "Immunoglobulins": {
            "name": "Immunoglobulins",
            "url": "https://app.pathprimer.com/document/3f4c3eeb-94a3-4d0d-8636-688031e42490/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "Immunoglobulin specificity is attributed to region of antibody molecule containing the hypervariable region"
                  },
                  {
                    "text": "Biologic activity includes neutralization of toxins, immobilization of microorganisms, neutralization of viral activity, and agglutination of microorganisms"
                  },
                  {
                    "text": "Basic immunoglobulin structureHeavy chain is composed of constant region and variable regionLight chain is composed of constant region and variable regionHinge region permits flexibility between 2 Fab arms of Y-shaped antibodyVariable region contains part of molecule that binds antigen",
                    "sub_points": [
                      "Heavy chain is composed of constant region and variable region",
                      "Light chain is composed of constant region and variable region",
                      "Hinge region permits flexibility between 2 Fab arms of Y-shaped antibody",
                      "Variable region contains part of molecule that binds antigen"
                    ]
                  },
                  {
                    "text": "Immunoglobulin variantsIsotypes IgG, IgM, IgA, IgD, IgE determined by amino acid sequence in constant region of heavy chainAllotypes usually are the result of only 1 or 2 amino acid differences in otherwise identical constant region of heavy or light chainsIdiotypes are confined to amino acid differences in variable region of the heavy and light chains",
                    "sub_points": [
                      "Isotypes IgG, IgM, IgA, IgD, IgE determined by amino acid sequence in constant region of heavy chain",
                      "Allotypes usually are the result of only 1 or 2 amino acid differences in otherwise identical constant region of heavy or light chains",
                      "Idiotypes are confined to amino acid differences in variable region of the heavy and light chains"
                    ]
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Important Features of Immunoglobulins": [
                  {
                    "text": "SpecificityAttributed to region of antibody molecule containing hypervariable regionRestricts ability of antibody to combine with only particular antigenic structures",
                    "sub_points": [
                      "Attributed to region of antibody molecule containing hypervariable region",
                      "Restricts ability of antibody to combine with only particular antigenic structures"
                    ]
                  },
                  {
                    "text": "Biologic activityNeutralization of toxinsImmobilization of microorganismsNeutralization of viral activityAgglutination of microorganisms",
                    "sub_points": [
                      "Neutralization of toxins",
                      "Immobilization of microorganisms",
                      "Neutralization of viral activity",
                      "Agglutination of microorganisms"
                    ]
                  }
                ],
                "Enzymatic Digestion": [
                  {
                    "text": "Papain2 Fab fragmentsFragments are identicalCan still bind antigen but can no longer precipitate1 Fc fragmentFragment crystallizableCannot bind antigen but is responsible for biologic activity",
                    "sub_points": [
                      "2 Fab fragmentsFragments are identicalCan still bind antigen but can no longer precipitate",
                      "Fragments are identical",
                      "Can still bind antigen but can no longer precipitate",
                      "1 Fc fragmentFragment crystallizableCannot bind antigen but is responsible for biologic activity",
                      "Fragment crystallizable",
                      "Cannot bind antigen but is responsible for biologic activity"
                    ]
                  },
                  {
                    "text": "MercaptoethanolBreaks disulfide bonds4 chains2 identical light chains with molecular weight of 22,000 Da2 identical heavy chains with molecular weight of 53,000 Da",
                    "sub_points": [
                      "Breaks disulfide bonds",
                      "4 chains2 identical light chains with molecular weight of 22,000 Da2 identical heavy chains with molecular weight of 53,000 Da",
                      "2 identical light chains with molecular weight of 22,000 Da",
                      "2 identical heavy chains with molecular weight of 53,000 Da"
                    ]
                  }
                ],
                "Basic Immunoglobulin Structure": [
                  {
                    "text": "Heavy chainComposed of constant region and variable region5 constant region amino acid sequences have been identified: γ, μ, α, δ, ε",
                    "sub_points": [
                      "Composed of constant region and variable region",
                      "5 constant region amino acid sequences have been identified: γ, μ, α, δ, ε"
                    ]
                  },
                  {
                    "text": "Light chainComposed of constant region and variable region2 constant region amino acid sequences have been identified: κ, λ",
                    "sub_points": [
                      "Composed of constant region and variable region",
                      "2 constant region amino acid sequences have been identified: κ, λ"
                    ]
                  },
                  {
                    "text": "DomainsIntrachain disulfide bonds exist that form loops within heavy chain and light chainThey occur at approximately equal intervals of approximately 100-110 amino acids resulting in compact, globular structureLight chains have 2 globular domainsOne in variable regionOne in constant regionHeavy chainsγ, α, δ have 3 globular domainsμ, ε have 4 globular domains",
                    "sub_points": [
                      "Intrachain disulfide bonds exist that form loops within heavy chain and light chain",
                      "They occur at approximately equal intervals of approximately 100-110 amino acids resulting in compact, globular structure",
                      "Light chains have 2 globular domainsOne in variable regionOne in constant region",
                      "One in variable region",
                      "One in constant region",
                      "Heavy chainsγ, α, δ have 3 globular domainsμ, ε have 4 globular domains",
                      "γ, α, δ have 3 globular domains",
                      "μ, ε have 4 globular domains"
                    ]
                  },
                  {
                    "text": "Hinge regionPermits flexibility between 2 Fab arms of Y-shaped antibodyLocated between CH1 and CH2 domains of heavy chainPredominately composed of cysteine and proline amino acid residues",
                    "sub_points": [
                      "Permits flexibility between 2 Fab arms of Y-shaped antibody",
                      "Located between CH1 and CH2 domains of heavy chain",
                      "Predominately composed of cysteine and proline amino acid residues"
                    ]
                  },
                  {
                    "text": "Variable regionContains part of the molecule that binds antigenResides in N-terminal110 amino acids of both the heavy and the light chainContains 3 hypervariable regionsThese are regions involved in antigen recognition",
                    "sub_points": [
                      "Contains part of the molecule that binds antigen",
                      "Resides in N-terminal110 amino acids of both the heavy and the light chain",
                      "110 amino acids of both the heavy and the light chain",
                      "Contains 3 hypervariable regionsThese are regions involved in antigen recognition",
                      "These are regions involved in antigen recognition"
                    ]
                  }
                ],
                "Immunoglobulin Variants": [
                  {
                    "text": "IsotypesIgG, IgM, IgA, IgD, IgEDetermined by amino acid sequence in constant region of heavy chain",
                    "sub_points": [
                      "IgG, IgM, IgA, IgD, IgE",
                      "Determined by amino acid sequence in constant region of heavy chain"
                    ]
                  },
                  {
                    "text": "AllotypesUsually result of only 1 or 2 amino acid differences in otherwise identical constant region of heavy or light chain",
                    "sub_points": [
                      "Usually result of only 1 or 2 amino acid differences in otherwise identical constant region of heavy or light chain"
                    ]
                  },
                  {
                    "text": "IdiotypesConfined to amino acid differences in variable region of the heavy and light chains",
                    "sub_points": [
                      "Confined to amino acid differences in variable region of the heavy and light chains"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Lymphocyte Populations": {
            "name": "Lymphocyte Populations",
            "url": "https://app.pathprimer.com/document/c3d802f5-bf40-4c59-bf09-af9632c4ad6d/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "γδT cellsLack CD4 and CD8 coreceptorsDo not respond to peptides associated with MHC moleculesDo not show memoryPossess several properties of innate immune response",
                    "sub_points": [
                      "Lack CD4 and CD8 coreceptors",
                      "Do not respond to peptides associated with MHC molecules",
                      "Do not show memory",
                      "Possess several properties of innate immune response"
                    ]
                  },
                  {
                    "text": "αβT cellsSelf MHC restricted after thymic educationRespond to small antigenic peptides associated with MHC moleculesExpress either CD4 or CD8Show memory",
                    "sub_points": [
                      "Self MHC restricted after thymic education",
                      "Respond to small antigenic peptides associated with MHC molecules",
                      "Express either CD4 or CD8",
                      "Show memory"
                    ]
                  },
                  {
                    "text": "B cellsBind native antigen (not processed and presented on MHC)Show memoryReceptor secreted after stimulation and may class switch",
                    "sub_points": [
                      "Bind native antigen (not processed and presented on MHC)",
                      "Show memory",
                      "Receptor secreted after stimulation and may class switch"
                    ]
                  },
                  {
                    "text": "NK cellsExpress CD16, CD56, and CD57Most develop in bone marrowInvolved in early phase of immune response and considered part of innate immune defenses",
                    "sub_points": [
                      "Express CD16, CD56, and CD57",
                      "Most develop in bone marrow",
                      "Involved in early phase of immune response and considered part of innate immune defenses"
                    ]
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "T Cells": [
                  {
                    "text": "γδT cellsExpressed in association with CD3 and ζLack CD4 and CD8 coreceptorsPredominantly at mucosal epithelial sites, such as skin, gut, and lung10% of intraepithelial lymphocytes express γδConsist of V and C regions (Vγ + Cγ and Vδ + Cδ); antigen binding composed of Vγ + VδHave some features of adaptive immune response (use of antigen-specific clonally expressed receptors)Several properties of innate immune responseRespond within hours to mycobacteria, cytomegalovirus, andPlasmodium falciparumSynthesis IFN-α and TNFHave cytotoxic functionDo not respond to peptides associated with MHC moleculesDo not show memoryγδTCR is closer in shape to BCR (immunoglobulin) than αβTCRArise earlier in ontogeny than αβ T cellSuggested role in protecting neonate from pathogens",
                    "sub_points": [
                      "Expressed in association with CD3 and ζ",
                      "Lack CD4 and CD8 coreceptors",
                      "Predominantly at mucosal epithelial sites, such as skin, gut, and lung10% of intraepithelial lymphocytes express γδ",
                      "10% of intraepithelial lymphocytes express γδ",
                      "Consist of V and C regions (Vγ + Cγ and Vδ + Cδ); antigen binding composed of Vγ + Vδ",
                      "Have some features of adaptive immune response (use of antigen-specific clonally expressed receptors)",
                      "Several properties of innate immune responseRespond within hours to mycobacteria, cytomegalovirus, andPlasmodium falciparumSynthesis IFN-α and TNFHave cytotoxic function",
                      "Respond within hours to mycobacteria, cytomegalovirus, andPlasmodium falciparum",
                      "Synthesis IFN-α and TNF",
                      "Have cytotoxic function",
                      "Do not respond to peptides associated with MHC molecules",
                      "Do not show memory",
                      "γδTCR is closer in shape to BCR (immunoglobulin) than αβTCR",
                      "Arise earlier in ontogeny than αβ T cellSuggested role in protecting neonate from pathogens",
                      "Suggested role in protecting neonate from pathogens"
                    ]
                  },
                  {
                    "text": "αβT cellsExpressed in association with CD3 and ζExpress either CD4 or CD8 coreceptorsPresent in all lymph organsConsist of V and C regions (Vα + Cα and Vβ + Cβ); antigen-binding site composed of Vα + VβRespond to small antigenic peptides associated with MHC moleculesCD4 T cells recognize peptides (12-17 amino acid residues in size) bound to class II MHCCD8 T cells recognize peptides (8-9 amino acid residues in size) bound to class I MHCShow memoryHave co-stimulator ligands that serve as second signals for activation (first signal is TCR); CD28, CTLA-4 (CD152), CD154 (CD40L)Have adhesion and homing molecules; CD2, CD11a/CD18 (LFA-1), ICAM-3 (CD50), CD62L (L-selectin)Produce several cytokinesSelf MHC restricted after thymic educationPositive selection followed by negative selectionReceptor not secreted after stimulation and does not change after stimulation",
                    "sub_points": [
                      "Expressed in association with CD3 and ζ",
                      "Express either CD4 or CD8 coreceptors",
                      "Present in all lymph organs",
                      "Consist of V and C regions (Vα + Cα and Vβ + Cβ); antigen-binding site composed of Vα + Vβ",
                      "Respond to small antigenic peptides associated with MHC moleculesCD4 T cells recognize peptides (12-17 amino acid residues in size) bound to class II MHCCD8 T cells recognize peptides (8-9 amino acid residues in size) bound to class I MHC",
                      "CD4 T cells recognize peptides (12-17 amino acid residues in size) bound to class II MHC",
                      "CD8 T cells recognize peptides (8-9 amino acid residues in size) bound to class I MHC",
                      "Show memory",
                      "Have co-stimulator ligands that serve as second signals for activation (first signal is TCR); CD28, CTLA-4 (CD152), CD154 (CD40L)",
                      "Have adhesion and homing molecules; CD2, CD11a/CD18 (LFA-1), ICAM-3 (CD50), CD62L (L-selectin)",
                      "Produce several cytokines",
                      "Self MHC restricted after thymic educationPositive selection followed by negative selection",
                      "Positive selection followed by negative selection",
                      "Receptor not secreted after stimulation and does not change after stimulation"
                    ]
                  }
                ],
                "B Cells": [
                  {
                    "text": "Have immunoglobulin as antigen receptor"
                  },
                  {
                    "text": "Bind native antigen (not processed and presented on MHC)"
                  },
                  {
                    "text": "Differentiate in bone marrow through series of stages from pro-B cell to mature-B cell"
                  },
                  {
                    "text": "Show memory"
                  },
                  {
                    "text": "Receptor secreted after stimulation and may class switch"
                  }
                ],
                "NK Cells": [
                  {
                    "text": "Most develop in bone marrowSome develop in thymus at early stage of double negative (no CD4 or CD8) stage before TCR gene rearrangesDo not express any TCR",
                    "sub_points": [
                      "Some develop in thymus at early stage of double negative (no CD4 or CD8) stage before TCR gene rearranges",
                      "Do not express any TCR"
                    ]
                  },
                  {
                    "text": "Involved in early phase of immune response and considered part of innate immune defenses"
                  },
                  {
                    "text": "Kill viruses and tumor cells"
                  },
                  {
                    "text": "Express CD16, CD56, and CD57"
                  }
                ]
              },
              "LABORATORY METHODS": {
                "Evaluation of Cellular Components of Immune System": [
                  {
                    "text": "White blood cell count (WBC) with complete differential"
                  },
                  {
                    "text": "Serum IgG, IgM, IgA levels"
                  },
                  {
                    "text": "Flow cytometryCD3, CD4, CD8, CD19, CD16+56 measurementsOther CD markers",
                    "sub_points": [
                      "CD3, CD4, CD8, CD19, CD16+56 measurements",
                      "Other CD markers"
                    ]
                  },
                  {
                    "text": "In vivo measurements of functionMitogen stimulation PHA, PWM, ConANK cell functional assays using K562 target cells",
                    "sub_points": [
                      "Mitogen stimulation PHA, PWM, ConA",
                      "NK cell functional assays using K562 target cells"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cytokines": {
            "name": "Cytokines",
            "url": "https://app.pathprimer.com/document/bb0e0022-8250-4b00-b296-7ef1f4554e24/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "IL-1, IL-6, TNF-α, and IFN-α facilitate innate immune responses"
                  },
                  {
                    "text": "TH1 lineage of T cells is induced by IL-12, IL-23, and IL-27"
                  },
                  {
                    "text": "TH2 lineage of T cells is induced by IL-4"
                  },
                  {
                    "text": "IL-17 family protects against extracellular bacteria and some fungi"
                  },
                  {
                    "text": "IFN-γ produced by TH1 inhibits proliferation of TH2 cells"
                  },
                  {
                    "text": "IL-10 and TGF-β produced by TH2 cells inhibits proliferation of TH1 cells"
                  },
                  {
                    "text": "IL-1, IL-6, IL-10, IL-23, and TNF-α promote inflammatory immune responses"
                  },
                  {
                    "text": "Chemokines are potent attractors of leukocytesIL-8 is produced by monocytes, macrophages, fibroblasts, keratinocytes, and endothelial cells and attracts neutrophils and naïve T cellsRANTES is produced by T cells, endothelial cells, and platelets and attracts monocytes, NK cells, T cells, basophils, and dendritic cellsMCP-1 is produced by monocytes, macrophages, fibroblasts, and keratinocytes and attracts monocytes, NK cells, T cells, basophils, and dendritic cellsMIP-1α is produced by monocytes, macrophages, T cells, mast cells, and fibroblasts and attracts monocytes, NK cells, T cells, basophils, and dendritic cellsMIP-1β is produced by monocytes, macrophages, neutrophils, and endothelial cells; attracts monocytes, NK cells, T cells, and dendritic cells; and competes with HIV-1 for chemokine receptor binding",
                    "sub_points": [
                      "IL-8 is produced by monocytes, macrophages, fibroblasts, keratinocytes, and endothelial cells and attracts neutrophils and naïve T cells",
                      "RANTES is produced by T cells, endothelial cells, and platelets and attracts monocytes, NK cells, T cells, basophils, and dendritic cells",
                      "MCP-1 is produced by monocytes, macrophages, fibroblasts, and keratinocytes and attracts monocytes, NK cells, T cells, basophils, and dendritic cells",
                      "MIP-1α is produced by monocytes, macrophages, T cells, mast cells, and fibroblasts and attracts monocytes, NK cells, T cells, basophils, and dendritic cells",
                      "MIP-1β is produced by monocytes, macrophages, neutrophils, and endothelial cells; attracts monocytes, NK cells, T cells, and dendritic cells; and competes with HIV-1 for chemokine receptor binding"
                    ]
                  },
                  {
                    "text": "Cytokine receptors can be divided into 5 families of receptorsImmunoglobulin superfamilyClass I cytokine receptor familyClass II cytokine receptor familyTNF receptor superfamilyChemokine receptor family",
                    "sub_points": [
                      "Immunoglobulin superfamily",
                      "Class I cytokine receptor family",
                      "Class II cytokine receptor family",
                      "TNF receptor superfamily",
                      "Chemokine receptor family"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Interleukin (IL)"
                  },
                  {
                    "text": "Tumor necrosis factor (TNF)"
                  },
                  {
                    "text": "Interferon (IFN)"
                  },
                  {
                    "text": "C-reactive protein (CRP)"
                  },
                  {
                    "text": "Mannan-binding lectin (MBL)"
                  },
                  {
                    "text": "T-helper (TH)"
                  },
                  {
                    "text": "Transforming growth factor (TGF)"
                  },
                  {
                    "text": "Regulated on activation, normal T cell expressed and secreted (RANTES)"
                  },
                  {
                    "text": "Natural killer (NK)"
                  },
                  {
                    "text": "Monocyte chemoattractant protein (MCP)"
                  },
                  {
                    "text": "Macrophage inhibitory protein (MIP)"
                  },
                  {
                    "text": "Human immunodeficiency virus (HIV)"
                  },
                  {
                    "text": "Colony-stimulating factor (CSF)"
                  },
                  {
                    "text": "Macrophage colony-stimulating factor (M-CSF)"
                  },
                  {
                    "text": "Granulocyte colony-stimulating factor (G-CSF)"
                  },
                  {
                    "text": "Granulocyte-macrophage colony-stimulating factor (GM-CSF)"
                  },
                  {
                    "text": "Platelet factor (PF)"
                  },
                  {
                    "text": "Monocyte chemotactic and activating factor (MCAF)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Cytokines That Facilitate Innate Immune Responses": [
                  {
                    "text": "IL-1, IL-6, TNF-α, IFN-αProduced by macrophages and neutrophilsEndogenous pyrogens (cause fever)Initiate acute-phase response resulting in increased CRP and MBL levelsIFN-α levels increase after viral infection",
                    "sub_points": [
                      "Produced by macrophages and neutrophils",
                      "Endogenous pyrogens (cause fever)",
                      "Initiate acute-phase response resulting in increased CRP and MBL levels",
                      "IFN-α levels increase after viral infection"
                    ]
                  }
                ],
                "Cytokines That Induce Differentiation of Distinct T-Cell Lineages": [
                  {
                    "text": "TH1 lineage of T cellsIL-12, IL-23, IL-27",
                    "sub_points": [
                      "IL-12, IL-23, IL-27"
                    ]
                  },
                  {
                    "text": "TH2 lineage of T cellsIL-4",
                    "sub_points": [
                      "IL-4"
                    ]
                  },
                  {
                    "text": "TH17 lineage of T cellsIL-17 family protects against extracellular bacteria and some fungiIL-17A (IL-17 CTLA-8), IL-17B (CX1 NERF), IL-17C (CX2), IL-17D (IL-27), IL-17E (IL-25), IL-17F (ML-1)",
                    "sub_points": [
                      "IL-17 family protects against extracellular bacteria and some fungiIL-17A (IL-17 CTLA-8), IL-17B (CX1 NERF), IL-17C (CX2), IL-17D (IL-27), IL-17E (IL-25), IL-17F (ML-1)",
                      "IL-17A (IL-17 CTLA-8), IL-17B (CX1 NERF), IL-17C (CX2), IL-17D (IL-27), IL-17E (IL-25), IL-17F (ML-1)"
                    ]
                  }
                ],
                "Cytokines That Inhibit Lineage-Specific T-Cell Differentiation": [
                  {
                    "text": "IFN-γ produced by TH1 inhibits proliferation of TH2 cells"
                  },
                  {
                    "text": "IL-10 and TGF-β produced by TH2 cells inhibits proliferation of TH1 cells"
                  }
                ],
                "Cytokines That Promote Inflammatory Responses": [
                  {
                    "text": "IL-1, IL-6, IL-10, IL-23, TNF-αCause increased vascular permeability",
                    "sub_points": [
                      "Cause increased vascular permeability"
                    ]
                  },
                  {
                    "text": "IFN-γ chemotactically attracts macrophages and increases their phagocytic activity"
                  },
                  {
                    "text": "TGF-β terminates inflammatory response by promoting accumulation and proliferation of fibroblasts"
                  }
                ],
                "Cytokines That Affect Leukocyte Movement": [
                  {
                    "text": "Chemokines are potent attractors of leukocytesIL-8 produced by monocytes, macrophages, fibroblasts, keratinocytes, endothelial cellsAttracts neutrophils and naïve T cellsPromotes angiogenesisRANTES produced by T cells, endothelial cells, plateletsAttracts monocytes, NK cells, T cells, basophils, dendritic cellsDegranulates basophils, activates T cellsMCP-1 produced by monocytes, macrophages, fibroblasts, keratinocytesAttracts monocytes, NK cells, T cells, basophils, dendritic cellsActivates macrophages, stimulates basophil histamine release, promotes TH2 immunityMIP-1α produced by monocytes, macrophages, T cells, mast cells, fibroblastsAttracts monocytes, NK cells, T cells, basophils, dendritic cellsPromotes TH1 immunity, competes with HIV-1MIP-1β produced by monocytes, macrophages, neutrophils, endothelial cellsAttracts monocytes, NK cells, T cells, dendritic cellsCompetes with HIV-1 for chemokine receptor binding",
                    "sub_points": [
                      "IL-8 produced by monocytes, macrophages, fibroblasts, keratinocytes, endothelial cellsAttracts neutrophils and naïve T cellsPromotes angiogenesis",
                      "Attracts neutrophils and naïve T cells",
                      "Promotes angiogenesis",
                      "RANTES produced by T cells, endothelial cells, plateletsAttracts monocytes, NK cells, T cells, basophils, dendritic cellsDegranulates basophils, activates T cells",
                      "Attracts monocytes, NK cells, T cells, basophils, dendritic cells",
                      "Degranulates basophils, activates T cells",
                      "MCP-1 produced by monocytes, macrophages, fibroblasts, keratinocytesAttracts monocytes, NK cells, T cells, basophils, dendritic cellsActivates macrophages, stimulates basophil histamine release, promotes TH2 immunity",
                      "Attracts monocytes, NK cells, T cells, basophils, dendritic cells",
                      "Activates macrophages, stimulates basophil histamine release, promotes TH2 immunity",
                      "MIP-1α produced by monocytes, macrophages, T cells, mast cells, fibroblastsAttracts monocytes, NK cells, T cells, basophils, dendritic cellsPromotes TH1 immunity, competes with HIV-1",
                      "Attracts monocytes, NK cells, T cells, basophils, dendritic cells",
                      "Promotes TH1 immunity, competes with HIV-1",
                      "MIP-1β produced by monocytes, macrophages, neutrophils, endothelial cellsAttracts monocytes, NK cells, T cells, dendritic cellsCompetes with HIV-1 for chemokine receptor binding",
                      "Attracts monocytes, NK cells, T cells, dendritic cells",
                      "Competes with HIV-1 for chemokine receptor binding"
                    ]
                  }
                ],
                "Cytokines That Stimulate Hematopoiesis": [
                  {
                    "text": "CSFs induce growth of hematopoietic cells in vitro using cultures of bone marrowM-CSFG-CSFGM-CSFIL-3 promotes proliferation of granulocytes, macrophages, megakaryocytes, eosinophils, basophils, mast cells",
                    "sub_points": [
                      "M-CSF",
                      "G-CSF",
                      "GM-CSF",
                      "IL-3 promotes proliferation of granulocytes, macrophages, megakaryocytes, eosinophils, basophils, mast cells"
                    ]
                  }
                ],
                "Cytokine Receptors": [
                  {
                    "text": "Can be divided into 5 families of receptors"
                  },
                  {
                    "text": "Immunoglobulin superfamilyUsed by IL-1, M-CSF",
                    "sub_points": [
                      "Used by IL-1, M-CSF"
                    ]
                  },
                  {
                    "text": "Class I cytokine receptor familyHematopoietin receptor familyUsually have α chain and β chain and sometimes γ chainMost cytokines discovered so far use class I receptorsUsed by IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-11, IL-12, IL-13, IL-15, GM-CSF, G-CSF",
                    "sub_points": [
                      "Hematopoietin receptor family",
                      "Usually have α chain and β chain and sometimes γ chain",
                      "Most cytokines discovered so far use class I receptors",
                      "Used by IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-11, IL-12, IL-13, IL-15, GM-CSF, G-CSF"
                    ]
                  },
                  {
                    "text": "Class II cytokine receptor familyInterferon receptor familyUsed by IFN-α, IFN-β, IFN-γ, IL-10All have biologic activities that overlap",
                    "sub_points": [
                      "Interferon receptor family",
                      "Used by IFN-α, IFN-β, IFN-γ, IL-10All have biologic activities that overlap",
                      "All have biologic activities that overlap"
                    ]
                  },
                  {
                    "text": "TNF receptor superfamilyDeath receptorsDecoy receptorsActivating receptorsUsed by TNF-α, TNF-β, TNF-γ, CD30L, CD40L, Fas L",
                    "sub_points": [
                      "Death receptors",
                      "Decoy receptors",
                      "Activating receptors",
                      "Used by TNF-α, TNF-β, TNF-γ, CD30L, CD40L, Fas L"
                    ]
                  },
                  {
                    "text": "Chemokine receptor familySerpentine G-protein-coupled receptorsCC, CXC, CXCR4, CC5Used by IL-8, RANTES, MIP-1, PF4, MCAF",
                    "sub_points": [
                      "Serpentine G-protein-coupled receptors",
                      "CC, CXC, CXCR4, CC5",
                      "Used by IL-8, RANTES, MIP-1, PF4, MCAF"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Complement": {
            "name": "Complement",
            "url": "https://app.pathprimer.com/document/43c9a699-3b6a-4a9b-8c71-83203714c8fc/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "2% of primary immune deficiency disorders are disorders of some component of the complement system"
                  }
                ],
                "Biologic Concepts": [
                  {
                    "text": "Autoimmune-like diseases"
                  },
                  {
                    "text": "Recurrent bacterial infections"
                  },
                  {
                    "text": "Hereditary angioedema"
                  },
                  {
                    "text": "Glycosyl phosphatidyl inositol (GPI) protein deficiencies"
                  },
                  {
                    "text": "Paroxysmal nocturnal hemoglobinuria (PNH)"
                  }
                ]
              },
              "OVERVIEW": {
                "Frequency": [
                  {
                    "text": "Congenital defects have been described for all components of the complement system"
                  },
                  {
                    "text": "2% of primary immune deficiency disorders are disorders of some component of the complement system"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Congenital Defects": [
                  {
                    "text": "Congenital defects lead to distinct clinical syndromesHereditary angioedemaParoxysmal nocturnal hemoglobinuria (PNH)Recurrent bacterial infectionsAutoimmune-like diseases",
                    "sub_points": [
                      "Hereditary angioedema",
                      "Paroxysmal nocturnal hemoglobinuria (PNH)",
                      "Recurrent bacterial infections",
                      "Autoimmune-like diseases"
                    ]
                  }
                ],
                "Classical Pathway": [
                  {
                    "text": "C1, C2, C4Deficiency leads to immune-complex diseaseIncreased infections with encapsulated organisms",
                    "sub_points": [
                      "Deficiency leads to immune-complex disease",
                      "Increased infections with encapsulated organisms"
                    ]
                  }
                ],
                "Mannose-Binding Lectin (MBL) Pathway": [
                  {
                    "text": "MBL, MASP1, MASP2, C2, C4Deficiency of MBL leads to bacterial infections, mainly in childhood",
                    "sub_points": [
                      "Deficiency of MBL leads to bacterial infections, mainly in childhood"
                    ]
                  }
                ],
                "Alternative Pathway": [
                  {
                    "text": "Factor D, factor P"
                  },
                  {
                    "text": "Deficiency leads to infections with pyogenic bacteria andNeisseriaspp., but not immune-complex disease"
                  }
                ],
                "C3b Deposition": [
                  {
                    "text": "C3Deficiency leads to infection with pyogenic bacteria andNeisseriaspp. and sometimes immune-complex disease",
                    "sub_points": [
                      "Deficiency leads to infection with pyogenic bacteria andNeisseriaspp. and sometimes immune-complex disease"
                    ]
                  }
                ],
                "Membrane-Attack Components": [
                  {
                    "text": "C5, C6, C7, C8, C9Deficiency leads to infection withNeisseriaspp. only",
                    "sub_points": [
                      "Deficiency leads to infection withNeisseriaspp. only"
                    ]
                  }
                ],
                "Defective Control of Complement Components": [
                  {
                    "text": "Hereditary angioedemaPatients lack functional C1 esterase inhibitorKallikrein system uncontrolled results in vasoactive peptides increasing vessel permeability",
                    "sub_points": [
                      "Patients lack functional C1 esterase inhibitor",
                      "Kallikrein system uncontrolled results in vasoactive peptides increasing vessel permeability"
                    ]
                  },
                  {
                    "text": "Glycosyl phosphatidyl inositol (GPI) protein deficienciesDecay-accelerating factor (DAF or CD55) and CD59 protect cells from spontaneous lysis by complementLack of CD55 and CD59 results in lysis of granulocytes, platelets, and RBCs",
                    "sub_points": [
                      "Decay-accelerating factor (DAF or CD55) and CD59 protect cells from spontaneous lysis by complement",
                      "Lack of CD55 and CD59 results in lysis of granulocytes, platelets, and RBCs"
                    ]
                  },
                  {
                    "text": "Paroxysmal nocturnal hemoglobinuria (PNH)Deficiency in an enzyme required for production of all GPI-anchored proteins",
                    "sub_points": [
                      "Deficiency in an enzyme required for production of all GPI-anchored proteins"
                    ]
                  }
                ]
              },
              "LABORATORY METHODS": {
                "Hemolytic Assays": [
                  {
                    "text": "Total hemolytic complement assay (CH50)Detects function of C1 through C9If abnormal, levels of each individual component can be measured",
                    "sub_points": [
                      "Detects function of C1 through C9",
                      "If abnormal, levels of each individual component can be measured"
                    ]
                  },
                  {
                    "text": "Alternate pathway hemolytic assayUses unsensitized rabbit erythrocytes as activators of the alternative pathway",
                    "sub_points": [
                      "Uses unsensitized rabbit erythrocytes as activators of the alternative pathway"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Major Histocompatibility Complex": {
            "name": "Major Histocompatibility Complex",
            "url": "https://app.pathprimer.com/document/02bb0951-30ef-4be1-b3ec-1416444536dc/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "MHC molecules function to bind peptide fragments of pathogens and present them on cell surface for recognition by TCR on appropriate T cell"
                  }
                ],
                "Biologic Concepts": [
                  {
                    "text": "MHC class I: Consists of HLA-A, HLA-B, and HLA-C molecules; present antigen peptides to CD8+ T cells; expressed on all nucleated cells"
                  },
                  {
                    "text": "MHC class II: Consists of HLA-DR, HLA-DP, and HLA-DQ molecules; present antigen peptides to CD4+ T cells; expressed on antigen-presenting cells"
                  }
                ]
              },
              "OVERVIEW": {
                "Major Histocompatibility Complex": [
                  {
                    "text": "Functions to bind peptide fragments of pathogens and present them on cell surface for recognition by appropriate T cellPolygenic: Contains several different major histocompatibility complex (MHC) class I and class II genes; as a result, individuals possess set of MHC molecules with wide range of peptide-binding abilityPolymorphic: Multiple variants exist of each gene within population (they are most polymorphic genes known)",
                    "sub_points": [
                      "Polygenic: Contains several different major histocompatibility complex (MHC) class I and class II genes; as a result, individuals possess set of MHC molecules with wide range of peptide-binding ability",
                      "Polymorphic: Multiple variants exist of each gene within population (they are most polymorphic genes known)"
                    ]
                  },
                  {
                    "text": "Located on chromosome 6 in humans; 7 x 10⁶ base pairs long; contains > 200 genes"
                  },
                  {
                    "text": "Genes encoding α chain of MHC class I molecules and α and β chains of MHC class II are linked; genes for β₂-microglobulin and invariant chain are on chromosome 15 and 5, respectively"
                  },
                  {
                    "text": "Genes for MHC complex are codominant; individual expresses 2 HLA-A, 2 HLA-B, 2 HLA-C, 2 HLA-DR, 2 HLA-DP, 2 HLA-DQ productsPresence of several different MHC molecules means any one individual is equipped to present broad range of peptides",
                    "sub_points": [
                      "Presence of several different MHC molecules means any one individual is equipped to present broad range of peptides"
                    ]
                  },
                  {
                    "text": "Particular combination of MHC alleles found on single chromosome is known as MHC haplotype"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "MHC Class I": [
                  {
                    "text": "Three class I α-chain genes: HLA-A, HLA-B, and HLA-CResulting molecule has 3 domains in α chain and 1 domain in β₂microglobulin",
                    "sub_points": [
                      "Resulting molecule has 3 domains in α chain and 1 domain in β₂microglobulin"
                    ]
                  },
                  {
                    "text": "Expressed on all nucleated cells"
                  },
                  {
                    "text": "Bind to peptides derived from proteins synthesized, and degrade in cytosol"
                  },
                  {
                    "text": "This peptide-class I complex is recognized by TCR on CD8+ T cells, which are then activated to killCD8 binding site is in α₃ domain",
                    "sub_points": [
                      "CD8 binding site is in α₃ domain"
                    ]
                  },
                  {
                    "text": "Peptide-binding grooveLocated between α₁ and α₂ domainsThis region contains α helices and β-pleated sheet structuresGroove can hold peptide of 8-9 amino acids",
                    "sub_points": [
                      "Located between α₁ and α₂ domains",
                      "This region contains α helices and β-pleated sheet structures",
                      "Groove can hold peptide of 8-9 amino acids"
                    ]
                  }
                ],
                "MHC Class II": [
                  {
                    "text": "Three pairs of class II α and β-chain genes: HLA-DR, HLA-DP, and HLA-DQResulting α and β chains have 2 domains",
                    "sub_points": [
                      "Resulting α and β chains have 2 domains"
                    ]
                  },
                  {
                    "text": "Two TAP genes lie in MHC class II region that are involved in transporting MHC gene products"
                  },
                  {
                    "text": "Expressed on antigen-presenting cells"
                  },
                  {
                    "text": "Bind to peptides derived from proteins degraded by endocytic vesicles"
                  },
                  {
                    "text": "This peptide-class II complex is recognized by TCR on CD4+ T cells, which are then programmed to activate other cells (such as B cells or macrophages)CD4 binding site is in β₂ domain",
                    "sub_points": [
                      "CD4 binding site is in β₂ domain"
                    ]
                  },
                  {
                    "text": "Peptide-binding grooveLocated at N terminal domain of α₁ and β₁ domainsThis region contains α helices and β-pleated sheet structuresGroove can hold peptide of 12-17 amino acids",
                    "sub_points": [
                      "Located at N terminal domain of α₁ and β₁ domains",
                      "This region contains α helices and β-pleated sheet structures",
                      "Groove can hold peptide of 12-17 amino acids"
                    ]
                  }
                ]
              },
              "LABORATORY METHODS": {
                "Clinical Applications of Testing": [
                  {
                    "text": "Paternity testing"
                  },
                  {
                    "text": "Forensic testing"
                  },
                  {
                    "text": "Disease associationsAnkylosing spondylitis: HLA-B27",
                    "sub_points": [
                      "Ankylosing spondylitis: HLA-B27"
                    ]
                  },
                  {
                    "text": "Transplantation"
                  }
                ],
                "Methods of Typing": [
                  {
                    "text": "Complement cytotoxicity assay (low-resolution typing)"
                  },
                  {
                    "text": "Panels of HLA antisera incubated with donor/recipient lymphocytes"
                  },
                  {
                    "text": "Molecular typing using PCR results in high-resolution typing necessary in bone marrow transplants"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Principles of Immune Activation": {
            "name": "Principles of Immune Activation",
            "url": "https://app.pathprimer.com/document/a9ffde7c-56cb-42ee-8f87-1f0071836727/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "MHC molecules recognize peptides of proteins: Class I can bind peptides 8-9 amino acids in size; class II can bind peptides 12-17 amino acids in size"
                  },
                  {
                    "text": "TCRs recognize protein peptides presented on self MHC; CD8 recognize peptides presented on class I MHC; CD4 recognize peptides presented on class II MHC"
                  },
                  {
                    "text": "BCRs recognize intact antigen; BCRs also recognize intact proteins, nucleic acids, polysaccharide"
                  },
                  {
                    "text": "APC phagocytize, process, and re-express antigen on their surface on MHC molecules"
                  },
                  {
                    "text": "T-cell activationStarts when TCR binds appropriate MHC+peptide structureCD3 complex composed of multichain complex composed of γε, δε, ζζ chainsMultichained complex has immunoreceptor tyrosine-based activation motifs (ITAMs) on cytoplasmic tails, which transmit signalCascade eventually produces nuclear binding factors NFAT, NF-κB, and AP-1, which travel to nucleus and activate promoter gene for cytokine synthesis",
                    "sub_points": [
                      "Starts when TCR binds appropriate MHC+peptide structure",
                      "CD3 complex composed of multichain complex composed of γε, δε, ζζ chains",
                      "Multichained complex has immunoreceptor tyrosine-based activation motifs (ITAMs) on cytoplasmic tails, which transmit signal",
                      "Cascade eventually produces nuclear binding factors NFAT, NF-κB, and AP-1, which travel to nucleus and activate promoter gene for cytokine synthesis"
                    ]
                  },
                  {
                    "text": "B-cell activationIg on surface of B cells has short cytoplasmic tail and cannot transmit signalAssociated molecules have ITAM on their cytoplasmic tail and transmit signal into cellCascade eventually produces nuclear binding factors that activate Ig synthesis and cytokine production",
                    "sub_points": [
                      "Ig on surface of B cells has short cytoplasmic tail and cannot transmit signal",
                      "Associated molecules have ITAM on their cytoplasmic tail and transmit signal into cell",
                      "Cascade eventually produces nuclear binding factors that activate Ig synthesis and cytokine production"
                    ]
                  },
                  {
                    "text": "T-B cooperationBCR binds antigen and internalizes it; B cell re-expresses peptides of antigen it bound on MHC moleculesTCR recognizes the MHC+peptide on surface of B cellB cell and T cell have now recognized same antigen but different parts of moleculeB cell then expresses cytokine receptors for T-cell-derived cytokines, such as IL-4 and IFN-γ",
                    "sub_points": [
                      "BCR binds antigen and internalizes it; B cell re-expresses peptides of antigen it bound on MHC molecules",
                      "TCR recognizes the MHC+peptide on surface of B cell",
                      "B cell and T cell have now recognized same antigen but different parts of molecule",
                      "B cell then expresses cytokine receptors for T-cell-derived cytokines, such as IL-4 and IFN-γ"
                    ]
                  }
                ]
              },
              "OVERVIEW": {
                "Immune System Activation": [
                  {
                    "text": "Foreign antigen first must be recognized by immune system"
                  },
                  {
                    "text": "Once recognized, immune cells respond by proliferation and differentiation into effector cells﻿"
                  },
                  {
                    "text": "Effector cells function to eliminate foreign antigen"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "MHC Molecules Bind Antigenic Peptides of Proteins": [
                  {
                    "text": "Class I: Can bind peptides 8-9 amino acids in sizeBind peptides from endogenous antigens, such as viral protein in cytoplasm that are digested by proteasomePeptides bind to peptide binding site as class I molecule is assembled in endoplasmic reticulum and then transported via Golgi apparatus to cell surfaceHas site in its α₃ domain that is recognized by CD8",
                    "sub_points": [
                      "Bind peptides from endogenous antigens, such as viral protein in cytoplasm that are digested by proteasome",
                      "Peptides bind to peptide binding site as class I molecule is assembled in endoplasmic reticulum and then transported via Golgi apparatus to cell surface",
                      "Has site in its α₃ domain that is recognized by CD8"
                    ]
                  },
                  {
                    "text": "Class II: Can bind peptides 12-17 amino acids in sizeBind peptides from exogenous antigens, such as virus proteins in vaccine that are digested in acid vesiclesPeptides bind to peptide binding site, as class II molecule is transported to cell membrane in vesicleExchange is mediated by HLA-DMHas site in its β₂ domain that is recognized by CD4",
                    "sub_points": [
                      "Bind peptides from exogenous antigens, such as virus proteins in vaccine that are digested in acid vesicles",
                      "Peptides bind to peptide binding site, as class II molecule is transported to cell membrane in vesicleExchange is mediated by HLA-DM",
                      "Exchange is mediated by HLA-DM",
                      "Has site in its β₂ domain that is recognized by CD4"
                    ]
                  }
                ],
                "T Cells Recognize Antigenic Peptides on MHC Molecules": [
                  {
                    "text": "T-cell receptor (TCR) learned self molecules in the thymus"
                  },
                  {
                    "text": "Recognizes a peptide presented on MHC moleculesCD4 recognize peptides presented on class II MHCCD8 recognize peptides presented on class I MHC",
                    "sub_points": [
                      "CD4 recognize peptides presented on class II MHC",
                      "CD8 recognize peptides presented on class I MHC"
                    ]
                  }
                ],
                "B Cells Recognize Intact Antigenic Molecules": [
                  {
                    "text": "B-cell receptors (BCRs) recognize intact proteins, nucleic acids, polysaccharide"
                  },
                  {
                    "text": "Activation initiated by cross-linking of its receptor"
                  }
                ],
                "Antigen-Presenting Cells Phagocytize, Process, and Re-express Antigens": [
                  {
                    "text": "Antigen-presenting cells (APCs) phagocytize and process antigens, and re-express them on their cell surfaces bound to MHCTake up antigens in nonspecific wayProcess antigens by denaturation or partial digestion and re-express them on their surface to antigen-specific cells",
                    "sub_points": [
                      "Take up antigens in nonspecific way",
                      "Process antigens by denaturation or partial digestion and re-express them on their surface to antigen-specific cells"
                    ]
                  }
                ],
                "T Cell Activation": [
                  {
                    "text": "Starts when TCR binds appropriate MHC+peptide structure"
                  },
                  {
                    "text": "TCR has short cytoplasmic tail, so it cannot transmit signal into cell; CD3 complex transmits signal"
                  },
                  {
                    "text": "CD3 complex composed of multichain complex composed of γε, δε, ζζ chains"
                  },
                  {
                    "text": "Multichained complex has immunoreceptor tyrosine-based activation motifs (ITAMs) on cytoplasmic tails, which transmit signal"
                  },
                  {
                    "text": "Binding of TCR activates ITAMs, resulting in conformational change that allows Fyn and LcK tyrosine kinases to bind"
                  },
                  {
                    "text": "Once Fyn and LcK bind, they allow activation of ζ chains via ZAP-70"
                  },
                  {
                    "text": "ZAP-70 activates linker for activation of T cells (LAT)"
                  },
                  {
                    "text": "LAT attracts more molecules into signaling complex (including SLP76)"
                  },
                  {
                    "text": "Cascade eventually produces nuclear binding factors NFAT, NF-κB, and AP-1, which travel to nucleus and activate promoter gene for cytokine synthesis"
                  }
                ],
                "B Cell Activation": [
                  {
                    "text": "Ig on surface of B cells has short cytoplasmic tail and cannot transmit signal"
                  },
                  {
                    "text": "Cell surface Ig is on surface of cell associated with Igα/Igβ (CD79a, CD79b)"
                  },
                  {
                    "text": "Associated molecules have ITAM on their cytoplasmic tail and transmit signal into cell"
                  },
                  {
                    "text": "Cascade is similar to that of T cell, using activator molecules Syk, Fyn, Lyn, Btk, and BLNK"
                  },
                  {
                    "text": "Cascade eventually produces nuclear binding factors that activate Ig synthesis and cytokine production"
                  }
                ],
                "T-B Cooperation": [
                  {
                    "text": "BCR binds antigen and internalizes it"
                  },
                  {
                    "text": "B cell re-expresses peptides of antigen that it bound on MHC molecules"
                  },
                  {
                    "text": "TCR recognizes MHC+peptide on surface of B cell"
                  },
                  {
                    "text": "B cell and T cell have now recognized same antigen, but different parts of molecule"
                  },
                  {
                    "text": "B cell CD40 interacts with CD40L on T cell to initiate class switching"
                  },
                  {
                    "text": "B7 interacts with the CD28 on T cell"
                  },
                  {
                    "text": "B cell then expresses cytokine receptors for T-cell-derived cytokines, such as IL-4 and IFN-γ"
                  }
                ],
                "APC-T Cell Cooperation": [
                  {
                    "text": "APC presents peptide+MHC to TCR"
                  },
                  {
                    "text": "Activated T cell then expresses CD152 (CTLA-4) and CD154 (CD 40L)"
                  },
                  {
                    "text": "Interactions are enhanced by the following APC/T cell molecules interactingCD80 and 86 (B7) interacting with CD28 on T cellCD54 (ICAM-1) interacting with CD11a/CD18 on T cellCD58 (LFA-3) interacting with CD2 on T cellLFA-1 interacting with CD50 (ICAM-3) on T cell",
                    "sub_points": [
                      "CD80 and 86 (B7) interacting with CD28 on T cell",
                      "CD54 (ICAM-1) interacting with CD11a/CD18 on T cell",
                      "CD58 (LFA-3) interacting with CD2 on T cell",
                      "LFA-1 interacting with CD50 (ICAM-3) on T cell"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Antigen Recognition Molecules": {
            "name": "Antigen Recognition Molecules",
            "url": "https://app.pathprimer.com/document/2574e4d6-64a5-48ae-b3eb-14b9d132a2b5/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "TCR is composed of αβTCR (clonally expressed), CD3 γε δε, ζζ; recognizes sequential antigenic peptides bound to MHC class I (CD8 T cells) or class II (CD4 T cells) molecules"
                  },
                  {
                    "text": "BCR is composed of 2 heavy chains (γ, μ, α, ε, or δ) and 2 light chains (κ or λ); recognizes three-dimensional or sequential determinants of free antigen"
                  },
                  {
                    "text": "MHC class I is composed of 1 α chain and 1 β₂m chain; presents endogenous antigens to CD8 cells"
                  },
                  {
                    "text": "MHC class II is composed of 1 α chain and 1 β chain; presents exogenous antigens to CD4 cells"
                  },
                  {
                    "text": "Ig superfamilyIg-fold domains (as a result of intrachain disulfide bonds) are seen in many proteins that are membrane boundIncludes Ig, TCR, BCR, MHC class I, MHC class II, CD4, CD8",
                    "sub_points": [
                      "Ig-fold domains (as a result of intrachain disulfide bonds) are seen in many proteins that are membrane bound",
                      "Includes Ig, TCR, BCR, MHC class I, MHC class II, CD4, CD8"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "T-cell receptor (TCR)"
                  },
                  {
                    "text": "Immunoreceptor tyrosine-based activation motif (ITAM)"
                  },
                  {
                    "text": "B-cell receptor (BCR)"
                  },
                  {
                    "text": "Major histocompatibility complex (MHC)"
                  },
                  {
                    "text": "Human leukocyte antigen (HLA)"
                  },
                  {
                    "text": "β₂-Microglobulin (β₂m)"
                  },
                  {
                    "text": "Immunoglobulin (Ig)"
                  },
                  {
                    "text": "Interferon-γ (IFN-γ)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "TCR": [
                  {
                    "text": "Composed of αβTCR (clonally expressed), CD3 γε, δε, ζζThis multimolecular complex is termed the TCR complexEach chain of CD3 complex contains 1 tyrosine-containing sequence, referred to as ITAM",
                    "sub_points": [
                      "This multimolecular complex is termed the TCR complex",
                      "Each chain of CD3 complex contains 1 tyrosine-containing sequence, referred to as ITAM"
                    ]
                  },
                  {
                    "text": "Recognizes sequential antigenic peptides bound to MHC class I (CD8 T cells) or class II (CD4 T cells) molecules"
                  },
                  {
                    "text": "Signal transduction occurs via CD3 complex via ITAM"
                  }
                ],
                "BCR": [
                  {
                    "text": "Composed of 2 heavy chains (γ, μ, α, ε, or δ) and 2 light chains (κ or λ)Each heavy and light chain is composed of constant region domain and variable region domain",
                    "sub_points": [
                      "Each heavy and light chain is composed of constant region domain and variable region domain"
                    ]
                  },
                  {
                    "text": "Antigen binding site composed of variable regions in heavy chain and light chain"
                  },
                  {
                    "text": "Biologic activity contained in Fc portion of heavy chains (i.e., complement fixation), crossing placenta, binding to Fc receptors on mast cells, eosinophils, basophils, macrophages, granulocytes, or other cells"
                  },
                  {
                    "text": "Recognize three-dimensional or sequential determinants of free antigen"
                  },
                  {
                    "text": "Have short cytoplasmic tail and do not transmit signal directly into cell"
                  },
                  {
                    "text": "Signal transduction via CD79a, CD79b (Igα/Igβ)"
                  }
                ],
                "MHC Class I (HLA-A, HLA-B, and HLA-C)": [
                  {
                    "text": "Composed of 1 α chain and 1 β₂m chainβ₂m has structure homology to single Ig domain",
                    "sub_points": [
                      "β₂m has structure homology to single Ig domain"
                    ]
                  },
                  {
                    "text": "Bind peptides that are 8-9 amino acids in length"
                  },
                  {
                    "text": "Have CD8 binding site in α₃ domain of α chain"
                  },
                  {
                    "text": "Peptide binding groove composed of parts of α₁ and α₂ domains"
                  },
                  {
                    "text": "Every MHC class I molecule can bind several different peptides but only 1 at a time"
                  },
                  {
                    "text": "Present endogenous antigens to CD8 cells"
                  },
                  {
                    "text": "On all nucleated cells"
                  }
                ],
                "MHC Class II (HLA-DP, HLA-DQ, and HLA-DR)": [
                  {
                    "text": "Composed of 1 α chain and 1 β chain"
                  },
                  {
                    "text": "Bind peptides that are 12-17 amino acids in length"
                  },
                  {
                    "text": "Have CD8 binding site in β₂ domain of β chain"
                  },
                  {
                    "text": "Peptide binding groove composed of N terminal parts of β₁ and α₁ domains"
                  },
                  {
                    "text": "Every MHC class II molecule can bind several different peptides but only 1 at a time"
                  },
                  {
                    "text": "Present exogenous antigens to CD4 cells"
                  },
                  {
                    "text": "On all antigen presenting cells (macrophages, dendritic cells, B cells, thymic epithelial cells) and induced on many cell types by IFN-γ"
                  }
                ],
                "Ig Superfamily": [
                  {
                    "text": "Ig-fold domains (as a result of intrachain disulfide bonds) seen in many proteins that are membrane boundClassified as members of Ig superfamily because of structural similarityFunctional and genetic analyses show Ig-fold domains have evolved independentlyFacilitate interactions between membrane proteinsCD4 with class II MHCCD8 with class I MHC",
                    "sub_points": [
                      "Classified as members of Ig superfamily because of structural similarity",
                      "Functional and genetic analyses show Ig-fold domains have evolved independently",
                      "Facilitate interactions between membrane proteinsCD4 with class II MHCCD8 with class I MHC",
                      "CD4 with class II MHC",
                      "CD8 with class I MHC"
                    ]
                  },
                  {
                    "text": "Representative members of Ig superfamilyIgTCR (αβTCR)CD3 γ, δ, εMHC class IMHC class IICD4 and CD8",
                    "sub_points": [
                      "Ig",
                      "TCR (αβTCR)",
                      "CD3 γ, δ, ε",
                      "MHC class I",
                      "MHC class II",
                      "CD4 and CD8"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Genetic Basis of Antibody Structure": {
            "name": "Genetic Basis of Antibody Structure",
            "url": "https://app.pathprimer.com/document/1a8df655-96b7-4be1-aaa4-07f4a7cc1cf3/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "B and T cells use unique recombination mechanism in which limited number of gene segments are combined in genome of developing lymphocyte"
                  },
                  {
                    "text": "Process mediated by enzyme complex (VDJ recombinase)Two components specifically expressed in lymphocytes﻿RAG-1RAG-2Required for cutting and joining DNA in developing lymphocytes",
                    "sub_points": [
                      "Two components specifically expressed in lymphocytes﻿RAG-1RAG-2",
                      "RAG-1",
                      "RAG-2",
                      "Required for cutting and joining DNA in developing lymphocytes"
                    ]
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "κ-Chain Synthesis (Located on Chromosome 2)": [
                  {
                    "text": "Germline DNA contains 40 different Vκ gene segments (arranged linearly and separated from each other by introns), 5 different Jκ segments (downstream of Vκ genes), and single Cκ gene (downstream from Jκ genes)"
                  },
                  {
                    "text": "Each Vκ gene can code for N-terminal 95 amino acids; Jκ genes can code for 13 amino acids"
                  },
                  {
                    "text": "Early in development, each B cell randomly selects one Vκ gene and physically joins it to one Jκ segmentMediated by V(D)J recombinase enzyme complex (RAG-1 and RAG-2), which fixes antigen recognition specificity of light chain",
                    "sub_points": [
                      "Mediated by V(D)J recombinase enzyme complex (RAG-1 and RAG-2), which fixes antigen recognition specificity of light chain"
                    ]
                  },
                  {
                    "text": "After DNA of developing B cell make this VJ rearrangement, primary RNA transcript is madePrimary transcript then spliced to give mature mRNA in which VκJκ and Cκ exons brought together and additional J exons removed",
                    "sub_points": [
                      "Primary transcript then spliced to give mature mRNA in which VκJκ and Cκ exons brought together and additional J exons removed"
                    ]
                  },
                  {
                    "text": "In endoplasmic reticulum, this mRNA then translated into complete κ-light chain"
                  }
                ],
                "λ-Chain Synthesis (Located on Chromosome 22)": [
                  {
                    "text": "Similar to κ-chain synthesis"
                  },
                  {
                    "text": "Occurs when rearrangement of κ loci unsuccessful"
                  }
                ],
                "Heavy-Chain Gene Rearrangement (Located on Chromosome 14)": [
                  {
                    "text": "Germline DNA contains 50 different VH gene segments, 25 different DH genes (diversity), 6 different JH genes, and 9 different CH genes (1 for each Ig class and subclass)"
                  },
                  {
                    "text": "Uses same mechanism for rearrangement described for light chainsV(D)J recombinase and RAG-1 and RAG-2 mediate cutting of DNA and joining different gene segments",
                    "sub_points": [
                      "V(D)J recombinase and RAG-1 and RAG-2 mediate cutting of DNA and joining different gene segments"
                    ]
                  },
                  {
                    "text": "First rearrangement is joining of one D gene with one J gene (DJ); second is rearrangement of one V gene to DJ unit, resulting in VDJThis fixes antigen recognition specificity of heavy chain",
                    "sub_points": [
                      "This fixes antigen recognition specificity of heavy chain"
                    ]
                  },
                  {
                    "text": "VDJ unit is transcribed with closest C-region gene Cμ, allowing immature B cell to express IgM on its surfaceOnce IgM is on surface, next step is for VDL unit to be transcribed with both the 2 closest CH-region genes, Cμ and CδPrimary transcript that contains both Cμ and Cδ RNA is spliced in 2 different ways (alternative splicing) to yield either VDJ-μ or VDJ-δNow a mature B cell with IgM and IgD on its surface",
                    "sub_points": [
                      "Once IgM is on surface, next step is for VDL unit to be transcribed with both the 2 closest CH-region genes, Cμ and Cδ",
                      "Primary transcript that contains both Cμ and Cδ RNA is spliced in 2 different ways (alternative splicing) to yield either VDJ-μ or VDJ-δNow a mature B cell with IgM and IgD on its surface",
                      "Now a mature B cell with IgM and IgD on its surface"
                    ]
                  }
                ],
                "Class Switching": [
                  {
                    "text": "When B cell is stimulated by antigen in presence of signal from T cell, it undergoes further rearrangement of its DNA"
                  },
                  {
                    "text": "Change in heavy chain occurs at switching regions preceding DNA for each Ig heavy chain"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Antibody Structure and Function": {
            "name": "Antibody Structure and Function",
            "url": "https://app.pathprimer.com/document/a878314f-93fb-4327-9401-cce9a6aecd42/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "IgG: Predominant immunoglobulin in blood, lymph fluid, cerebrospinal fluid, and peritoneal fluid"
                  },
                  {
                    "text": "IgM: Pentamer, consisting of 5 units of identical 4-chain structure: 2 H chains (μ chain, which has extra CH4 domain as compared to IgG) and 2 L chains (κ or λ), with MW of 900,000 Da, and sedimentation rate of 19S"
                  },
                  {
                    "text": "IgA: Major Ig found in secretions (saliva, mucus, tears, gastric fluids)"
                  },
                  {
                    "text": "IgD: Coexpressed on cell surface with IgM on mature B cells; functions (along with IgM) as B-cell antigen-specific BCR"
                  },
                  {
                    "text": "IgE: When antigen attaches to Fab portion of IgE that is attached to the high-affinity receptors on mast cells and basophils, cell is activated and releases granules containing histamine, heparin, leukotrienes"
                  }
                ]
              },
              "OVERVIEW": {
                "Humoral Immunity": [
                  {
                    "text": "B cells are initially activated to secrete antibodies after binding antigens to antigen-specific membrane immunoglobulin (B-cell receptor, BCR)"
                  },
                  {
                    "text": "Each B cell expresses approximately 100,000 BCRs of exactly the same specificity"
                  },
                  {
                    "text": "Once BCR is ligated, B cells receive signals to begin producing secreted form of immunoglobulin (Ig)"
                  },
                  {
                    "text": "Immunoglobulins have common structural features that enable them to(1) Recognize and bind to an epitope on an antigen(2) Perform a common biological function",
                    "sub_points": [
                      "(1) Recognize and bind to an epitope on an antigen",
                      "(2) Perform a common biological function"
                    ]
                  },
                  {
                    "text": "Ig consists of 2 identical light (L) chains and 2 identical heavy (H) chains, linked together by disulfide bondsRegion of molecule that binds antigen consists of area composed of amino-terminal (V) regions of both H and LBased on differences in H chain (γ, μ, α, δ, ε), there are 5 major classes (biological activity determined by amino acids in H chain) — IgG, IgM, IgA, IgD, IgE",
                    "sub_points": [
                      "Region of molecule that binds antigen consists of area composed of amino-terminal (V) regions of both H and L",
                      "Based on differences in H chain (γ, μ, α, δ, ε), there are 5 major classes (biological activity determined by amino acids in H chain) — IgG, IgM, IgA, IgD, IgE"
                    ]
                  },
                  {
                    "text": "Binding between antigen and antibody is not covalent and depends on several relatively weak forces (hydrogen bonds, van der Waals forces, hydrophobic interactions)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Structure and Function of IgG": [
                  {
                    "text": "Predominant immunoglobulin in blood, lymph fluid, cerebrospinal fluid, and peritoneal fluid"
                  },
                  {
                    "text": "Consists of 2 identical γ H chains (MW 50,000 Da) and 2 identical L chains, either κ or λ (MW 25,000 Da)Total MW of IgG is 150,000 Da with sedimentation coefficient of 7SLeast anodic of all serum proteins; migrates in γ range of serum globulins (thus termed γ-globulin)Contains 4 subclasses — IgG₁, IgG₂, IgG₃, IgG₄Except for variable region, a 90% homology exists in their amino acid sequences",
                    "sub_points": [
                      "Total MW of IgG is 150,000 Da with sedimentation coefficient of 7SLeast anodic of all serum proteins; migrates in γ range of serum globulins (thus termed γ-globulin)",
                      "Least anodic of all serum proteins; migrates in γ range of serum globulins (thus termed γ-globulin)",
                      "Contains 4 subclasses — IgG₁, IgG₂, IgG₃, IgG₄Except for variable region, a 90% homology exists in their amino acid sequences",
                      "Except for variable region, a 90% homology exists in their amino acid sequences"
                    ]
                  },
                  {
                    "text": "Half-life = 23 daysLongest half-life of all Ig isotypes",
                    "sub_points": [
                      "Longest half-life of all Ig isotypes"
                    ]
                  },
                  {
                    "text": "Agglutination and precipitationAgglutination of microorganisms and insoluble antigens allows them to be phagocytized and destroyed",
                    "sub_points": [
                      "Agglutination of microorganisms and insoluble antigens allows them to be phagocytized and destroyed"
                    ]
                  },
                  {
                    "text": "Placenta passage into neonates (all except IgG₂)Transfer is facilitated by expression of IgG protection receptor (FcRn), expressed on placental cells, that binds Fc portion of IgG; starts at 3rd or 4th month of pregnancy, and confers immunity to infection to fetus",
                    "sub_points": [
                      "Transfer is facilitated by expression of IgG protection receptor (FcRn), expressed on placental cells, that binds Fc portion of IgG; starts at 3rd or 4th month of pregnancy, and confers immunity to infection to fetus"
                    ]
                  },
                  {
                    "text": "Opsonization (i.e., \"to prepare for eating\"): Macrophages and PMN phagocytes bear receptors for Fc portion; they adhere to antibody-coated microorganism, leading to engulfment and destruction"
                  },
                  {
                    "text": "Antibody-dependent cell-mediated cytotoxicity (ADCC): Natural killer cells (sometimes called NK cells, large granular lymphocytes, or LGLs) have Fc receptors for IgG on their membrane and can target antibody-coated microorganisms or tumor cells for killing, destroying the target via toxic substances contained in their cytoplasmic granules (not by phagocytosis)"
                  },
                  {
                    "text": "Complement activation: Series of cascading enzymatic events leading to opsonization, phagocytosis, or lyses of antigen targeted by IgG"
                  },
                  {
                    "text": "Toxin neutralization: By blocking toxin-active sites, this can be used for passive immunization (venomous snake bites)"
                  },
                  {
                    "text": "Virus neutralization: Blocks viral attachment to target cells; blocks viral penetration and shedding"
                  }
                ],
                "Structure and Function of IgM": [
                  {
                    "text": "Pentamer consisting of 5 units of identical 4-chain structure: 2 H chains (μ, which has extra CH4 domain when compared to IgG) and 2 L chains (κ or λ)MW of 900,000 Da and sedimentation rate of 19S",
                    "sub_points": [
                      "MW of 900,000 Da and sedimentation rate of 19S"
                    ]
                  },
                  {
                    "text": "Pentameric structure is joined by polypeptide called the J chain"
                  },
                  {
                    "text": "Half-life = 5 days"
                  },
                  {
                    "text": "Agglutination: Excellent due to pentameric structure"
                  },
                  {
                    "text": "Complement activation: Excellent due to pentameric structure"
                  },
                  {
                    "text": "Responses against antigens that are polysaccharide in nature or have repetitive antigenic determinants: Excellent"
                  },
                  {
                    "text": "Isohemagglutinins: Naturally occurring antibodies against RBC antigens of ABO blood groups"
                  },
                  {
                    "text": "Does not cross placenta"
                  }
                ],
                "Structure and Function of IgA": [
                  {
                    "text": "Major Ig found in secretions (saliva, mucus, tears, gastric fluids)"
                  },
                  {
                    "text": "Two formsMonomeric in serumDimeric in secretions",
                    "sub_points": [
                      "Monomeric in serum",
                      "Dimeric in secretions"
                    ]
                  },
                  {
                    "text": "Consists of 2 identical α H chains (MW 60,000 Da) and 2 identical L chains (κ or λ) (MW 25,000 Da)Total MW of monomeric form: 160,000 DaTotal MW for dimeric secretory form: 400,000 DaTwo subclasses: IgA₁ (93%) and IgA₂ (7%)",
                    "sub_points": [
                      "Total MW of monomeric form: 160,000 Da",
                      "Total MW for dimeric secretory form: 400,000 Da",
                      "Two subclasses: IgA₁ (93%) and IgA₂ (7%)"
                    ]
                  },
                  {
                    "text": "Half-life = 5.5 days"
                  },
                  {
                    "text": "Secretory IgA contains J chain and S chain (secretory component)S chain produced in epithelial cells as a poly Ig receptor that binds IgA and transports it through cell into lumen; S component protects IgA from proteolytic cleavage",
                    "sub_points": [
                      "S chain produced in epithelial cells as a poly Ig receptor that binds IgA and transports it through cell into lumen; S component protects IgA from proteolytic cleavage"
                    ]
                  },
                  {
                    "text": "Does not cross placenta"
                  },
                  {
                    "text": "Agglutination: Good due to dimeric form"
                  },
                  {
                    "text": "Complement: Does not activate"
                  },
                  {
                    "text": "Protects via blocking attachment and penetration of epithelial cell"
                  },
                  {
                    "text": "Virus neutralization: Prevents virus from entering target cells"
                  }
                ],
                "Structure and Function of IgD": [
                  {
                    "text": "Coexpressed on cell surface with IgM on mature B cells"
                  },
                  {
                    "text": "Functions (along with IgM) as B-cell antigen-specific BCR"
                  },
                  {
                    "text": "Composed of 2 identical δ H chains (MW 55,000 Da) and 2 identical L chains (κ or λ) (MW 25,000 Da)"
                  },
                  {
                    "text": "Present as monomer with MW of 180,000 Da, primarily on B-cell surfaces; very low or trace amount in serum"
                  }
                ],
                "Structure and Function of IgE": [
                  {
                    "text": "Consists of 2 identical ε H chains, which have extra CH4 domain (like IgM) and 2 identical L chains (κ or λ)Total MW of 200,000 Da",
                    "sub_points": [
                      "Total MW of 200,000 Da"
                    ]
                  },
                  {
                    "text": "Lowest concentration of any Ig in serum (partly because CH4 domain binds to high-affinity Fcε receptors on mast cells and basophils)"
                  },
                  {
                    "text": "Once bound, they remain attached for weeks or months"
                  },
                  {
                    "text": "Half-life = 2 days"
                  },
                  {
                    "text": "Termed reaginic antibody"
                  },
                  {
                    "text": "When antigen attaches to Fab portion of IgE that is attached to the high-affinity receptors, cell is activated and releases granules containing histamine, heparin, leukotrienes"
                  },
                  {
                    "text": "No agglutinating or complement activation capability"
                  },
                  {
                    "text": "Role for protection against parasites via inflammatory response"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Biology of B Lymphocytes": {
            "name": "Biology of B Lymphocytes",
            "url": "https://app.pathprimer.com/document/13ace2ce-f819-4f6f-b90b-34b36ca80a9c/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "Pro-B cell (D to J rearrangement): Begin to express CD10 and CD19"
                  },
                  {
                    "text": "Pre-B cell (V-DJ rearrangement)"
                  },
                  {
                    "text": "Immature B cell: κ-chain rearrangement occurs first, but if unsuccessful λ-chain rearrangement occurs"
                  },
                  {
                    "text": "Immature B cell stops expressing CD10, continues to express CD19, and begins to express CD20"
                  },
                  {
                    "text": "Mature B cell expresses IgM and IgD with identical antigenic specificity (same V region heavy and light genes)"
                  },
                  {
                    "text": "Plasma cells synthesize and secrete Ig molecules after the interaction of their membrane Ig receptor with its specific antigen"
                  },
                  {
                    "text": "Memory B cells develop after stimulation with thymus-dependent antigens"
                  }
                ]
              },
              "OVERVIEW": {
                "Development of B Lymphocytes": [
                  {
                    "text": "Occurs in bone marrowNonlymphoid cells (stroma) secrete IL-7 that promotes survival and proliferation of cells early in B-cell lineage",
                    "sub_points": [
                      "Nonlymphoid cells (stroma) secrete IL-7 that promotes survival and proliferation of cells early in B-cell lineage"
                    ]
                  },
                  {
                    "text": "Key stages characterized by specific Ig gene rearrangements and expression of CD surface markers"
                  },
                  {
                    "text": "Certain developmental checkpoints occurPresence or absence of signals received determines which pathway the cell follows including cell death",
                    "sub_points": [
                      "Presence or absence of signals received determines which pathway the cell follows including cell death"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Interleukin (IL)"
                  },
                  {
                    "text": "Immunoglobulin (Ig)"
                  },
                  {
                    "text": "B-cell receptor (BCR)"
                  },
                  {
                    "text": "Bruton tyrosine kinase (BTK)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "First Ig Gene Rearrangements": [
                  {
                    "text": "Pro-B cell (D to J rearrangement)Earliest recognizable cell in B-cell lineageAt heavy chain locus, DH gene segment rearranges to JH gene segment resulting in DHJHMediated by V(D)J recombinaseBegins to express CD10 and CD19",
                    "sub_points": [
                      "Earliest recognizable cell in B-cell lineage",
                      "At heavy chain locus, DH gene segment rearranges to JH gene segment resulting in DHJHMediated by V(D)J recombinase",
                      "Mediated by V(D)J recombinase",
                      "Begins to express CD10 and CD19"
                    ]
                  },
                  {
                    "text": "Pre-B cell (V-DJ rearrangement)Second Ig heavy chain gene rearrangement mediated by V(D)J recombinaseHeavy chain VH gene segment joins to DHJH forming VDJ unitNo light chain rearrangement has occurredContinues to express CD10 and CD19Expresses pre-BCRConsists of μ chain and D179a plus CD179b and CD79a plus CD79bIf cell does not make pre-BCR, it dies by apoptosisBruton tyrosine kinase (BTK)Enzyme involved in intracellular signaling from pre-BCR required in transition of pre-B cell to immature B cell",
                    "sub_points": [
                      "Second Ig heavy chain gene rearrangement mediated by V(D)J recombinase",
                      "Heavy chain VH gene segment joins to DHJH forming VDJ unit",
                      "No light chain rearrangement has occurred",
                      "Continues to express CD10 and CD19",
                      "Expresses pre-BCRConsists of μ chain and D179a plus CD179b and CD79a plus CD79bIf cell does not make pre-BCR, it dies by apoptosisBruton tyrosine kinase (BTK)Enzyme involved in intracellular signaling from pre-BCR required in transition of pre-B cell to immature B cell",
                      "Consists of μ chain and D179a plus CD179b and CD79a plus CD79b",
                      "If cell does not make pre-BCR, it dies by apoptosis",
                      "Bruton tyrosine kinase (BTK)Enzyme involved in intracellular signaling from pre-BCR required in transition of pre-B cell to immature B cell",
                      "Enzyme involved in intracellular signaling from pre-BCR required in transition of pre-B cell to immature B cell"
                    ]
                  }
                ],
                "Light Chain Gene Rearrangement": [
                  {
                    "text": "Immature B cellSignaling through pre-BCR causes pre-B cell to proliferate and begin light chain gene rearrangementκ-Chain rearrangement occurs firstIf unsuccessful, λ-chain rearrangement occursIf no light chain product is formed, cell diesImmature B cell stops expressing CD10, continues to express CD19, and begins to express CD20Because rearrangement of Ig genes was a random event, immature B cells express IgM specific for foreign antigens and self-antigensIgM specific for foreign antigens leaves bone marrowIgM specific for self-antigens interacts with self-antigens in bone marrow and is deleted by apoptosis (negative selection)",
                    "sub_points": [
                      "Signaling through pre-BCR causes pre-B cell to proliferate and begin light chain gene rearrangement",
                      "κ-Chain rearrangement occurs firstIf unsuccessful, λ-chain rearrangement occurs",
                      "If unsuccessful, λ-chain rearrangement occurs",
                      "If no light chain product is formed, cell dies",
                      "Immature B cell stops expressing CD10, continues to express CD19, and begins to express CD20",
                      "Because rearrangement of Ig genes was a random event, immature B cells express IgM specific for foreign antigens and self-antigensIgM specific for foreign antigens leaves bone marrowIgM specific for self-antigens interacts with self-antigens in bone marrow and is deleted by apoptosis (negative selection)",
                      "IgM specific for foreign antigens leaves bone marrow",
                      "IgM specific for self-antigens interacts with self-antigens in bone marrow and is deleted by apoptosis (negative selection)"
                    ]
                  },
                  {
                    "text": "Mature B cellExpresses IgM and IgD with identical antigenic specificity (same V region heavy and light genes)Mature B cells are naive B cells and express both CD19 and CD20",
                    "sub_points": [
                      "Expresses IgM and IgD with identical antigenic specificity (same V region heavy and light genes)",
                      "Mature B cells are naive B cells and express both CD19 and CD20"
                    ]
                  },
                  {
                    "text": "Plasma cellsSynthesize and secrete Ig molecules after the interaction of their membrane Ig receptor with its specific antigenThymus-dependent antigens require T helper cells for synthesis of antibodyThymus-independent antigens (polysaccharides) do not require T helper cells for synthesis of antibodyTerminal differentiation stage of B cellsNo membrane form of IgExpress high levels of CD27 but no CD19 or CD20",
                    "sub_points": [
                      "Synthesize and secrete Ig molecules after the interaction of their membrane Ig receptor with its specific antigenThymus-dependent antigens require T helper cells for synthesis of antibodyThymus-independent antigens (polysaccharides) do not require T helper cells for synthesis of antibody",
                      "Thymus-dependent antigens require T helper cells for synthesis of antibody",
                      "Thymus-independent antigens (polysaccharides) do not require T helper cells for synthesis of antibody",
                      "Terminal differentiation stage of B cells",
                      "No membrane form of Ig",
                      "Express high levels of CD27 but no CD19 or CD20"
                    ]
                  },
                  {
                    "text": "Memory B cellsDevelop after stimulation with thymus-dependent antigensDo not express IgM or IgDExpress IgG, IgA, and IgEExpress CD27, CD19, and CD20Nonproliferating but respond rapidly to secondary antigenic stimulus",
                    "sub_points": [
                      "Develop after stimulation with thymus-dependent antigens",
                      "Do not express IgM or IgD",
                      "Express IgG, IgA, and IgE",
                      "Express CD27, CD19, and CD20",
                      "Nonproliferating but respond rapidly to secondary antigenic stimulus"
                    ]
                  }
                ]
              },
              "LABORATORY METHODS": {
                "Evaluation of B-Cell Components of Immune System": [
                  {
                    "text": "Serum IgG, IgM, IgA, IgE"
                  },
                  {
                    "text": "Measure specific antibody levels"
                  },
                  {
                    "text": "Flow cytometry CD10, CD19, CD20, CD27 and cell surface immunoglobulin"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Biology of T Lymphocytes": {
            "name": "Biology of T Lymphocytes",
            "url": "https://app.pathprimer.com/document/ae802945-ad6d-4e72-b77d-746c41511369/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "T cells express clonally distributed antigen-specific receptor generated in same manner as Ig molecules on B cells"
                  },
                  {
                    "text": "αβ TCR is expressed on most mature T cells: CD3 consists of 3 polypeptides, γ, δ, ε, which are expressed on the surface as 2 sets of molecules, γε and δε"
                  },
                  {
                    "text": "CoreceptorsCD4 and CD8 are on T-cell surface in close association with TCRCD4 binds to MHC class II and functions by producing cytokines; CD8 binds to MHC class I and functions by killing infected cells",
                    "sub_points": [
                      "CD4 and CD8 are on T-cell surface in close association with TCR",
                      "CD4 binds to MHC class II and functions by producing cytokines; CD8 binds to MHC class I and functions by killing infected cells"
                    ]
                  },
                  {
                    "text": "Genes coding for TCRα and γ chains are constructed from V and J gene segments similar to Ig light chainsβ and δ chains are constructed from V, D, and J segments similar to Ig heavy chains",
                    "sub_points": [
                      "α and γ chains are constructed from V and J gene segments similar to Ig light chains",
                      "β and δ chains are constructed from V, D, and J segments similar to Ig heavy chains"
                    ]
                  },
                  {
                    "text": "Thymic selection is 2-step process: Positive selection (thymic education) and negative selection (central tolerance)"
                  },
                  {
                    "text": "Characteristics of T cell leaving thymus: Single positive CD4 or CD8 cells, MHC restricted, self-tolerant"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "T-cell receptor (TCR)"
                  },
                  {
                    "text": "Immunoglobulin (Ig)"
                  },
                  {
                    "text": "Immunoreceptor tyrosine-based activation motif (ITAM)"
                  },
                  {
                    "text": "Major histocompatibility complex (MHC)"
                  },
                  {
                    "text": "Lymphocyte function-associated antigen (LFA)"
                  },
                  {
                    "text": "Intercellular adhesion molecule (ICAM)"
                  },
                  {
                    "text": "Antigen-presenting cell (APC)"
                  },
                  {
                    "text": "Cytomegalovirus (CMV)"
                  },
                  {
                    "text": "Interferon (IFN)"
                  },
                  {
                    "text": "Tumor necrosis factor (TNF)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Antigen-Specific TCR": [
                  {
                    "text": "T cells express clonally distributed antigen-specific receptor generated in same manner as Ig molecules on B cells"
                  },
                  {
                    "text": "αβ TCR expressed on most mature T cellsComprises 2 disulfide-linked polypeptide chains that span dell membraneα and β chains are glycoproteins with short cytoplasmic tailsConsist of variable (V) and constant (C) regions (analogous to regions in Ig molecules)Similarities between structures of TCR and Ig and organization of their genes suggest that TCR and Ig evolved from common ancestral geneTCR interacts with small linear peptides derived by degradation of proteins that are bound to MHC moleculesTCR is expressed on surface of T cells in close association with CD3 and 2 identical ζ chainsCD3 consists of 3 polypeptides, γ, δ, ε, which are expressed on the surface as 2 sets of molecules, γε and δεTCR and CD3 is called TCR complexEach chain of CD3 complex contains ITAMCoreceptorsCD4 and CD8 are on T-cell surface in close association with TCRCD4 binds to MHC class II and functions by producing cytokinesCD8 binds to MHC class I and functions by killing infected cells",
                    "sub_points": [
                      "Comprises 2 disulfide-linked polypeptide chains that span dell membrane",
                      "α and β chains are glycoproteins with short cytoplasmic tailsConsist of variable (V) and constant (C) regions (analogous to regions in Ig molecules)",
                      "Consist of variable (V) and constant (C) regions (analogous to regions in Ig molecules)",
                      "Similarities between structures of TCR and Ig and organization of their genes suggest that TCR and Ig evolved from common ancestral gene",
                      "TCR interacts with small linear peptides derived by degradation of proteins that are bound to MHC molecules",
                      "TCR is expressed on surface of T cells in close association with CD3 and 2 identical ζ chains",
                      "CD3 consists of 3 polypeptides, γ, δ, ε, which are expressed on the surface as 2 sets of molecules, γε and δεTCR and CD3 is called TCR complex",
                      "TCR and CD3 is called TCR complex",
                      "Each chain of CD3 complex contains ITAM",
                      "CoreceptorsCD4 and CD8 are on T-cell surface in close association with TCRCD4 binds to MHC class II and functions by producing cytokinesCD8 binds to MHC class I and functions by killing infected cells",
                      "CD4 and CD8 are on T-cell surface in close association with TCRCD4 binds to MHC class II and functions by producing cytokinesCD8 binds to MHC class I and functions by killing infected cells",
                      "CD4 binds to MHC class II and functions by producing cytokines",
                      "CD8 binds to MHC class I and functions by killing infected cells"
                    ]
                  },
                  {
                    "text": "Adhesion and homing moleculesCD2 binds to LFA-3 (CD58)LFA-1 (CD11a/CD18) binds to ICAM-1 (CD54) on endothelial cells and macrophages and dendritic cellsICAM-3 binds to LFA-1 on APC",
                    "sub_points": [
                      "CD2 binds to LFA-3 (CD58)",
                      "LFA-1 (CD11a/CD18) binds to ICAM-1 (CD54) on endothelial cells and macrophages and dendritic cells",
                      "ICAM-3 binds to LFA-1 on APC"
                    ]
                  },
                  {
                    "text": "γδ T cellsLack CD4 and CD8Found in mucosal epithelial sitesRespond rapidly to mycobacteria, CMV, andPlasmodium falciparumSynthesize IFN-α and TNF",
                    "sub_points": [
                      "Lack CD4 and CD8",
                      "Found in mucosal epithelial sites",
                      "Respond rapidly to mycobacteria, CMV, andPlasmodium falciparum",
                      "Synthesize IFN-α and TNF"
                    ]
                  }
                ],
                "Genes Coding for TCR": [
                  {
                    "text": "α and γ chains constructed from V and J gene segments similar to Ig light chains"
                  },
                  {
                    "text": "β and δ chains constructed from V, D, and J segments similar to Ig heavy chains"
                  },
                  {
                    "text": "β and γ loci are on different chromosomes"
                  },
                  {
                    "text": "α and δ loci are on the same chromosome"
                  },
                  {
                    "text": "There are many more Vα and Vβ genes (40-50) than Vγ and Vδ genes (5-10)"
                  },
                  {
                    "text": "Two different Cβ genes (Cβ₁ and Cβ₂)"
                  }
                ],
                "TCR Diversity": [
                  {
                    "text": "Mechanisms similar to mechanisms seen in B-cell Ig gene rearrangement"
                  },
                  {
                    "text": "Recombination activation genes (RAG1andRAG2) link up VJ and VDJ units"
                  }
                ],
                "T-Cell Differentiation in Thymus": [
                  {
                    "text": "Bone marrow-derived lymphoid precursor cells enter thymus at junction of cortex and medulla with TCR gene unrearranged (germline)"
                  },
                  {
                    "text": "RAG1andRAG2are expressed and TCR gene rearrangement begins simultaneously with β, δ, γ genesAt this time cells are double-negative (CD4⁻ and CD8⁻)",
                    "sub_points": [
                      "At this time cells are double-negative (CD4⁻ and CD8⁻)"
                    ]
                  },
                  {
                    "text": "Decision whether αβ or γδ is made at double-negative stage but is not fully understoodDouble-negative cells that are going to rearrange both γ and δ shut down β-gene rearrangement and express γδ TCRCells leave thymus as double-negative cells and form pool of pre-T cells found predominately in epithelial sites",
                    "sub_points": [
                      "Double-negative cells that are going to rearrange both γ and δ shut down β-gene rearrangement and express γδ TCR",
                      "Cells leave thymus as double-negative cells and form pool of pre-T cells found predominately in epithelial sites"
                    ]
                  },
                  {
                    "text": "Pre-T cellsDouble-negative cells that rearrange β-gene, then express it on the surface in close association with CD3, ζ, and pre-Tα (pre-TCR)Pre-Tα is invariant and not formed by gene rearrangementSignaling through pre-TCR upregulates expression of CD4 and CD8 and proliferation resulting in double-positive cells (CD4⁺CD8⁺)",
                    "sub_points": [
                      "Double-negative cells that rearrange β-gene, then express it on the surface in close association with CD3, ζ, and pre-Tα (pre-TCR)",
                      "Pre-Tα is invariant and not formed by gene rearrangement",
                      "Signaling through pre-TCR upregulates expression of CD4 and CD8 and proliferation resulting in double-positive cells (CD4⁺CD8⁺)"
                    ]
                  }
                ],
                "Thymic Selection": [
                  {
                    "text": "Two-step processPositive selection (thymic education)Double-positive pre-T cells interact with MHC class I and MHC class II containing peptide derived from self-moleculesDouble-positive pre-T cells that do not interact die by apoptosisResults in self-MHC restricted T cellsNegative selection (central tolerance)Double-negative pre-T cells that have high affinity to self-MHC are deleted by apoptosis (central tolerance)",
                    "sub_points": [
                      "Positive selection (thymic education)Double-positive pre-T cells interact with MHC class I and MHC class II containing peptide derived from self-moleculesDouble-positive pre-T cells that do not interact die by apoptosisResults in self-MHC restricted T cells",
                      "Double-positive pre-T cells interact with MHC class I and MHC class II containing peptide derived from self-molecules",
                      "Double-positive pre-T cells that do not interact die by apoptosisResults in self-MHC restricted T cells",
                      "Results in self-MHC restricted T cells",
                      "Negative selection (central tolerance)Double-negative pre-T cells that have high affinity to self-MHC are deleted by apoptosis (central tolerance)",
                      "Double-negative pre-T cells that have high affinity to self-MHC are deleted by apoptosis (central tolerance)"
                    ]
                  },
                  {
                    "text": "Thymocytes that have an affinity that is too low (positive selection) or too high (negative selection) for self-MHC do not survive thymic selection"
                  },
                  {
                    "text": "Characteristics of T cell leaving thymusSingle positive CD4 or CD8 cellsMHC restrictedSelf-tolerant",
                    "sub_points": [
                      "Single positive CD4 or CD8 cells",
                      "MHC restricted",
                      "Self-tolerant"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immunity to Bacteria": {
            "name": "Immunity to Bacteria",
            "url": "https://app.pathprimer.com/document/0c160a84-bb35-48b0-a8a2-dba34a5943b8/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "Antibacterial defenses include lysis, antibody, complement, opsonization, and phagocytosis"
                  },
                  {
                    "text": "Bacteria are internalized by APCs (macrophages, dendritic cells), processed, and presented to CD4 T cells via class II MHC"
                  },
                  {
                    "text": "Four classes of bacteria pathogens: (1) gram-positive, (2) gram-negative, (3) mycobacteria, (4) spirochetes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Antigen-presenting cells (APCs)"
                  },
                  {
                    "text": "Major histocompatibility complex (MHC)"
                  },
                  {
                    "text": "T-helper (TH)"
                  },
                  {
                    "text": "Lipopolysaccharide (LPS)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "General Considerations": [
                  {
                    "text": "Mechanisms of protection include humoral and cell-mediated immunity"
                  },
                  {
                    "text": "Immunity includes bacterial lysis, opsonization, phagocytosis"
                  },
                  {
                    "text": "Bacteria or their products are internalized by APCs, processed, and presented to CD4 cells in the context of MHC class II molecules"
                  },
                  {
                    "text": "Different immune mechanisms are used against bacteria depending on type of pathogenPolysaccharide capsuleIntracellularCellular immunity involving TH17 T cellsExtracellularHumoral immunity",
                    "sub_points": [
                      "Polysaccharide capsule",
                      "IntracellularCellular immunity involving TH17 T cells",
                      "Cellular immunity involving TH17 T cells",
                      "ExtracellularHumoral immunity",
                      "Humoral immunity"
                    ]
                  }
                ],
                "Gram-Positive Cell Wall": [
                  {
                    "text": "Teichoic acids are major antigenic determinants in gram-positive cell wall"
                  },
                  {
                    "text": "Thick cell wall makes bacteria resistant to lysis by complement system"
                  },
                  {
                    "text": "Specific antibody allows opsonization and phagocytosis"
                  },
                  {
                    "text": "Alternative complement pathway can be activated directly by gram-positive cell wall"
                  }
                ],
                "Gram-Negative Cell Wall": [
                  {
                    "text": "LPS is major antigenic determinant in gram-negative cell wall"
                  },
                  {
                    "text": "Alternative complement pathway can lyse some gram-negative bacteria directly after activation via LPS"
                  },
                  {
                    "text": "Thin cell wall makes bacteria sensitive to lysis by complement system"
                  },
                  {
                    "text": "Defense against gram-negative bacteria includes classical and alternative complement system, specific antibody, phagocytic cells"
                  }
                ],
                "Mycobacteria": [
                  {
                    "text": "Primary defense mechanisms are macrophages and cell-mediated immunity"
                  },
                  {
                    "text": "Strong humoral response, but protective role is limited (intracellular)"
                  }
                ],
                "Spirochetes": [
                  {
                    "text": "Thin outer membrane"
                  },
                  {
                    "text": "Effective defense mechanisms are complement, specific antibody, cell-mediated immunity"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immunity to Viruses": {
            "name": "Immunity to Viruses",
            "url": "https://app.pathprimer.com/document/d5c96245-5702-4147-8ca0-d92684c7d1ea/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "Innate immune mechanismsProduction of IFN-α by leukocytes, IFN-β by fibroblasts, and IFN-γ by T cells and NK cells",
                    "sub_points": [
                      "Production of IFN-α by leukocytes, IFN-β by fibroblasts, and IFN-γ by T cells and NK cells"
                    ]
                  },
                  {
                    "text": "Adaptive immune responsesHumoral immune responseCell-mediated immune response",
                    "sub_points": [
                      "Humoral immune response",
                      "Cell-mediated immune response"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Interferon (IFN)"
                  },
                  {
                    "text": "Natural killer (NK)"
                  },
                  {
                    "text": "Major histocompatibility complex (MHC)"
                  },
                  {
                    "text": "Antibody-dependent cell-mediated cytotoxicity (ADCC)"
                  },
                  {
                    "text": "Cytotoxic T lymphocytes (CTLs)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Innate Immune Mechanisms": [
                  {
                    "text": "Production of IFN-α by leukocytes, IFN-β by fibroblasts, and IFN-γ by T cells and NK cellsIFNs are antiviral proteins produced in response to viral infectionsActivate genes that interfere with viral replicationIFNs stimulate MHC class I molecules and proteasome proteins that enhance ability of virally infected cells to present viral peptides to T cellsIFN-α and IFN-β activate NK cells that recognize and kill host cells infected with virusesNK cells provide early cellular defense against virus without need for prior sensitizationComplement system proteins damage the envelope of some viruses",
                    "sub_points": [
                      "IFNs are antiviral proteins produced in response to viral infectionsActivate genes that interfere with viral replication",
                      "Activate genes that interfere with viral replication",
                      "IFNs stimulate MHC class I molecules and proteasome proteins that enhance ability of virally infected cells to present viral peptides to T cells",
                      "IFN-α and IFN-β activate NK cells that recognize and kill host cells infected with viruses",
                      "NK cells provide early cellular defense against virus without need for prior sensitization",
                      "Complement system proteins damage the envelope of some viruses"
                    ]
                  }
                ],
                "Adaptive Immune Responses": [
                  {
                    "text": "Humoral immune responseNeutralizing antibodies impede infectivity of viruses for susceptible host cellsFix complement and promote complement damage to virionsInhibit viral enzymesPromote opsonization of viral particlesPromote ADCC by NK cells",
                    "sub_points": [
                      "Neutralizing antibodies impede infectivity of viruses for susceptible host cells",
                      "Fix complement and promote complement damage to virions",
                      "Inhibit viral enzymes",
                      "Promote opsonization of viral particles",
                      "Promote ADCC by NK cells"
                    ]
                  },
                  {
                    "text": "Cell-mediated immune responseCD4 cells are involved in production of effector antibody response and isotype class switchingCD4 cells produce cytokines that stimulate inflammatory responses at site of infection and activate macrophagesCD8 CTLs are principal effector T cells against virusesCD8 CTLs recognize viral antigens in the context of MHC class I and can kill virally infected host cells",
                    "sub_points": [
                      "CD4 cells are involved in production of effector antibody response and isotype class switching",
                      "CD4 cells produce cytokines that stimulate inflammatory responses at site of infection and activate macrophages",
                      "CD8 CTLs are principal effector T cells against viruses",
                      "CD8 CTLs recognize viral antigens in the context of MHC class I and can kill virally infected host cells"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immunity to Parasites": {
            "name": "Immunity to Parasites",
            "url": "https://app.pathprimer.com/document/2b58b313-8c1c-4f75-be46-38b5d7d7135c/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "TH2 cells dominate adaptive immune response"
                  },
                  {
                    "text": "TH2 produce IL-4, IL-5, IL-9, and IL-13 in response to parasites"
                  }
                ],
                "Biologic Concepts": [
                  {
                    "text": "Innate mechanisms involve complement combined with phagocytosis by neutrophils and macrophages"
                  },
                  {
                    "text": "Humoral immunity mediates protection for amebiasis, malaria, and trypanosomiasis"
                  },
                  {
                    "text": "Cellular immunity is important for leishmaniasis and toxoplasmosis"
                  },
                  {
                    "text": "Eosinophils and mast cells are primary effector cells"
                  },
                  {
                    "text": "IgE antibodies are used by eosinophils in ADCC killing of helminths"
                  },
                  {
                    "text": "Vaccines are currently unavailable"
                  }
                ]
              },
              "OVERVIEW": {
                "General Considerations in Immunity to Parasites": [
                  {
                    "text": "Diverse group of pathogens that includes helminths and protozoa"
                  },
                  {
                    "text": "Variety of tissue stages that include many different cellular locations and antigenic composition"
                  },
                  {
                    "text": "Innate and adaptive mechanisms involved in protection"
                  },
                  {
                    "text": "TH2 cells dominate adaptive immune response"
                  },
                  {
                    "text": "TH2 produce IL-4, IL-5, IL-9, IL-13 in response to parasites"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "T-helper (TH)"
                  },
                  {
                    "text": "Interleukin (IL)"
                  },
                  {
                    "text": "Antibody-dependent cell-mediated cytotoxicity (ADCC)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Protozoa": [
                  {
                    "text": "Exist as metabolically active trophozoite or dormant cyst"
                  },
                  {
                    "text": "Some active complement system through alternative pathway"
                  },
                  {
                    "text": "Innate mechanisms involve complement combined with phagocytosis by neutrophils and macrophages"
                  },
                  {
                    "text": "Humoral immunity mediates protection for amebiasis, malaria, trypanosomiasis"
                  },
                  {
                    "text": "Cellular immunity important for leishmaniasis and toxoplasmosis"
                  },
                  {
                    "text": "Vaccines currently unavailable"
                  }
                ],
                "Helminths": [
                  {
                    "text": "Large macroscopic pathogens"
                  },
                  {
                    "text": "Size an issue for effective innate and adaptive responses"
                  },
                  {
                    "text": "Cause chronic infections"
                  },
                  {
                    "text": "Eosinophils and mast cells are primary effector cells"
                  },
                  {
                    "text": "IgE-specific helminth antigens elicit strong humoral response"
                  },
                  {
                    "text": "IgE antibodies used by eosinophils in ADCC killing of helminths"
                  },
                  {
                    "text": "Vaccines currently unavailable"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immunity to Fungi": {
            "name": "Immunity to Fungi",
            "url": "https://app.pathprimer.com/document/efd2e545-4c75-4875-9ae0-fe7631fb9d9f/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "Serious infections in individuals with impaired immune system"
                  },
                  {
                    "text": "Candida albicansis most common fungal infection"
                  },
                  {
                    "text": "TH17 lineage CD4 cells are important in host defense to fungi that are intracellular pathogens"
                  }
                ]
              },
              "OVERVIEW": {
                "General Considerations in Immunity to Fungi": [
                  {
                    "text": "Serious infections in individuals with impaired immune system"
                  },
                  {
                    "text": "Candida albicansis most common fungal infectionMost cases require a break in skin or depletion of neutrophils (chemotherapy)MucosalCandidainfections occur in immunocompromised patients",
                    "sub_points": [
                      "Most cases require a break in skin or depletion of neutrophils (chemotherapy)",
                      "MucosalCandidainfections occur in immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Cell wall is composed of cross-linked polysaccharides, making fungi resistant to complement lysis"
                  },
                  {
                    "text": "TH17 lineage CD4 cells are important in host defense to fungi that are intracellular pathogens"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "T-helper (TH)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Transplantation": {
            "name": "Transplantation",
            "url": "https://app.pathprimer.com/document/0665091e-933e-4907-a940-a1454612b311/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "Host-vs.-graft disease: Immunocompetent host rejects graft"
                  },
                  {
                    "text": "GVHD: Immunocompetent T cells within graft reject immunocompromised host"
                  },
                  {
                    "text": "Diagnosis: Elevated CRP, ESR, WBC count; elevated bilirubin, transaminases, alkaline phosphatase; presence of opportunistic infection"
                  },
                  {
                    "text": "Goal of BMTReconstitution of recipient's BM after myeloablation of recipient's BMReconstitution of recipient's BM because of primary immunodeficiency disease",
                    "sub_points": [
                      "Reconstitution of recipient's BM after myeloablation of recipient's BM",
                      "Reconstitution of recipient's BM because of primary immunodeficiency disease"
                    ]
                  },
                  {
                    "text": "Non-antigen-specific immunosuppression: Cytotoxic drugs, folic acid analogues, vinca alkaloids, corticosteroids, cyclosporine, sirolimus (Rapamune, rapamycin)"
                  },
                  {
                    "text": "Antigen-specific immunosuppression: Induction of antigen-specific tolerance by infusion of donor cells before transplant, ATG, anti-CD3, experimental anti-CD4"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Graft-vs.-host disease (GVHD)"
                  },
                  {
                    "text": "C-reactive protein (CRP)"
                  },
                  {
                    "text": "Erythrocyte sedimentation rate (ESR)"
                  },
                  {
                    "text": "White blood cell (BC)"
                  },
                  {
                    "text": "Bone marrow transplantation (BMT)"
                  },
                  {
                    "text": "Bone marrow (BM)"
                  },
                  {
                    "text": "Red blood cell (RBC)"
                  },
                  {
                    "text": "Human leukocyte antigen (HLA)"
                  },
                  {
                    "text": "Interleukin (IL)"
                  },
                  {
                    "text": "Antithymocyte globulin (ATG)"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Graft Rejection": [
                  {
                    "text": "Host-vs.-graft diseaseImmunocompetent host rejects graft",
                    "sub_points": [
                      "Immunocompetent host rejects graft"
                    ]
                  },
                  {
                    "text": "GVHDImmunocompetent T cells within graft reject immunocompromised host",
                    "sub_points": [
                      "Immunocompetent T cells within graft reject immunocompromised host"
                    ]
                  },
                  {
                    "text": "DiagnosisElevated CRP, ESR, WBC countElevated bilirubin, transaminases, alkaline phosphatasePresence of opportunistic infection",
                    "sub_points": [
                      "Elevated CRP, ESR, WBC count",
                      "Elevated bilirubin, transaminases, alkaline phosphatase",
                      "Presence of opportunistic infection"
                    ]
                  }
                ],
                "Bone Marrow Transplantation": [
                  {
                    "text": "Goal of BMTReconstitution of recipient's BM after myeloablation of recipient's BMReconstitution of recipient's BM because of primary immunodeficiency disease",
                    "sub_points": [
                      "Reconstitution of recipient's BM after myeloablation of recipient's BM",
                      "Reconstitution of recipient's BM because of primary immunodeficiency disease"
                    ]
                  },
                  {
                    "text": "Conditions treated with BMTLeukemiasMyelodysplastic/proliferative disordersLymphoproliferative disordersCancersPhagocytic disordersImmunodeficienciesInherited RBC disorders",
                    "sub_points": [
                      "Leukemias",
                      "Myelodysplastic/proliferative disorders",
                      "Lymphoproliferative disorders",
                      "Cancers",
                      "Phagocytic disorders",
                      "Immunodeficiencies",
                      "Inherited RBC disorders"
                    ]
                  },
                  {
                    "text": "Stem cells (CD34+) harvested from BM or peripheral blood"
                  },
                  {
                    "text": "High-resolution HLA typing required to match donor and recipientAutologous transplant often used",
                    "sub_points": [
                      "Autologous transplant often used"
                    ]
                  },
                  {
                    "text": "Indicators of engraftment (usually 2-4 weeks)Neutrophil counts > 0.5 x 10⁹/L for 3 successive daysPlatelet count 20 x 10⁹/L maintained without transfusion",
                    "sub_points": [
                      "Neutrophil counts > 0.5 x 10⁹/L for 3 successive days",
                      "Platelet count 20 x 10⁹/L maintained without transfusion"
                    ]
                  }
                ],
                "Transplantation Immunosuppression": [
                  {
                    "text": "Non-antigen-specific drugsCytotoxic drugsTarget actively proliferating cellsAlkylating agents: cyclophosphamidePyrimidine/purine analogues: Azathioprine, 6-mercaptopurine, 6-thioguanine, 5-fluorouracil, cytosine arabinosideFolic acid analogues: Methotrexate, aminopterinVinca alkaloidsMetaphase arrestVincristine, vinblastineCorticosteroidsInhibit antigen-driven T-cell proliferations via inhibition of IL-1 production leading to lack of IL-2 production by T cellsCyclosporineBlocks calcineurin, required for IL-2Tacrolimus (FK506)Directly inhibits IL-2 production by T cellsSirolimus (Rapamune, rapamycin)Inhibits production of IL-2, IL-4, IL-15",
                    "sub_points": [
                      "Cytotoxic drugsTarget actively proliferating cellsAlkylating agents: cyclophosphamidePyrimidine/purine analogues: Azathioprine, 6-mercaptopurine, 6-thioguanine, 5-fluorouracil, cytosine arabinoside",
                      "Target actively proliferating cells",
                      "Alkylating agents: cyclophosphamide",
                      "Pyrimidine/purine analogues: Azathioprine, 6-mercaptopurine, 6-thioguanine, 5-fluorouracil, cytosine arabinoside",
                      "Folic acid analogues: Methotrexate, aminopterin",
                      "Vinca alkaloidsMetaphase arrestVincristine, vinblastine",
                      "Metaphase arrest",
                      "Vincristine, vinblastine",
                      "CorticosteroidsInhibit antigen-driven T-cell proliferations via inhibition of IL-1 production leading to lack of IL-2 production by T cells",
                      "Inhibit antigen-driven T-cell proliferations via inhibition of IL-1 production leading to lack of IL-2 production by T cells",
                      "CyclosporineBlocks calcineurin, required for IL-2",
                      "Blocks calcineurin, required for IL-2",
                      "Tacrolimus (FK506)Directly inhibits IL-2 production by T cells",
                      "Directly inhibits IL-2 production by T cells",
                      "Sirolimus (Rapamune, rapamycin)Inhibits production of IL-2, IL-4, IL-15",
                      "Inhibits production of IL-2, IL-4, IL-15"
                    ]
                  },
                  {
                    "text": "Antigen-specific immunosuppressionInduction of antigen-specific tolerance by infusion of donor cells before transplantATGPolyclonal antiseraAnti-CD3Humanized mouse anti-CD3Results in CD3 T-cell depletionExperimental anti-CD4Humanized mouse anti-CD4Results in CD4 T-cell depletion",
                    "sub_points": [
                      "Induction of antigen-specific tolerance by infusion of donor cells before transplant",
                      "ATGPolyclonal antisera",
                      "Polyclonal antisera",
                      "Anti-CD3Humanized mouse anti-CD3Results in CD3 T-cell depletion",
                      "Humanized mouse anti-CD3",
                      "Results in CD3 T-cell depletion",
                      "Experimental anti-CD4Humanized mouse anti-CD4Results in CD4 T-cell depletion",
                      "Humanized mouse anti-CD4",
                      "Results in CD4 T-cell depletion"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Allograft Rejection": {
            "name": "Allograft Rejection",
            "url": "https://app.pathprimer.com/document/7b885e4c-8036-42ca-bba2-bc01b4c9955e/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "Types of rejectionHyperacute: Preformed antibodies to MHC antigens; occurs within minutes or hours of transplantAcute: Antibody mediated; occurs 3 months after transplantTreated with B-cell directed drugs (e.g., Rituxan)Acute: Cellular mediated; occurs 1-6 weeks to several years after transplantTreated with immunosuppressive therapy (e.g., cyclosporine)Chronic: Caused by both antibody responses and cellular responses",
                    "sub_points": [
                      "Hyperacute: Preformed antibodies to MHC antigens; occurs within minutes or hours of transplant",
                      "Acute: Antibody mediated; occurs 3 months after transplantTreated with B-cell directed drugs (e.g., Rituxan)",
                      "Treated with B-cell directed drugs (e.g., Rituxan)",
                      "Acute: Cellular mediated; occurs 1-6 weeks to several years after transplantTreated with immunosuppressive therapy (e.g., cyclosporine)",
                      "Treated with immunosuppressive therapy (e.g., cyclosporine)",
                      "Chronic: Caused by both antibody responses and cellular responses"
                    ]
                  },
                  {
                    "text": "MHC = good target for T-cell graft rejectionT cells are self MHC restrictedTCRs were educated to see MHC molecules because of structural similarities in self MHC and nonself MHC moleculesThey bind nonself MHC molecules well and become activatedForeign MHC can activate up to 5% of all T cells",
                    "sub_points": [
                      "T cells are self MHC restricted",
                      "TCRs were educated to see MHC molecules because of structural similarities in self MHC and nonself MHC molecules",
                      "They bind nonself MHC molecules well and become activated",
                      "Foreign MHC can activate up to 5% of all T cells"
                    ]
                  },
                  {
                    "text": "CD4 cytokines produced in response to allograftsIL-2 leads to T-cell proliferation and differentiation of CD8 cells and TH1IFN-γ activate macrophages that infiltrate graftTNF-β is cytotoxic to cells in graftIn graft, IFN-α, IFN-β, TNF-α, and TNF-β increase expression of class I, and INF-γ increases expression of class II, thereby increasing effectiveness of antigen recognition and leading to graft rejection",
                    "sub_points": [
                      "IL-2 leads to T-cell proliferation and differentiation of CD8 cells and TH1",
                      "IFN-γ activate macrophages that infiltrate graft",
                      "TNF-β is cytotoxic to cells in graft",
                      "In graft, IFN-α, IFN-β, TNF-α, and TNF-β increase expression of class I, and INF-γ increases expression of class II, thereby increasing effectiveness of antigen recognition and leading to graft rejection"
                    ]
                  }
                ]
              },
              "OVERVIEW": {
                "Hyperacute": [
                  {
                    "text": "Preformed antibodies to MHC antigensOccurs within minutes or hours of transplantArise from previous transplant, blood transfusion, pregnancyAntibodies are cytotoxic and activate complement cascade, followed by platelet activationThrombosis and fibrinoid necrosis result in rejection",
                    "sub_points": [
                      "Occurs within minutes or hours of transplantArise from previous transplant, blood transfusion, pregnancyAntibodies are cytotoxic and activate complement cascade, followed by platelet activationThrombosis and fibrinoid necrosis result in rejection",
                      "Arise from previous transplant, blood transfusion, pregnancy",
                      "Antibodies are cytotoxic and activate complement cascade, followed by platelet activation",
                      "Thrombosis and fibrinoid necrosis result in rejection"
                    ]
                  }
                ],
                "Acute": [
                  {
                    "text": "Antibody mediatedOccurs 3 months after transplantDonor-specific antibody is detected, and complement system is activatedTreated with B-cell directed drugs (e.g., Rituxan)",
                    "sub_points": [
                      "Occurs 3 months after transplantDonor-specific antibody is detected, and complement system is activated",
                      "Donor-specific antibody is detected, and complement system is activated",
                      "Treated with B-cell directed drugs (e.g., Rituxan)"
                    ]
                  },
                  {
                    "text": "Cellular mediatedOccurs 1-6 weeks to several years after transplantIntense infiltration of lymphocytes and macrophages into graftTreated with immunosuppressive therapy (e.g., cyclosporine)",
                    "sub_points": [
                      "Occurs 1-6 weeks to several years after transplantIntense infiltration of lymphocytes and macrophages into graft",
                      "Intense infiltration of lymphocytes and macrophages into graft",
                      "Treated with immunosuppressive therapy (e.g., cyclosporine)"
                    ]
                  }
                ],
                "Chronic": [
                  {
                    "text": "Occurs months or years after organ has been functioning normallyCaused by both antibody responses and cellular responsesMicrovascular inflammatory responses occur",
                    "sub_points": [
                      "Caused by both antibody responses and cellular responses",
                      "Microvascular inflammatory responses occur"
                    ]
                  }
                ],
                "Major Histocompatibility Molecules": [
                  {
                    "text": "Prime target for T cellsT cells are self-MHC-restrictedT cell antigen receptors (TCRs) were educated to see MHC molecules because of structural similarities in self MHC molecules and nonself MHC moleculesThey bind nonself MHC molecules well and become activatedForeign MHC can activate up to 5% of all T cellsMHC class I are on all nucleated cells",
                    "sub_points": [
                      "T cells are self-MHC-restrictedT cell antigen receptors (TCRs) were educated to see MHC molecules because of structural similarities in self MHC molecules and nonself MHC moleculesThey bind nonself MHC molecules well and become activatedForeign MHC can activate up to 5% of all T cells",
                      "T cell antigen receptors (TCRs) were educated to see MHC molecules because of structural similarities in self MHC molecules and nonself MHC molecules",
                      "They bind nonself MHC molecules well and become activated",
                      "Foreign MHC can activate up to 5% of all T cells",
                      "MHC class I are on all nucleated cells"
                    ]
                  }
                ],
                "T-Cell Allograft Recognition": [
                  {
                    "text": "DirectForeign cells have their own MHC peptide on membrane, and host TCR is fooled into recognizing this foreign peptide bound to foreign MHC",
                    "sub_points": [
                      "Foreign cells have their own MHC peptide on membrane, and host TCR is fooled into recognizing this foreign peptide bound to foreign MHC"
                    ]
                  },
                  {
                    "text": "IndirectHost antigen-presenting cells (APCs) process alloantigens of donor and present these alloantigen peptides on host MHC molecules (this is how minor H antigens are presented)",
                    "sub_points": [
                      "Host antigen-presenting cells (APCs) process alloantigens of donor and present these alloantigen peptides on host MHC molecules (this is how minor H antigens are presented)"
                    ]
                  }
                ],
                "Cytokines Produced by T Cells in Response to Allograft Recognition": [
                  {
                    "text": "CD4IL-2, IFN-α, IFN-β, IFN-γ, TNF-α, TNF-βIL-2 leads to T-cell proliferation and differentiation of CD8 cells and TH1IFN-γ activate macrophages that infiltrate graftTNF-β is cytotoxic to cells in graftIn graft, IFN-α, IFN-β, TNF-α, and TNF-β increase expression of class I, and INF-γ increases expression of class II, thereby increasing effectiveness of antigen recognition and leading to graft rejection",
                    "sub_points": [
                      "IL-2, IFN-α, IFN-β, IFN-γ, TNF-α, TNF-β",
                      "IL-2 leads to T-cell proliferation and differentiation of CD8 cells and TH1",
                      "IFN-γ activate macrophages that infiltrate graft",
                      "TNF-β is cytotoxic to cells in graft",
                      "In graft, IFN-α, IFN-β, TNF-α, and TNF-β increase expression of class I, and INF-γ increases expression of class II, thereby increasing effectiveness of antigen recognition and leading to graft rejection"
                    ]
                  }
                ]
              },
              "LABORATORY METHODS": {
                "Tissue Typing": [
                  {
                    "text": "Complement-dependent cytotoxicity (CDC)Uses panel of anti-HLA antibodies obtained from women with limited number of pregnancies; monoclonal antibodies can be usedDonor cells are mixed with antisera plus complement, followed by addition of vital dyeIf cells have HLA antigens to which antisera are directed, cells are killed",
                    "sub_points": [
                      "Uses panel of anti-HLA antibodies obtained from women with limited number of pregnancies; monoclonal antibodies can be used",
                      "Donor cells are mixed with antisera plus complement, followed by addition of vital dyeIf cells have HLA antigens to which antisera are directed, cells are killed",
                      "If cells have HLA antigens to which antisera are directed, cells are killed"
                    ]
                  },
                  {
                    "text": "Cross matchingIf recipient has been presensitized against donor HLA antigens, donor cells are killed and transplant is not performed",
                    "sub_points": [
                      "If recipient has been presensitized against donor HLA antigens, donor cells are killed and transplant is not performed"
                    ]
                  },
                  {
                    "text": "Panel typing for preformed antibodyRecipient sera collected over period of time are evaluated in CDC test against panel of cells having wide range of HLA typesCan determine the HLA types against which recipient has preformed antibodies",
                    "sub_points": [
                      "Recipient sera collected over period of time are evaluated in CDC test against panel of cells having wide range of HLA types",
                      "Can determine the HLA types against which recipient has preformed antibodies"
                    ]
                  },
                  {
                    "text": "Molecular typing using PCR for high-resolution sequencing is necessary for bone marrow transplant"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Alternative Pathway of Complement": {
            "name": "Alternative Pathway of Complement",
            "url": "https://app.pathprimer.com/document/4f4f5936-6627-4f36-bd1b-fda6ff0a3cf4/lesson/fef11366-b277-4d2c-a7af-d886c8bd2b4e",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "Alternative pathway: Activated when complement component C3b deposits on surface of pathogen; plays key part of innate immune defenses because it does not need antibody for activationC3b is normally always in circulation in small amounts due to spontaneous cleavage of reactive thiol group in C3; therefore, alternative pathway is always on",
                    "sub_points": [
                      "C3b is normally always in circulation in small amounts due to spontaneous cleavage of reactive thiol group in C3; therefore, alternative pathway is always on"
                    ]
                  },
                  {
                    "text": "Three pathways of complement activation: Classical, lectin, and alternativeAll pathways converge at cleavage of complement component C3",
                    "sub_points": [
                      "All pathways converge at cleavage of complement component C3"
                    ]
                  },
                  {
                    "text": "Activators: Lipopolysaccharides, yeast cell walls, snake venom, viruses, aggregated immunoglobulins, necrotic cells"
                  },
                  {
                    "text": "Early stepsDeposition of C3b on cell surfacesC3bBb is alternative pathway C3 convertase, which cleaves C3 into C3a and C3b",
                    "sub_points": [
                      "Deposition of C3b on cell surfaces",
                      "C3bBb is alternative pathway C3 convertase, which cleaves C3 into C3a and C3b"
                    ]
                  },
                  {
                    "text": "Activation of C3 and C5 (shared by all 3 pathways)C3bBb cleaves C3 into C3a and C3b; C3a is released into fluid and C3b binds to cell surface to continue the cascadeC5 then binds and is cleaved into C5a and C5b; C5a is released into fluid and C5b binds to cell surface",
                    "sub_points": [
                      "C3bBb cleaves C3 into C3a and C3b; C3a is released into fluid and C3b binds to cell surface to continue the cascade",
                      "C5 then binds and is cleaved into C5a and C5b; C5a is released into fluid and C5b binds to cell surface"
                    ]
                  },
                  {
                    "text": "Terminal pathwayC5b, C6, C7, C8, and C9 are common to all 3 pathways",
                    "sub_points": [
                      "C5b, C6, C7, C8, and C9 are common to all 3 pathways"
                    ]
                  },
                  {
                    "text": "Regulation of alternative pathwayComplement receptor 1 (CR1, CD35), decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46)Factor H",
                    "sub_points": [
                      "Complement receptor 1 (CR1, CD35), decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46)",
                      "Factor H"
                    ]
                  }
                ]
              },
              "OVERVIEW": {
                "Pathways of Complement Activation": [
                  {
                    "text": "Three pathways1) Classical pathwayActivated when complement component C1 binds to antibody-antigen complex2) Lectin pathwayActivated when mannan-binding lectin (MBL) binds to terminal polysaccharide residues on surface of gram-positive and gram-negative bacteria, fungi, or yeast3) Alternative pathwayActivated when complement component C3b deposits on surface of pathogen",
                    "sub_points": [
                      "1) Classical pathwayActivated when complement component C1 binds to antibody-antigen complex",
                      "Activated when complement component C1 binds to antibody-antigen complex",
                      "2) Lectin pathwayActivated when mannan-binding lectin (MBL) binds to terminal polysaccharide residues on surface of gram-positive and gram-negative bacteria, fungi, or yeast",
                      "Activated when mannan-binding lectin (MBL) binds to terminal polysaccharide residues on surface of gram-positive and gram-negative bacteria, fungi, or yeast",
                      "3) Alternative pathwayActivated when complement component C3b deposits on surface of pathogen",
                      "Activated when complement component C3b deposits on surface of pathogen"
                    ]
                  },
                  {
                    "text": "Pathways converge at cleavage of complement component C3"
                  }
                ],
                "Alternative Pathway": [
                  {
                    "text": "ActivatorsAlmost any foreign substanceLipopolysaccharidesYeast cell wallsSnake venomVirusesAggregated immunoglobulinsNecrotic cells",
                    "sub_points": [
                      "Almost any foreign substanceLipopolysaccharidesYeast cell wallsSnake venomVirusesAggregated immunoglobulinsNecrotic cells",
                      "Lipopolysaccharides",
                      "Yeast cell walls",
                      "Snake venom",
                      "Viruses",
                      "Aggregated immunoglobulins",
                      "Necrotic cells"
                    ]
                  },
                  {
                    "text": "Plays key part of innate immune defenses because it does not need antibody for activation"
                  },
                  {
                    "text": "Early stepsDeposition of C3b on cell surfacesC3b is normally always in circulation in small amounts due to spontaneous cleavage of reactive thiol group in C3Alternative pathway is always onThis preformed C3b binds to proteins and carbohydrates on cell surface of pathogensUnbound C3b has short half-lifeFactor B combines with C3b on cell surface to form C3bB complexFactor D then cleaves factor B in the C3bB complex to form fragments Ba and BbBa is released into fluidBb remains attached to C3bC3bBb is alternative pathway C3 convertase, which cleaves C3 into C3a and C3b",
                    "sub_points": [
                      "Deposition of C3b on cell surfacesC3b is normally always in circulation in small amounts due to spontaneous cleavage of reactive thiol group in C3Alternative pathway is always on",
                      "C3b is normally always in circulation in small amounts due to spontaneous cleavage of reactive thiol group in C3",
                      "Alternative pathway is always on",
                      "This preformed C3b binds to proteins and carbohydrates on cell surface of pathogens",
                      "Unbound C3b has short half-life",
                      "Factor B combines with C3b on cell surface to form C3bB complex",
                      "Factor D then cleaves factor B in the C3bB complex to form fragments Ba and BbBa is released into fluidBb remains attached to C3b",
                      "Ba is released into fluid",
                      "Bb remains attached to C3b",
                      "C3bBb is alternative pathway C3 convertase, which cleaves C3 into C3a and C3b"
                    ]
                  },
                  {
                    "text": "Activation of C3 and C5 (shared by all 3 pathways)C3bBb cleaves C3 into C3a and C3bC3a is released into fluidC3b binds to cell surface to continue the cascadeFactor P (properdin) binds and stabilizes C3bBb complex and allows it to rapidly cleave C3 (amplification step)C5 then binds and is cleaved into C5a and C5bC5a is released into fluidC5b binds to cell surface",
                    "sub_points": [
                      "C3bBb cleaves C3 into C3a and C3bC3a is released into fluidC3b binds to cell surface to continue the cascade",
                      "C3a is released into fluid",
                      "C3b binds to cell surface to continue the cascade",
                      "Factor P (properdin) binds and stabilizes C3bBb complex and allows it to rapidly cleave C3 (amplification step)",
                      "C5 then binds and is cleaved into C5a and C5bC5a is released into fluidC5b binds to cell surface",
                      "C5a is released into fluid",
                      "C5b binds to cell surface"
                    ]
                  },
                  {
                    "text": "Terminal pathwayC5b, C6, C7, C8, and C9 are common to all 3 pathwaysC6 binds to C5b followed by binding of C7 and C8C5bC6C7C8 complex penetrates into cell membrane and acts as receptor for C9C5bC6C7C8C9 form the membrane attack complex (MAC)Results in transmembrane channel that disturbs cell's osmotic equilibrium and allows cell lysis",
                    "sub_points": [
                      "C5b, C6, C7, C8, and C9 are common to all 3 pathways",
                      "C6 binds to C5b followed by binding of C7 and C8",
                      "C5bC6C7C8 complex penetrates into cell membrane and acts as receptor for C9",
                      "C5bC6C7C8C9 form the membrane attack complex (MAC)Results in transmembrane channel that disturbs cell's osmotic equilibrium and allows cell lysis",
                      "Results in transmembrane channel that disturbs cell's osmotic equilibrium and allows cell lysis"
                    ]
                  },
                  {
                    "text": "Regulation of alternative pathwayComplement receptor 1 (CR1, CD35), decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46)All 3 will accelerate dissociation of C3bBb complex, which slows or stops cleavage of C3Factor HCompetes with factor B for the binding to C3b on surface of cellsFactor B binding to C3b on cell surface continues the alternative pathway, but if factor H binds to C3b, the pathway stops",
                    "sub_points": [
                      "Complement receptor 1 (CR1, CD35), decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46)All 3 will accelerate dissociation of C3bBb complex, which slows or stops cleavage of C3",
                      "All 3 will accelerate dissociation of C3bBb complex, which slows or stops cleavage of C3",
                      "Factor HCompetes with factor B for the binding to C3b on surface of cellsFactor B binding to C3b on cell surface continues the alternative pathway, but if factor H binds to C3b, the pathway stops",
                      "Competes with factor B for the binding to C3b on surface of cells",
                      "Factor B binding to C3b on cell surface continues the alternative pathway, but if factor H binds to C3b, the pathway stops"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Laboratory Testing of Immune Function": {
        "name": "Laboratory Testing of Immune Function",
        "url": "https://app.pathprimer.com/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
        "topics": {
          "Flow Cytometry": {
            "name": "Flow Cytometry",
            "url": "https://app.pathprimer.com/document/3ed491d5-7e99-4315-a5ae-dfbe72368973/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "Flow cytometry: Measuring properties of cells in flow"
                  },
                  {
                    "text": "Flow sorting: Sorting cells based on properties measured in flow (fluorescence-activated cell sorter, or FACS)"
                  },
                  {
                    "text": "Fluidics: Cell suspension flow in single-file through illuminated volume"
                  },
                  {
                    "text": "Optics: Cells scatter light and emit fluorescence signals that are filtered and directed to detectorsForward angle light scatter (FALS) tends to be more sensitive to surface properties and size of cellRight angle light scatter (RALS) tends to be more sensitive to inclusions within cell (e.g., granules, shape of nucleus, internal complexity)",
                    "sub_points": [
                      "Forward angle light scatter (FALS) tends to be more sensitive to surface properties and size of cell",
                      "Right angle light scatter (RALS) tends to be more sensitive to inclusions within cell (e.g., granules, shape of nucleus, internal complexity)"
                    ]
                  },
                  {
                    "text": "Lasers provide single coherent wavelength of light"
                  },
                  {
                    "text": "Electronics: Fluorescence signals converted to digital values that are analyzed and stored on computer"
                  },
                  {
                    "text": "DetectorsPhotodiode used for strong signals of light when saturation is potential problem (such as with FALS)Photomultiplier tube more sensitive than photodiode; used to detect RALS and fluorescent signal (SS)",
                    "sub_points": [
                      "Photodiode used for strong signals of light when saturation is potential problem (such as with FALS)",
                      "Photomultiplier tube more sensitive than photodiode; used to detect RALS and fluorescent signal (SS)"
                    ]
                  },
                  {
                    "text": "Fluorescent dyesUsually coupled to monoclonal antibody directed to cell surface CD markersLasers (1, 2, or 3) can be used on instrument to expand number of possible fluorescent dyesMultiple parameter analysis of 4-12 colors takes enormous computer time and is best performed on workstation separate from flow cytometer computer",
                    "sub_points": [
                      "Usually coupled to monoclonal antibody directed to cell surface CD markers",
                      "Lasers (1, 2, or 3) can be used on instrument to expand number of possible fluorescent dyes",
                      "Multiple parameter analysis of 4-12 colors takes enormous computer time and is best performed on workstation separate from flow cytometer computer"
                    ]
                  }
                ]
              },
              "OVERVIEW": {
                "Definitions": [
                  {
                    "text": "Flow cytometry: Measuring properties of cells in flow"
                  },
                  {
                    "text": "Flow sorting: Sorting cells based on properties measured in flow (fluorescence-activated cell sorter, or FACS)"
                  }
                ],
                "Flow Cytometry Basics": [
                  {
                    "text": "FluidicsCells must be in suspension and flowing single-file through illuminated volumeAccomplished by injecting sample into sheath fluid as it passes through small orifice (30-300 μm)Occurs in flow cellLaminar flow: When conditions are right, sample fluid flows in central core within sheath fluidHydrodynamic focusing: Introduction of large volume into small volume, such that it becomes \"focused\" along axis",
                    "sub_points": [
                      "Cells must be in suspension and flowing single-file through illuminated volumeAccomplished by injecting sample into sheath fluid as it passes through small orifice (30-300 μm)Occurs in flow cellLaminar flow: When conditions are right, sample fluid flows in central core within sheath fluidHydrodynamic focusing: Introduction of large volume into small volume, such that it becomes \"focused\" along axis",
                      "Accomplished by injecting sample into sheath fluid as it passes through small orifice (30-300 μm)Occurs in flow cell",
                      "Occurs in flow cell",
                      "Laminar flow: When conditions are right, sample fluid flows in central core within sheath fluid",
                      "Hydrodynamic focusing: Introduction of large volume into small volume, such that it becomes \"focused\" along axis"
                    ]
                  },
                  {
                    "text": "OpticsCells scatter light and emit fluorescence signals that are filtered and directed to detectorsOptical channel is path that light can follow from illuminated volume to detectorForward angle light scatter (FALS): Amount of light scattered in forward direction (along same axis that laser light is traveling)Tends to be more sensitive to surface properties and cell sizeRight angle light scatter (RALS): Amount of light scattered to side (perpendicular to axis along which laser light is traveling)Tends to be more sensitive to inclusions within cell (e.g., granules, shape of nucleus, internal complexity)Optical filters or optic fibers channel different wavelengths of light, both laser and fluorescence, to appropriate detector",
                    "sub_points": [
                      "Cells scatter light and emit fluorescence signals that are filtered and directed to detectors",
                      "Optical channel is path that light can follow from illuminated volume to detectorForward angle light scatter (FALS): Amount of light scattered in forward direction (along same axis that laser light is traveling)Tends to be more sensitive to surface properties and cell sizeRight angle light scatter (RALS): Amount of light scattered to side (perpendicular to axis along which laser light is traveling)Tends to be more sensitive to inclusions within cell (e.g., granules, shape of nucleus, internal complexity)",
                      "Forward angle light scatter (FALS): Amount of light scattered in forward direction (along same axis that laser light is traveling)Tends to be more sensitive to surface properties and cell size",
                      "Tends to be more sensitive to surface properties and cell size",
                      "Right angle light scatter (RALS): Amount of light scattered to side (perpendicular to axis along which laser light is traveling)Tends to be more sensitive to inclusions within cell (e.g., granules, shape of nucleus, internal complexity)",
                      "Tends to be more sensitive to inclusions within cell (e.g., granules, shape of nucleus, internal complexity)",
                      "Optical filters or optic fibers channel different wavelengths of light, both laser and fluorescence, to appropriate detector"
                    ]
                  },
                  {
                    "text": "ElectronicsFluorescence signals are converted to digital values that are analyzed and stored on computer",
                    "sub_points": [
                      "Fluorescence signals are converted to digital values that are analyzed and stored on computer"
                    ]
                  },
                  {
                    "text": "Light sourceLasers provide single coherent wavelength of light",
                    "sub_points": [
                      "Lasers provide single coherent wavelength of light"
                    ]
                  },
                  {
                    "text": "DetectorsPhotodiode: Used for strong signals of light when saturation is potential problem (such as with FALS)Photomultiplier tube: More sensitive than photodiode; used to detect RALS and fluorescent signal (SS)Most instruments can measure at least 4 different wavelengths of fluorescence (some up to 12)",
                    "sub_points": [
                      "Photodiode: Used for strong signals of light when saturation is potential problem (such as with FALS)",
                      "Photomultiplier tube: More sensitive than photodiode; used to detect RALS and fluorescent signal (SS)",
                      "Most instruments can measure at least 4 different wavelengths of fluorescence (some up to 12)"
                    ]
                  },
                  {
                    "text": "Fluorescent dyesUsually coupled to monoclonal antibody directed to cell surface CD markersMust be excited by wavelength of laser light usedLasers (1, 2, or 3) can be used on instrument to expand number of possible fluorescent dyesMultiple parameter analysis of 4-12 colors takes enormous computer time and is best performed on workstation separate from flow cytometer computer",
                    "sub_points": [
                      "Usually coupled to monoclonal antibody directed to cell surface CD markers",
                      "Must be excited by wavelength of laser light usedLasers (1, 2, or 3) can be used on instrument to expand number of possible fluorescent dyesMultiple parameter analysis of 4-12 colors takes enormous computer time and is best performed on workstation separate from flow cytometer computer",
                      "Lasers (1, 2, or 3) can be used on instrument to expand number of possible fluorescent dyes",
                      "Multiple parameter analysis of 4-12 colors takes enormous computer time and is best performed on workstation separate from flow cytometer computer"
                    ]
                  },
                  {
                    "text": "Specimen handlingWhole blood is preferred specimen for immunophenotyping of immunodeficienciesAnticoagulantsEDTA for samples that will be analyzed within 30 hoursHeparin and acid citrate dextrose if sample will be > 30 hoursTissue, fine-needle aspirates, or fluids can be used if single cell suspension can be achieved through mechanical means; avoid enzymatic methods because they may strip cell membrane proteins from cell surfacesThese specimen types usually contain variety of normal cells as well as neoplastic cellsAnalysis should focus on distinguishing normal from neoplastic cellsCorrelation with morphologic examination is important for final diagnosis",
                    "sub_points": [
                      "Whole blood is preferred specimen for immunophenotyping of immunodeficienciesAnticoagulantsEDTA for samples that will be analyzed within 30 hoursHeparin and acid citrate dextrose if sample will be > 30 hours",
                      "AnticoagulantsEDTA for samples that will be analyzed within 30 hoursHeparin and acid citrate dextrose if sample will be > 30 hours",
                      "EDTA for samples that will be analyzed within 30 hours",
                      "Heparin and acid citrate dextrose if sample will be > 30 hours",
                      "Tissue, fine-needle aspirates, or fluids can be used if single cell suspension can be achieved through mechanical means; avoid enzymatic methods because they may strip cell membrane proteins from cell surfacesThese specimen types usually contain variety of normal cells as well as neoplastic cellsAnalysis should focus on distinguishing normal from neoplastic cellsCorrelation with morphologic examination is important for final diagnosis",
                      "These specimen types usually contain variety of normal cells as well as neoplastic cellsAnalysis should focus on distinguishing normal from neoplastic cellsCorrelation with morphologic examination is important for final diagnosis",
                      "Analysis should focus on distinguishing normal from neoplastic cells",
                      "Correlation with morphologic examination is important for final diagnosis"
                    ]
                  }
                ]
              },
              "LABORATORY METHODS": {
                "Flow Cytometry": [
                  {
                    "text": "ImmunophenotypingHIV infectionSuspected immunodeficiencyTransplantationHematopoietic neoplasms",
                    "sub_points": [
                      "HIV infection",
                      "Suspected immunodeficiency",
                      "Transplantation",
                      "Hematopoietic neoplasms"
                    ]
                  },
                  {
                    "text": "Leucocyte adhesion deficiencies"
                  },
                  {
                    "text": "Chronic granulomatous disease (oxidative burst)"
                  },
                  {
                    "text": "DNA content of tumors"
                  },
                  {
                    "text": "ImmunosuppressionTransplantation therapyAnti-CD3 use in kidney and heart transplant",
                    "sub_points": [
                      "Transplantation therapy",
                      "Anti-CD3 use in kidney and heart transplant"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immunoelectrophoresis": {
            "name": "Immunoelectrophoresis",
            "url": "https://app.pathprimer.com/document/ae8e9291-dfab-4da0-829d-bee0e0fb1edb/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "KEY CONCEPTS": {
                "Biologic Concepts": [
                  {
                    "text": "Charged particles in solution migrate according to their charge"
                  },
                  {
                    "text": "Major components of serum electrophoretic patternAlbumin, α₁-globulins, α₂-globulins, β-globulins, β-λ-globulin, λ-globulins",
                    "sub_points": [
                      "Albumin, α₁-globulins, α₂-globulins, β-globulins, β-λ-globulin, λ-globulins"
                    ]
                  },
                  {
                    "text": "M protein (having a single heavy-chain class and a single light-chain type) usually seen as dense, discrete band on agarose or as tall, narrow spike or peak in γ, β, or α₂ region"
                  },
                  {
                    "text": "Polyclonal immunoglobulin (having ≥ 1 heavy chain and both κ and λ light chains) produces broad-based peak and is limited to γ regionChronic infections, connective tissue disorders, and chronic liver diseases sometimes have large, broad-based polyclonal pattern",
                    "sub_points": [
                      "Chronic infections, connective tissue disorders, and chronic liver diseases sometimes have large, broad-based polyclonal pattern"
                    ]
                  },
                  {
                    "text": "Hypogammaglobulinemia characterized by decrease in γ component, with large light-chain M protein (Bence Jones protein) in urine"
                  },
                  {
                    "text": "Nephrotic syndrome produces pattern with decreased albumin and γ-globulin components and increased α₂-globulin and β-globulins"
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Serum Immunoelectrophoresis": [
                  {
                    "text": "Immunoglobulin (Ig): Molecule composed of amino acids with carboxyl group at one end and amino group at other"
                  },
                  {
                    "text": "Each Ig composed of 2 heavy chains and 2 light chains"
                  },
                  {
                    "text": "Proteins can either be polar or nonpolar at a given pH"
                  },
                  {
                    "text": "Proteins separated according to their electrical charge on agarose gel"
                  },
                  {
                    "text": "Albumin has largest number of negatively charged groups, so it has furthest anodal migration"
                  }
                ],
                "Concept": [
                  {
                    "text": "Charged particles in solution migrate according to their charge"
                  },
                  {
                    "text": "pH of buffer is selected to give best separation of individual components"
                  }
                ],
                "Sample Requirements": [
                  {
                    "text": "Fasting is preferred over hyperlipemia"
                  },
                  {
                    "text": "Clotted is preferredFibrinogen appears as distinct narrow band between the β and γ fraction and can be mistaken for M-protein",
                    "sub_points": [
                      "Fibrinogen appears as distinct narrow band between the β and γ fraction and can be mistaken for M-protein"
                    ]
                  }
                ],
                "Interpretation": [
                  {
                    "text": "Major components of serum electrophoretic patternAlbuminα₁-Globulin1) α₁-Antitrypsin2) α₁-Lipoprotein3) α₁-Acid glycoproteinα₂-Globulin1) α₂-Macroglobulin2) α₂-Lipoprotein3) Haptoglobin4) Ceruloplasmin5) Erythropoietinβ-Globulin1) β-Lipoprotein2) Transferrin3) Plasminogen4) Complement5) Hemopexinβ-λ-globulinFibrinogenλ-Globulin1) IgG2) IgA3) IgM4) IgD5) IgE",
                    "sub_points": [
                      "Albumin",
                      "α₁-Globulin1) α₁-Antitrypsin2) α₁-Lipoprotein3) α₁-Acid glycoprotein",
                      "1) α₁-Antitrypsin",
                      "2) α₁-Lipoprotein",
                      "3) α₁-Acid glycoprotein",
                      "α₂-Globulin1) α₂-Macroglobulin2) α₂-Lipoprotein3) Haptoglobin4) Ceruloplasmin5) Erythropoietin",
                      "1) α₂-Macroglobulin",
                      "2) α₂-Lipoprotein",
                      "3) Haptoglobin",
                      "4) Ceruloplasmin",
                      "5) Erythropoietin",
                      "β-Globulin1) β-Lipoprotein2) Transferrin3) Plasminogen4) Complement5) Hemopexin",
                      "1) β-Lipoprotein",
                      "2) Transferrin",
                      "3) Plasminogen",
                      "4) Complement",
                      "5) Hemopexin",
                      "β-λ-globulinFibrinogen",
                      "Fibrinogen",
                      "λ-Globulin1) IgG2) IgA3) IgM4) IgD5) IgE",
                      "1) IgG",
                      "2) IgA",
                      "3) IgM",
                      "4) IgD",
                      "5) IgE"
                    ]
                  },
                  {
                    "text": "M protein (having single heavy-chain class and single light-chain type)Usually seen as dense, discrete band on agarose or as tall, narrow spike or peak in γ, β, or α₂ region",
                    "sub_points": [
                      "Usually seen as dense, discrete band on agarose or as tall, narrow spike or peak in γ, β, or α₂ region"
                    ]
                  },
                  {
                    "text": "Polyclonal immunoglobulin (having ≥ 1 heavy chain and both κ and λ light chains)Produces broad-based peak and is limited to γ regionChronic infections, connective tissue disorders, and chronic liver diseases sometimes have large, broad-based polyclonal pattern",
                    "sub_points": [
                      "Produces broad-based peak and is limited to γ region",
                      "Chronic infections, connective tissue disorders, and chronic liver diseases sometimes have large, broad-based polyclonal pattern"
                    ]
                  },
                  {
                    "text": "HypogammaglobulinemiaCharacterized by decrease in γ component, with large light-chain M protein (Bence Jones protein) in urine",
                    "sub_points": [
                      "Characterized by decrease in γ component, with large light-chain M protein (Bence Jones protein) in urine"
                    ]
                  },
                  {
                    "text": "Nephrotic syndromeProduces pattern with decreased albumin and γ-globulin components and increased α₂-globulin and β-globulins",
                    "sub_points": [
                      "Produces pattern with decreased albumin and γ-globulin components and increased α₂-globulin and β-globulins"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Lymphocyte Mitogen Stimulation": {
            "name": "Lymphocyte Mitogen Stimulation",
            "url": "https://app.pathprimer.com/document/81b19da8-ba5f-40af-b149-709d36608614/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Normal T and B lymphocytes proliferate after stimulation with mitogens"
                  },
                  {
                    "text": "T and B lymphocytes from immunodeficient patients do not proliferate after mitogen stimulation"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Classic Clinical Findings": [
                  {
                    "text": "Useful in diagnosis of immunodeficiency diseases"
                  },
                  {
                    "text": "Recurrent bacterial infections (B-lymphocyte deficiency)"
                  },
                  {
                    "text": "Increased susceptibility to viral, fungal, and protozoan infections (T-lymphocyte deficiency)"
                  },
                  {
                    "text": "Acute and chronic infections with viral, bacterial, fungal, and protozoan organisms (T-deficiency and B-deficiency)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Culture Methods": [
                  {
                    "text": "Isolate lymphocytes from peripheral blood using density gradients"
                  },
                  {
                    "text": "Culture for 3 days in culture medium, PHA, PWM, ConA (mitogens)"
                  },
                  {
                    "text": "Add 3Htd for the last 2 hours of culture"
                  },
                  {
                    "text": "Harvest cells on glass fiber filter paper and allow to dry"
                  },
                  {
                    "text": "Count the amount of radioactive DNA in a scintillation counter"
                  },
                  {
                    "text": "Report results as counts per minute (cpm) and as a stimulation index (SI) (ratio of mitogen cpm/control cpm)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Oxidative Burst": {
            "name": "Oxidative Burst",
            "url": "https://app.pathprimer.com/document/f8e38c15-135c-44d1-808e-2adecfd14cea/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Chronic infections with organisms of low virulence"
                  },
                  {
                    "text": "Granulomas induce chronic stimulation of inflammatory processes"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Nitroblue tetrazolium (NBT) or oxidative burst using dihydrorhodamine 123 (DHR)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Peroxidase not generated in phagocytic cells, preventing killing of catalase-positive phagocytized bacteria"
                  },
                  {
                    "text": "Chronic granulomatous disease (CGD)X-linked or autosomal recessive",
                    "sub_points": [
                      "X-linked or autosomal recessive"
                    ]
                  },
                  {
                    "text": "Deficiencies in NADPH oxidase or NADH oxidase"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Chronic infections with organisms of low virulenceStaphylococcus aureus,Escherichia coli, andAspergillus",
                    "sub_points": [
                      "Staphylococcus aureus,Escherichia coli, andAspergillus"
                    ]
                  },
                  {
                    "text": "Ingested organisms remain alive and can spread"
                  },
                  {
                    "text": "Granulomas induce chronic stimulation of inflammatory processes"
                  },
                  {
                    "text": "Lymphadenopathy and hepatosplenomegaly are seen"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Antibiotics, antifungals, and interferon"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Nitroblue tetrazolium (NBT) or oxidative burst using dihydrorhodamine 123 (DHR)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cytokine Production": {
            "name": "Cytokine Production",
            "url": "https://app.pathprimer.com/document/a35a96f4-6add-483d-b42b-4311fadb6281/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "Cytokines: (1) Produced by broad range of cells, including macrophages, B cells, T cells, mast cells, endothelial cells, fibroblasts; (2) modulate balance between humoral and cell-based immunity (immunomodulating agents); (3) considerable redundancy"
                  }
                ],
                "Biologic Concepts": [
                  {
                    "text": "Six types of receptors are used"
                  },
                  {
                    "text": "Toxic shock syndrome: Initiated by release of enterotoxin (superantigen) by microorganisms (Staphylococcus aureusorStreptococcus pyogenes)"
                  },
                  {
                    "text": "Structure (4 basic types): (1) Four-α-helix bundle family; (3-dimensional structures with 4 bundles of α-helix; (2) IL-1 family; (3) IL-17 family; 4) cysteine-knot family"
                  },
                  {
                    "text": "Function: (1) Enhance cellular responses; (2) enhance humoral responses; (3) inflammatory cytokines; (4) chemotactic cytokines"
                  }
                ]
              },
              "OVERVIEW": {
                "Cytokines": [
                  {
                    "text": "Produced by broad range of cells, including macrophages, B cells, T cells, mast cells, endothelial cells, fibroblastsAny given cytokine may be produced by more than one cell type",
                    "sub_points": [
                      "Any given cytokine may be produced by more than one cell type"
                    ]
                  },
                  {
                    "text": "Modulate balance between humoral and cell-based immunity (immunomodulating agents)"
                  },
                  {
                    "text": "Can enhance or inhibit action of other cytokines"
                  },
                  {
                    "text": "Considerable redundancy"
                  },
                  {
                    "text": "Multiple ways to classifyStructuralFunctionalReceptor used",
                    "sub_points": [
                      "Structural",
                      "Functional",
                      "Receptor used"
                    ]
                  }
                ]
              },
              "BIOLOGIC CONCEPTS": {
                "Structural (4 Types)": [
                  {
                    "text": "Four-α-helix bundle family: Three-dimensional structures with 4 bundles of α-helixIL-2 familyINF familyIL-10 family",
                    "sub_points": [
                      "IL-2 family",
                      "INF family",
                      "IL-10 family"
                    ]
                  },
                  {
                    "text": "IL-1 familyIL-1 and IL-18",
                    "sub_points": [
                      "IL-1 and IL-18"
                    ]
                  },
                  {
                    "text": "IL-17 family"
                  },
                  {
                    "text": "Cysteine-knot familyTGF-β₁, TGF-β₂, TGF-β₃",
                    "sub_points": [
                      "TGF-β₁, TGF-β₂, TGF-β₃"
                    ]
                  }
                ],
                "Functional": [
                  {
                    "text": "Enhance cellular responsesTNFα, INF-γ, GM-CSF, IL-3, TNF-β; all produced by TH1 cells",
                    "sub_points": [
                      "TNFα, INF-γ, GM-CSF, IL-3, TNF-β; all produced by TH1 cells"
                    ]
                  },
                  {
                    "text": "Enhance humoral responsesTGF-β, IL-4, IL-5, IL-10, IL-3, IL-13; all produced by TH2 cells",
                    "sub_points": [
                      "TGF-β, IL-4, IL-5, IL-10, IL-3, IL-13; all produced by TH2 cells"
                    ]
                  },
                  {
                    "text": "Inflammatory cytokinesIL-1, IL-6, IL-10, IL-23, TNF-α; these initiate acute-phase response, resulting in production of acute-phase proteins CRP (C-reactive protein), MBL (mannan-binding lectin)",
                    "sub_points": [
                      "IL-1, IL-6, IL-10, IL-23, TNF-α; these initiate acute-phase response, resulting in production of acute-phase proteins CRP (C-reactive protein), MBL (mannan-binding lectin)"
                    ]
                  },
                  {
                    "text": "Chemotactic cytokinesIL-8, RANTES, MCP-1, MIP-1α, MIP-1β",
                    "sub_points": [
                      "IL-8, RANTES, MCP-1, MIP-1α, MIP-1β"
                    ]
                  }
                ],
                "Receptor Used": [
                  {
                    "text": "Immunoglobulin superfamily receptorsIL-1, M-CSF",
                    "sub_points": [
                      "IL-1, M-CSF"
                    ]
                  },
                  {
                    "text": "Class I cytokine receptors (several share common γ chain) (also see PATHPrimer topic Severe Combined Immunodeficiency Diseases)IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-11, IL-12, IL-13, IL-15, GM-CSF, G-CSF",
                    "sub_points": [
                      "IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-11, IL-12, IL-13, IL-15, GM-CSF, G-CSF"
                    ]
                  },
                  {
                    "text": "Class II cytokine receptorINF-α, INF-β, INF-γ, IL-10",
                    "sub_points": [
                      "INF-α, INF-β, INF-γ, IL-10"
                    ]
                  },
                  {
                    "text": "TNF receptorsTNF-α, TNF-β, CD30L, CD40L, CD154 (Fas L)",
                    "sub_points": [
                      "TNF-α, TNF-β, CD30L, CD40L, CD154 (Fas L)"
                    ]
                  },
                  {
                    "text": "Chemokine receptors (serpentine or seven-transmembrane helix receptor)IL-8, RANTES, MIP-1, PF4, MCAF",
                    "sub_points": [
                      "IL-8, RANTES, MIP-1, PF4, MCAF"
                    ]
                  },
                  {
                    "text": "IL-17 receptorIL-17RA, IL-17RB, IL-17RC, IL-17RD, IL-17-RE, IL-17RE",
                    "sub_points": [
                      "IL-17RA, IL-17RB, IL-17RC, IL-17RD, IL-17-RE, IL-17RE"
                    ]
                  }
                ],
                "Signal Transduction": [
                  {
                    "text": "Binding of cytokine to its receptor induces dimerization of receptor polypeptides at cell surfaceCauses their cytoplasmic tails to engageSignaling is initiated by activation of JAK kinases (protein tyrosine kinases) that phosphorylate tyrosine residues present on cytoplasmic tails of receptorFamily of transcription factors STATs (signal transducers and activators of transcription in cytoplasm) are also phosphorylatedOnce STAT is phosphorylated, it dimerizes and translocates from cytoplasm into nucleus where it activates transcription of genes induced by the cytokine",
                    "sub_points": [
                      "Causes their cytoplasmic tails to engage",
                      "Signaling is initiated by activation of JAK kinases (protein tyrosine kinases) that phosphorylate tyrosine residues present on cytoplasmic tails of receptor",
                      "Family of transcription factors STATs (signal transducers and activators of transcription in cytoplasm) are also phosphorylatedOnce STAT is phosphorylated, it dimerizes and translocates from cytoplasm into nucleus where it activates transcription of genes induced by the cytokine",
                      "Once STAT is phosphorylated, it dimerizes and translocates from cytoplasm into nucleus where it activates transcription of genes induced by the cytokine"
                    ]
                  }
                ],
                "Toxic Shock Syndrome": [
                  {
                    "text": "Initiated by release of enterotoxin (superantigen) by microorganisms (Staphylococcus aureusorStreptococcus pyogenes)Large numbers of CD4 T cells are activated because toxin can cross-link Vβ segment of TCRResults in excessive production of cytokines, dysregulation of cytokine network, and high levels of IL-1 and TNF-αThese cytokines induce systemic reactions, including fever, blood clotting, diarrhea, hypotension, and shockReactions are sometimes fatal",
                    "sub_points": [
                      "Large numbers of CD4 T cells are activated because toxin can cross-link Vβ segment of TCRResults in excessive production of cytokines, dysregulation of cytokine network, and high levels of IL-1 and TNF-αThese cytokines induce systemic reactions, including fever, blood clotting, diarrhea, hypotension, and shockReactions are sometimes fatal",
                      "Results in excessive production of cytokines, dysregulation of cytokine network, and high levels of IL-1 and TNF-α",
                      "These cytokines induce systemic reactions, including fever, blood clotting, diarrhea, hypotension, and shockReactions are sometimes fatal",
                      "Reactions are sometimes fatal"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Complement Function Assays": {
            "name": "Complement Function Assays",
            "url": "https://app.pathprimer.com/document/d17ad0ce-a0a4-4387-abe1-22935cfaccfc/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "CH50 AssaySheep RBCs sensitized for lysis with addition of anti-sheep RBC antibodies in absence of complement",
                    "sub_points": [
                      "Sheep RBCs sensitized for lysis with addition of anti-sheep RBC antibodies in absence of complement"
                    ]
                  },
                  {
                    "text": "EIA methodUses 2 unique antibodiesFirst is attached to microtiter well and used to bind an immune complexSecond is a split product of C9",
                    "sub_points": [
                      "Uses 2 unique antibodiesFirst is attached to microtiter well and used to bind an immune complexSecond is a split product of C9",
                      "First is attached to microtiter well and used to bind an immune complex",
                      "Second is a split product of C9"
                    ]
                  },
                  {
                    "text": "Individual component levelsC3, C4, C1-INH, and factor B are routinely measuredOther components require testing at national reference laboratories that specialize in complement evaluation",
                    "sub_points": [
                      "C3, C4, C1-INH, and factor B are routinely measured",
                      "Other components require testing at national reference laboratories that specialize in complement evaluation"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "CH50 assaySensitized RBC methodSheep RBCs sensitized for lysis with addition of anti-sheep RBC antibodies in absence of complementPatient serum (complement source) added to sensitized cells and incubated for 30-60 minutes, during which time RBCs are lysedCentrifuge sample to remove RBCsRead resultant supernatant at OD₄₁₂ to determine amount of RBC lysisAssay can be modified to evaluate any individual component of complement by adding all components except the one you wish to evaluate; that one comes from patient serumEIA methodUses 2 unique antibodiesFirst is attached to a microtiter well and used to bind an immune complexSecond is a split product of C9Add patient serum to microtiter well, followed by addition of antibody-antigen complex (supplied with kit)Antibody-antigen complex activates patient complement cascadeCascade eventually results in splitting of patient C9Detecting antibody is directed against antigenic determinate on the split C9; it has an enzyme attached to itAnti-C9 antibody reacts with attached C9 bound to the plate and is detected with addition of substrateColor change of substrate to product is used to determine complement activityAssay has been standardized to classic RBC CH50 assay",
                    "sub_points": [
                      "Sensitized RBC methodSheep RBCs sensitized for lysis with addition of anti-sheep RBC antibodies in absence of complementPatient serum (complement source) added to sensitized cells and incubated for 30-60 minutes, during which time RBCs are lysedCentrifuge sample to remove RBCsRead resultant supernatant at OD₄₁₂ to determine amount of RBC lysisAssay can be modified to evaluate any individual component of complement by adding all components except the one you wish to evaluate; that one comes from patient serum",
                      "Sheep RBCs sensitized for lysis with addition of anti-sheep RBC antibodies in absence of complement",
                      "Patient serum (complement source) added to sensitized cells and incubated for 30-60 minutes, during which time RBCs are lysedCentrifuge sample to remove RBCsRead resultant supernatant at OD₄₁₂ to determine amount of RBC lysis",
                      "Centrifuge sample to remove RBCs",
                      "Read resultant supernatant at OD₄₁₂ to determine amount of RBC lysis",
                      "Assay can be modified to evaluate any individual component of complement by adding all components except the one you wish to evaluate; that one comes from patient serum",
                      "EIA methodUses 2 unique antibodiesFirst is attached to a microtiter well and used to bind an immune complexSecond is a split product of C9Add patient serum to microtiter well, followed by addition of antibody-antigen complex (supplied with kit)Antibody-antigen complex activates patient complement cascadeCascade eventually results in splitting of patient C9Detecting antibody is directed against antigenic determinate on the split C9; it has an enzyme attached to itAnti-C9 antibody reacts with attached C9 bound to the plate and is detected with addition of substrateColor change of substrate to product is used to determine complement activityAssay has been standardized to classic RBC CH50 assay",
                      "Uses 2 unique antibodiesFirst is attached to a microtiter well and used to bind an immune complexSecond is a split product of C9",
                      "First is attached to a microtiter well and used to bind an immune complex",
                      "Second is a split product of C9",
                      "Add patient serum to microtiter well, followed by addition of antibody-antigen complex (supplied with kit)Antibody-antigen complex activates patient complement cascadeCascade eventually results in splitting of patient C9Detecting antibody is directed against antigenic determinate on the split C9; it has an enzyme attached to itAnti-C9 antibody reacts with attached C9 bound to the plate and is detected with addition of substrateColor change of substrate to product is used to determine complement activity",
                      "Antibody-antigen complex activates patient complement cascade",
                      "Cascade eventually results in splitting of patient C9",
                      "Detecting antibody is directed against antigenic determinate on the split C9; it has an enzyme attached to it",
                      "Anti-C9 antibody reacts with attached C9 bound to the plate and is detected with addition of substrate",
                      "Color change of substrate to product is used to determine complement activity",
                      "Assay has been standardized to classic RBC CH50 assay"
                    ]
                  },
                  {
                    "text": "Individual component levelsC3, C4, C1-INH, and factor B are routinely measuredOther components require testing at national reference laboratories that specialize in complement evaluation",
                    "sub_points": [
                      "C3, C4, C1-INH, and factor B are routinely measured",
                      "Other components require testing at national reference laboratories that specialize in complement evaluation"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Phagocyte Cell Functions": {
            "name": "Phagocyte Cell Functions",
            "url": "https://app.pathprimer.com/document/e6b14901-53b2-4c72-9f6f-0fc9b28e25dd/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Nitroblue tetrazolium (NBT)Colorless (sightly yellow) compound that forms insoluble formazan when reduced",
                    "sub_points": [
                      "Colorless (sightly yellow) compound that forms insoluble formazan when reduced"
                    ]
                  },
                  {
                    "text": "Dichlorofluorescein (DCF)Nonfluorescent dye that is cleaved to fluorescent form when oxidized",
                    "sub_points": [
                      "Nonfluorescent dye that is cleaved to fluorescent form when oxidized"
                    ]
                  },
                  {
                    "text": "Microbicidal assayEvaluates overall phagocytic activity: 1) phagocytosis, 2) respiratory burst",
                    "sub_points": [
                      "Evaluates overall phagocytic activity: 1) phagocytosis, 2) respiratory burst"
                    ]
                  },
                  {
                    "text": "Chemotaxis assayEvaluates ability of phagocytes to migrate in response to chemotaxis stimuli",
                    "sub_points": [
                      "Evaluates ability of phagocytes to migrate in response to chemotaxis stimuli"
                    ]
                  },
                  {
                    "text": "ImmunophenotypingLAD 1 missing the common CD18 β for expression of CD11a, CD11b, and CD11c",
                    "sub_points": [
                      "LAD 1 missing the common CD18 β for expression of CD11a, CD11b, and CD11c"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Classic Clinical Findings": [
                  {
                    "text": "History of cutaneous infections, perinatal abscesses, multiple episodes of pneumonia, delayed wound healing"
                  }
                ],
                "Phagocyte Dysfunction": [
                  {
                    "text": "Can be in monocytes/macrophages or neutrophils"
                  },
                  {
                    "text": "Can be genetically acquiredCell surface adhesion molecules, metabolic pathways (production of oxygen radicals)",
                    "sub_points": [
                      "Cell surface adhesion molecules, metabolic pathways (production of oxygen radicals)"
                    ]
                  },
                  {
                    "text": "Can be extrinsicFunction can be compromised by hypogammaglobulinemia, complement deficiencies, autoimmune diseases, immunosuppressive therapy",
                    "sub_points": [
                      "Function can be compromised by hypogammaglobulinemia, complement deficiencies, autoimmune diseases, immunosuppressive therapy"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Nitroblue Tetrazolium": [
                  {
                    "text": "Mechanism of microbial killing by phagocytes is production of oxygen free radicals"
                  },
                  {
                    "text": "Nitroblue tetrazolium (NBT)Colorless (sightly yellow) compound that forms insoluble formazan when reducedAdd NBT to phagocytes and incubate for 1 hourPrepare slide and examine phagocytes for blue granules (formazan) in cytoplasm",
                    "sub_points": [
                      "Colorless (sightly yellow) compound that forms insoluble formazan when reducedAdd NBT to phagocytes and incubate for 1 hourPrepare slide and examine phagocytes for blue granules (formazan) in cytoplasm",
                      "Add NBT to phagocytes and incubate for 1 hour",
                      "Prepare slide and examine phagocytes for blue granules (formazan) in cytoplasm"
                    ]
                  },
                  {
                    "text": "Diseases with defect in oxidative pathway (e.g., chronic granulomatous disease) cannot oxidize NBT to formazan"
                  }
                ],
                "Dichlorofluorescein": [
                  {
                    "text": "Nonfluorescent dye that is cleaved to fluorescent form when oxidizedPerformed on flow cytometerResult similar to NBT test, but more accurate",
                    "sub_points": [
                      "Performed on flow cytometer",
                      "Result similar to NBT test, but more accurate"
                    ]
                  }
                ],
                "Microbicidal Assay": [
                  {
                    "text": "Evaluates overall phagocytic activityPhagocytosisRespiratory burst",
                    "sub_points": [
                      "Phagocytosis",
                      "Respiratory burst"
                    ]
                  },
                  {
                    "text": "Opsonized bacteria added to monocytes or neutrophilsIncubated at 37⁰C with sampling and plating every 30 minutes for 2 hours",
                    "sub_points": [
                      "Incubated at 37⁰C with sampling and plating every 30 minutes for 2 hours"
                    ]
                  },
                  {
                    "text": "Samples plated in agar overnight, and colonies of bacteria counted next day"
                  },
                  {
                    "text": "Determine number of bacteria killed for each time pointBy 2-hour time point > 90% of bacteria should be killed",
                    "sub_points": [
                      "By 2-hour time point > 90% of bacteria should be killed"
                    ]
                  },
                  {
                    "text": "Requires fresh sample and test must begin within 6 hours of specimen collection"
                  }
                ],
                "Chemotaxis Assay": [
                  {
                    "text": "Determines migration of monocytes or neutrophils in response to specific chemotactic stimuli"
                  },
                  {
                    "text": "Place monocytes or neutrophils in chamber separated by 2 filters through which cells can migrate"
                  },
                  {
                    "text": "On one side of filters, place cells; on other side, place chemotactic factors"
                  },
                  {
                    "text": "Allow cell to migrate and then stain filter and count amount of migration as compared to control sample under same conditions"
                  },
                  {
                    "text": "Requires fresh sample and test must begin within 6 hours of specimen collection"
                  }
                ],
                "Immunophenotyping": [
                  {
                    "text": "LAD 1 missing the common CD18 β for expression of CD11a, CD11b, and CD11c"
                  },
                  {
                    "text": "Monoclonal antibodies are available for each of these cell adhesion molecules"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cell Adhesion Molecules": {
            "name": "Cell Adhesion Molecules",
            "url": "https://app.pathprimer.com/document/68e52b7e-f6a2-4934-9ed7-6b5cd71716f3/lesson/a2319631-6d63-421c-9ac8-828eaa5eec39",
            "content": {
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "LAD I mutation on chromosome 21 of β subunit of integrin molecules CD11a/CD18(LFA-1), CD11b/CD18(Mac-1), and CD 11c/CD18(CR4)"
                  },
                  {
                    "text": "LAD II mutation in selectin ligand resulting in migration defects"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Recurrent pyogenic infections"
                  },
                  {
                    "text": "Problems with wound healing"
                  },
                  {
                    "text": "Gingivitis"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Flow cytometric analysis of CD18 on WBCs"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Immunodeficiency Disorders": {
        "name": "Immunodeficiency Disorders",
        "url": "https://app.pathprimer.com/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
        "topics": {
          "Primary Immunodeficiency Syndromes": {
            "name": "Primary Immunodeficiency Syndromes",
            "url": "https://app.pathprimer.com/document/7867bcfe-5441-4552-aae6-dc0379734fba/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "General consequences of deficiencies include recurrent infections, often with opportunistic organisms"
                  },
                  {
                    "text": "Deficiencies fall into 5 major categories based upon the expressed defectB cellsT cellsT cells and B cellsPhagocytic cellsComplement components",
                    "sub_points": [
                      "B cells",
                      "T cells",
                      "T cells and B cells",
                      "Phagocytic cells",
                      "Complement components"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Immune deficiencies are primary or secondaryPrimary deficiency: the deficiency is the cause of the disease, usually congenital or genetically determinedSecondary deficiency: the deficiency is the result of other diseases or conditions such as cancers, chemotherapy, nutrition, infections (HIV)",
                    "sub_points": [
                      "Primary deficiency: the deficiency is the cause of the disease, usually congenital or genetically determined",
                      "Secondary deficiency: the deficiency is the result of other diseases or conditions such as cancers, chemotherapy, nutrition, infections (HIV)"
                    ]
                  },
                  {
                    "text": "General consequences of deficiencies include recurrent infections, often with opportunistic organismsCytomegalovirus (CMV)﻿﻿ToxoplasmosisPneumocystis cariniiMycobacterium avium",
                    "sub_points": [
                      "Cytomegalovirus (CMV)﻿",
                      "﻿Toxoplasmosis",
                      "Pneumocystis carinii",
                      "Mycobacterium avium"
                    ]
                  },
                  {
                    "text": "Deficiencies fall into 5 major categories based upon the expressed defect(1) B cellRecurrent bacterial infections with high-grade extracellular encapsulated pathogens (e.g., otitis media, pneumonia)(2) T cellIncreased susceptibility to low-grade opportunistic agentsFungiVirusesPneumocystis carinii(3) T cells and B cellsAcute and chronic infections with various organismsViralBacterialFungalProtozoal(4) Phagocytic cellsSystemic infections with bacteria of low virulenceSuperficial skin infectionsInfections with pyogenic organisms(5) Complement componentsRecurrent infections with pyogenic microorganisms",
                    "sub_points": [
                      "(1) B cellRecurrent bacterial infections with high-grade extracellular encapsulated pathogens (e.g., otitis media, pneumonia)",
                      "Recurrent bacterial infections with high-grade extracellular encapsulated pathogens (e.g., otitis media, pneumonia)",
                      "(2) T cellIncreased susceptibility to low-grade opportunistic agentsFungiVirusesPneumocystis carinii",
                      "Increased susceptibility to low-grade opportunistic agentsFungiVirusesPneumocystis carinii",
                      "Fungi",
                      "Viruses",
                      "Pneumocystis carinii",
                      "(3) T cells and B cellsAcute and chronic infections with various organismsViralBacterialFungalProtozoal",
                      "Acute and chronic infections with various organismsViralBacterialFungalProtozoal",
                      "Viral",
                      "Bacterial",
                      "Fungal",
                      "Protozoal",
                      "(4) Phagocytic cellsSystemic infections with bacteria of low virulenceSuperficial skin infectionsInfections with pyogenic organisms",
                      "Systemic infections with bacteria of low virulence",
                      "Superficial skin infections",
                      "Infections with pyogenic organisms",
                      "(5) Complement componentsRecurrent infections with pyogenic microorganisms",
                      "Recurrent infections with pyogenic microorganisms"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Immunophenotype": [
                  {
                    "text": "Flow cytometric enumeration of CD3, CD4, CD8, CD19, CD16, and CD56"
                  },
                  {
                    "text": "Measure serum Ig levels: IgG, IgM, IgA, IgG subtypes, serum immunoelectrophoresis"
                  },
                  {
                    "text": "Measure isohemagglutinin (IgM) titers"
                  },
                  {
                    "text": "Measure specific antibody levels: Tetanus ab, diphtheria ab"
                  },
                  {
                    "text": "Mitogen stimulation (PHA, PWM, ConA)"
                  },
                  {
                    "text": "Oxidative burst, phagocytosis"
                  },
                  {
                    "text": "Skin testing"
                  },
                  {
                    "text": "Complete blood count with differential"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Primary Immunodeficiency Diseases": {
            "name": "Primary Immunodeficiency Diseases",
            "url": "https://app.pathprimer.com/document/5352679f-48d5-4379-be19-3b1b29eb7bf2/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Disorders occur in T, B, and NK lymphocytes; phagocytic cells; and complement system"
                  },
                  {
                    "text": "Most are single-gene disorders"
                  },
                  {
                    "text": "More are X-linked resulting in disproportionate number of affected male patients; 70% of primary immunodeficiency disorders occur in male patients"
                  },
                  {
                    "text": "More than 100 different disorders have been described; 20 of these disorders represent > 90% of cases"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Group of single gene disorders"
                  },
                  {
                    "text": "Manifestations vary in terms of degree of severity"
                  },
                  {
                    "text": "Most are X-linked resulting in disproportionate number of affected male patients70% of primary immunodeficiency disorders occur in male patients",
                    "sub_points": [
                      "70% of primary immunodeficiency disorders occur in male patients"
                    ]
                  },
                  {
                    "text": "Most are detected before 5 years of age"
                  },
                  {
                    "text": "More than 100 different disorders have been described20 of these disorders represent > 90% of cases",
                    "sub_points": [
                      "20 of these disorders represent > 90% of cases"
                    ]
                  }
                ],
                "Major Clinical Appearance of Immune Disorders": [
                  {
                    "text": "B-cell deficiencyRecurrent bacterial infections such as otitis media and recurrent pneumonia",
                    "sub_points": [
                      "Recurrent bacterial infections such as otitis media and recurrent pneumonia"
                    ]
                  },
                  {
                    "text": "T-cell deficiencyIncreased susceptibility to viral, fungal, protozoal infections",
                    "sub_points": [
                      "Increased susceptibility to viral, fungal, protozoal infections"
                    ]
                  },
                  {
                    "text": "T and B cell deficiencyAcute and chronic infections with bacterial, viral, fungal, protozoal infections",
                    "sub_points": [
                      "Acute and chronic infections with bacterial, viral, fungal, protozoal infections"
                    ]
                  },
                  {
                    "text": "Phagocytic cell deficiencySystemic infections with bacteria of usually low virulenceInfections with pyogenic bacteriaImpaired pus formation and wound healing",
                    "sub_points": [
                      "Systemic infections with bacteria of usually low virulence",
                      "Infections with pyogenic bacteria",
                      "Impaired pus formation and wound healing"
                    ]
                  },
                  {
                    "text": "Natural killer (NK) cell deficiencyViral infectionsAssociated with several T-cell disorders and X-linked lymphoproliferative syndromes",
                    "sub_points": [
                      "Viral infections",
                      "Associated with several T-cell disorders and X-linked lymphoproliferative syndromes"
                    ]
                  },
                  {
                    "text": "Complement component deficiencyBacterial infectionsAutoimmunity",
                    "sub_points": [
                      "Bacterial infections",
                      "Autoimmunity"
                    ]
                  }
                ],
                "Warning Signs of Immunodeficiency": [
                  {
                    "text": "Eight or more ear infections in 1 year"
                  },
                  {
                    "text": "Two or more sinus infections in 1 year"
                  },
                  {
                    "text": "Oral antibiotics produce little improvement"
                  },
                  {
                    "text": "Two or more episodes of pneumonia in 1 year"
                  },
                  {
                    "text": "Failure to thrive"
                  },
                  {
                    "text": "Recurring deep skin or organ abscesses"
                  },
                  {
                    "text": "Oral or cutaneus candidiasis after 1 year"
                  },
                  {
                    "text": "One or more episodes of meningitis, osteomyelitis, cellulitis, sepsis"
                  },
                  {
                    "text": "History of autoimmune disease, lymphadenopathy, splenomegaly"
                  },
                  {
                    "text": "Family history of immunodeficiency"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Evaluation of Components of Immune System": [
                  {
                    "text": "White blood cell (WBC) count with complete differential"
                  },
                  {
                    "text": "Serum IgG, IgM, IgA levels"
                  },
                  {
                    "text": "Measure antibody levels to tetanus, diphtheria, isohemagglutinins"
                  },
                  {
                    "text": "Flow cytometryCD3, CD4, CD8, CD19, CD16/CD56 measurements",
                    "sub_points": [
                      "CD3, CD4, CD8, CD19, CD16/CD56 measurements"
                    ]
                  },
                  {
                    "text": "In vivo measurements of functionMitogen stimulation with phytohemagglutinin (PHA), pokeweed mitogen (PWM), concanavalin A (ConA)",
                    "sub_points": [
                      "Mitogen stimulation with phytohemagglutinin (PHA), pokeweed mitogen (PWM), concanavalin A (ConA)"
                    ]
                  },
                  {
                    "text": "Phagocytic evaluationCell adhesion moleculesOxidative burst",
                    "sub_points": [
                      "Cell adhesion molecules",
                      "Oxidative burst"
                    ]
                  },
                  {
                    "text": "Complement evaluationCH50C2, C3, C4 levelsOther classic and alternative pathway component levelsRegulator component levels",
                    "sub_points": [
                      "CH50",
                      "C2, C3, C4 levels",
                      "Other classic and alternative pathway component levels",
                      "Regulator component levels"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Severe Combined Immunodeficiency Diseases": {
            "name": "Severe Combined Immunodeficiency Diseases",
            "url": "https://app.pathprimer.com/document/a457954d-a215-4d10-a25f-055b7cd917b8/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Heterogeneous group of diseases in which cell-mediated immunity and antibody production are defective"
                  },
                  {
                    "text": "Susceptible to every type of microbial infection (viral, bacterial, fungal, protozoal) including opportunistic infection"
                  },
                  {
                    "text": "Vaccination with attenuated live virus can prove fatal"
                  },
                  {
                    "text": "Bone marrow transplantation is preferred treatment for all SCIDs"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "CD3, CD4, CD8, CD19, CD16, CD56 measurements"
                  },
                  {
                    "text": "Mitogen stimulation with PHA, PWM, ConA"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Severe Combined Immunodeficiency Diseases": [
                  {
                    "text": "Heterogeneous group of diseases in which cell-mediated immunity and antibody production are defective"
                  },
                  {
                    "text": "Susceptible to every type of microbial infection (viral, bacterial, fungal, protozoal) including opportunistic infection"
                  },
                  {
                    "text": "Vaccination with attenuated live virus can prove fatal"
                  },
                  {
                    "text": "Patients can be subdivided according to lymphocyte subsets present"
                  },
                  {
                    "text": "Bone marrow transplantation is preferred treatment for all severe combined immunodeficiency diseases (SCIDs)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Evaluation of Cellular Components of Immune System": [
                  {
                    "text": "White blood cell (WBC) count with complete differential"
                  },
                  {
                    "text": "Serum IgG, IgM, IgA"
                  },
                  {
                    "text": "Flow cytometryCD3, CD4, CD8, CD19, CD16, CD56 measurements",
                    "sub_points": [
                      "CD3, CD4, CD8, CD19, CD16, CD56 measurements"
                    ]
                  },
                  {
                    "text": "In vivo measurements of functionMitogen stimulation with phytohemagglutinin (PHA), pokeweed mitogen (PWM), concanavalin A (ConA)",
                    "sub_points": [
                      "Mitogen stimulation with phytohemagglutinin (PHA), pokeweed mitogen (PWM), concanavalin A (ConA)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "T-B+ Subgroup": {
            "name": "T-B+ Subgroup",
            "url": "https://app.pathprimer.com/document/c1670149-e8cb-4f23-b490-1bf11755989a/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "X-linked SCID"
                  },
                  {
                    "text": "Autosomal recessive SCID"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "No CD3, CD4, or CD8 T cells present in peripheral blood"
                  },
                  {
                    "text": "Only CD19 and CD20 B cells present in peripheral blood"
                  },
                  {
                    "text": "Genetic testing available for specific mutation for the γ chain gene and mutation for the ﻿JAK3 kinase gene"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Abbreviations": [
                  {
                    "text": "Severe combined immunodeficiency (SCID)"
                  }
                ],
                "Pathophysiology": [
                  {
                    "text": "X-linked SCID40-50% of SCID casesMutation in gene on X chromosome that codes for the common γ chain for IL-2, IL-4, IL-7, IL-9, and IL-15 receptorsImpairs response to a multitude of cytokines",
                    "sub_points": [
                      "40-50% of SCID cases",
                      "Mutation in gene on X chromosome that codes for the common γ chain for IL-2, IL-4, IL-7, IL-9, and IL-15 receptorsImpairs response to a multitude of cytokines",
                      "Impairs response to a multitude of cytokines"
                    ]
                  },
                  {
                    "text": "Autosomal recessive SCIDMutation in gene for ﻿JAK3 tyrosine kinase﻿JAK3 is an intracellular molecule responsible for transmitting signals from the γ chain or cytokine receptorsSame phenotype as X-linked SCID",
                    "sub_points": [
                      "Mutation in gene for ﻿JAK3 tyrosine kinase﻿JAK3 is an intracellular molecule responsible for transmitting signals from the γ chain or cytokine receptorsSame phenotype as X-linked SCID",
                      "﻿JAK3 is an intracellular molecule responsible for transmitting signals from the γ chain or cytokine receptors",
                      "Same phenotype as X-linked SCID"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Flow Cytometry": [
                  {
                    "text": "No CD3, CD4, or CD8 T cells present in peripheral blood"
                  },
                  {
                    "text": "Only CD19 and CD20 B cells present in peripheral blood"
                  }
                ],
                "Genetic testing": [
                  {
                    "text": "Genetic testing available for specific mutation for the γ chain gene and mutation for the ﻿JAK3 kinase gene"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "T-B- Subgroup": {
            "name": "T-B- Subgroup",
            "url": "https://app.pathprimer.com/document/4f24578e-d873-4690-af55-5b0b773bd9c1/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "ADA deficiency"
                  },
                  {
                    "text": "PNP deficiency"
                  },
                  {
                    "text": "Recombinase deficiencies and radiosensitivity SCID"
                  },
                  {
                    "text": "Omenn syndrome: Enlarged lymphoid tissue, high IgE, high eosinophil levels, severe erythroderma"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "CD3, CD4, CD8, CD19, CD16/CD56 measurements"
                  },
                  {
                    "text": "Mitogen stimulation with PHA, PWM, and ConA"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Adenosine deaminase (ADA) deficiencyADA is an enzyme in purine salvage pathwayDeficiency of ADA results in buildup of toxic wastesResults in failure of development of T and B cellsFirst human disease treated by gene transfer",
                    "sub_points": [
                      "ADA is an enzyme in purine salvage pathway",
                      "Deficiency of ADA results in buildup of toxic wastes",
                      "Results in failure of development of T and B cells",
                      "First human disease treated by gene transfer"
                    ]
                  },
                  {
                    "text": "Purine nucleoside phosphorylase (PNP) deficiencyPNP is an enzyme in purine salvage pathwayDeficiency of PNP results in buildup of toxic wastesResults in damage to neurologic system and T and B cellsFor unknown reasons, autoimmune disease is common",
                    "sub_points": [
                      "PNP is an enzyme in purine salvage pathway",
                      "Deficiency of PNP results in buildup of toxic wastes",
                      "Results in damage to neurologic system and T and B cells",
                      "For unknown reasons, autoimmune disease is common"
                    ]
                  },
                  {
                    "text": "Recombinase deficiencies and radiosensitivity severe combined immunodeficiency (SCID)Recombination-activating genesRAG-1andRAG-2code for enzymes involved in rearrangement of immunoglobulin genes in pre-B cells and T-cell receptor genes in pre-T cellsBoth are necessary for rearrangement to occurMutation in either results in complete lack of T cells and B cells",
                    "sub_points": [
                      "Recombination-activating genesRAG-1andRAG-2code for enzymes involved in rearrangement of immunoglobulin genes in pre-B cells and T-cell receptor genes in pre-T cells",
                      "Both are necessary for rearrangement to occurMutation in either results in complete lack of T cells and B cells",
                      "Mutation in either results in complete lack of T cells and B cells"
                    ]
                  },
                  {
                    "text": "Omenn syndromeEnlarged lymphoid tissue, high IgE, high eosinophil levels, severe erythrodermaSome have partialRAGactivity (leaky SCID) and low ADAT helper (TH2) type cytokines are elevatedAcute and chronic infections with viral, bacterial, fungal, and protozoal organisms",
                    "sub_points": [
                      "Enlarged lymphoid tissue, high IgE, high eosinophil levels, severe erythroderma",
                      "Some have partialRAGactivity (leaky SCID) and low ADA",
                      "T helper (TH2) type cytokines are elevated",
                      "Acute and chronic infections with viral, bacterial, fungal, and protozoal organisms"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Evaluation of Immune System": [
                  {
                    "text": "White blood cell (WBC) count with complete differential"
                  },
                  {
                    "text": "Serum IgG, IgM, IgA levels"
                  },
                  {
                    "text": "Flow cytometryCD3, CD4, CD8, CD19, CD16/CD56 measurements",
                    "sub_points": [
                      "CD3, CD4, CD8, CD19, CD16/CD56 measurements"
                    ]
                  },
                  {
                    "text": "In vivo measurements of functionMitogen stimulation with phytohemagglutinin (PHA), pokeweed mitogen (PWM), and concanavalin A (ConA)",
                    "sub_points": [
                      "Mitogen stimulation with phytohemagglutinin (PHA), pokeweed mitogen (PWM), and concanavalin A (ConA)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "T+B+ Subgroup": {
            "name": "T+B+ Subgroup",
            "url": "https://app.pathprimer.com/document/f84a4621-c854-4227-9ffb-9886c1c3a4cf/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "BLS categorized into 3 groups: Missing class I, missing class II, and missing classes I & IILack of MHC class I due to mutation in transporter protein (TAP, or transporter associated with antigen processing)Lack of MHC class II due to mutation in 1 of the 4 genes coding for regulatory factors required to transcribe class II genes",
                    "sub_points": [
                      "Lack of MHC class I due to mutation in transporter protein (TAP, or transporter associated with antigen processing)",
                      "Lack of MHC class II due to mutation in 1 of the 4 genes coding for regulatory factors required to transcribe class II genes"
                    ]
                  },
                  {
                    "text": "ZAP-70 molecule required for intracellular transduction of T-cell activation signal after binding of antigen to T-cell antigen receptor (TCR)"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Flow cytometryCD3, CD4, CD8, CD19, CD16,56 measurements; all are present but with functional abnormalities",
                    "sub_points": [
                      "CD3, CD4, CD8, CD19, CD16,56 measurements; all are present but with functional abnormalities"
                    ]
                  },
                  {
                    "text": "Mitogen stimulation PHA, PWM, ConA"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Bare Lymphocyte Syndrome": [
                  {
                    "text": "Bare lymphocyte syndrome (BLS) categorized into 3 groupsMissing class IMissing class IIMissing classes I & IIOnly those missing class II show immunodeficiencies",
                    "sub_points": [
                      "Missing class I",
                      "Missing class II",
                      "Missing classes I & IIOnly those missing class II show immunodeficiencies",
                      "Only those missing class II show immunodeficiencies"
                    ]
                  },
                  {
                    "text": "Lack of MHC class I due to mutation in transporter protein (TAP, or transporter associated with antigen processing)TAP transports peptides from cytosol to endoplasmic reticulum, where they interact with and stabilize structure of MHC class I moleculesPositive selection of CD8 T cells in thymus is defective, resulting in decreased levels of CD8 T cells in peripheral blood",
                    "sub_points": [
                      "TAP transports peptides from cytosol to endoplasmic reticulum, where they interact with and stabilize structure of MHC class I molecules",
                      "Positive selection of CD8 T cells in thymus is defective, resulting in decreased levels of CD8 T cells in peripheral blood"
                    ]
                  },
                  {
                    "text": "Lack of MHC class II due to mutation in 1 of the 4 genes coding for regulatory factors required to transcribe class II genesProtein antigens cannot be presented to CD4 cellsCollaboration does not occur between antigen-presenting cells and CD4 cellsNo helper T-cell function for B cells or CD8 cellsDecreased levels of CD4 T cellsAcute and chronic infections with viral, bacterial, fungal, and protozoal organisms",
                    "sub_points": [
                      "Protein antigens cannot be presented to CD4 cells",
                      "Collaboration does not occur between antigen-presenting cells and CD4 cells",
                      "No helper T-cell function for B cells or CD8 cells",
                      "Decreased levels of CD4 T cells",
                      "Acute and chronic infections with viral, bacterial, fungal, and protozoal organisms"
                    ]
                  }
                ],
                "ZAP-70 Mutation": [
                  {
                    "text": "ZAP-70 molecule required for intracellular transduction of T-cell activation signal after binding of antigen to TCR"
                  },
                  {
                    "text": "No CD8 cells in peripheral blood"
                  },
                  {
                    "text": "Peripheral blood lymphocytes do not respond in mitogen stimulation assay"
                  },
                  {
                    "text": "Acute and chronic infections with viral, bacterial, fungal, and protozoal organisms"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Evaluation of Cellular Components of Immune System": [
                  {
                    "text": "White blood cell count (WBC) with complete differential"
                  },
                  {
                    "text": "Serum IgG, IgM, IgA levels"
                  },
                  {
                    "text": "Flow cytometryCD3, CD4, CD8, CD19, CD16,56 measurements; all are present but with functional abnormalities",
                    "sub_points": [
                      "CD3, CD4, CD8, CD19, CD16,56 measurements; all are present but with functional abnormalities"
                    ]
                  },
                  {
                    "text": "﻿In vivo measurements of functionMitogen stimulation PHA, PWM, ConA",
                    "sub_points": [
                      "Mitogen stimulation PHA, PWM, ConA"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immunodeficiency Disorders Associated With T Cells and Cell-Mediated Immunity": {
            "name": "Immunodeficiency Disorders Associated With T Cells and Cell-Mediated Immunity",
            "url": "https://app.pathprimer.com/document/6c2cba7b-9c60-4782-9b34-22caff19dbbb/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "DiGeorge Syndrome (congenital thymic aplasia)"
                  },
                  {
                    "text": "Chronic mucocutaneous candidiasis"
                  },
                  {
                    "text": "Defects in control (3 known syndromes)1) Transcription factor autoimmune regulator (AIRE)2) Transcription factor Foxp33) Mutation in Fas protein (CD95)",
                    "sub_points": [
                      "1) Transcription factor autoimmune regulator (AIRE)",
                      "2) Transcription factor Foxp3",
                      "3) Mutation in Fas protein (CD95)"
                    ]
                  },
                  {
                    "text": "Autoimmune lymphoproliferative syndrome"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "DiGeorge SyndromeAbsence of thymic shadow on x-rayAbsence of CD3 cells",
                    "sub_points": [
                      "Absence of thymic shadow on x-ray",
                      "Absence of CD3 cells"
                    ]
                  },
                  {
                    "text": "Chronic mucocutaneous candidiasisIn vivo stimulation with candida antigen is low to absent",
                    "sub_points": [
                      "In vivo stimulation with candida antigen is low to absent"
                    ]
                  },
                  {
                    "text": "Defects in controlSplenomegaly, lymphadenopathy, high number of double-negative T cells, apoptosis assays (TUNEL), Fas and FasL gene abnormalities",
                    "sub_points": [
                      "Splenomegaly, lymphadenopathy, high number of double-negative T cells, apoptosis assays (TUNEL), Fas and FasL gene abnormalities"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "DiGeorge syndrome (congenital thymic aplasia)Defective migration of fetal neural rest cells into the 3rd and 4th pharyngeal pouchesWeek 12 of gestationHeart and face develop abnormallyThymus and parathyroids fail to formResults in thymic aplasia, hypoparathyroidism, and cardiac diseaseAbsence of CD3 cellsDeletion in chromosome 22q11Do not immunize with live attenuated viral vaccines",
                    "sub_points": [
                      "Defective migration of fetal neural rest cells into the 3rd and 4th pharyngeal pouchesWeek 12 of gestationHeart and face develop abnormallyThymus and parathyroids fail to formResults in thymic aplasia, hypoparathyroidism, and cardiac diseaseAbsence of CD3 cellsDeletion in chromosome 22q11Do not immunize with live attenuated viral vaccines",
                      "Week 12 of gestation",
                      "Heart and face develop abnormally",
                      "Thymus and parathyroids fail to formResults in thymic aplasia, hypoparathyroidism, and cardiac disease",
                      "Results in thymic aplasia, hypoparathyroidism, and cardiac disease",
                      "Absence of CD3 cells",
                      "Deletion in chromosome 22q11",
                      "Do not immunize with live attenuated viral vaccines"
                    ]
                  },
                  {
                    "text": "Chronic mucocutaneous candidiasisCharacterized byCandidainfection of skin and mucous membranesNormal T cell immunity except toCandidaNormal B cell immunity",
                    "sub_points": [
                      "Characterized byCandidainfection of skin and mucous membranes",
                      "Normal T cell immunity except toCandida",
                      "Normal B cell immunity"
                    ]
                  },
                  {
                    "text": "Defects in control (3 known syndromes)1) Transcription factor autoimmune regulator (AIRE)Results in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED)Autoimmune disease in multiple endocrine organs2) Transcription factor Foxp3Results in absence of T-regulatory cells (Tregs)Results in immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX)3) Mutation in Fas protein (CD95)Results in autoimmune lymphoproliferative syndrome (ALPS)Plays critical role in removal of autoreactive B and T lymphocytes",
                    "sub_points": [
                      "1) Transcription factor autoimmune regulator (AIRE)Results in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED)Autoimmune disease in multiple endocrine organs",
                      "Results in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED)Autoimmune disease in multiple endocrine organs",
                      "Autoimmune disease in multiple endocrine organs",
                      "2) Transcription factor Foxp3Results in absence of T-regulatory cells (Tregs)Results in immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX)",
                      "Results in absence of T-regulatory cells (Tregs)",
                      "Results in immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX)",
                      "3) Mutation in Fas protein (CD95)Results in autoimmune lymphoproliferative syndrome (ALPS)Plays critical role in removal of autoreactive B and T lymphocytes",
                      "Results in autoimmune lymphoproliferative syndrome (ALPS)",
                      "Plays critical role in removal of autoreactive B and T lymphocytes"
                    ]
                  },
                  {
                    "text": "Autoimmune lymphoproliferative syndrome (ALPS)Characterized by massive proliferation of lymphoid tissue and early lymphoma developmentChronic viral infectionsIncreased double negative (CD4⁻CD8⁻) T cellsMutation in the Fas protein (CD95)Signaling through this Fas normally activates apoptosisWith defective apoptosis, cells that should have died do not; results in unchecked proliferation",
                    "sub_points": [
                      "Characterized by massive proliferation of lymphoid tissue and early lymphoma development",
                      "Chronic viral infections",
                      "Increased double negative (CD4⁻CD8⁻) T cells",
                      "Mutation in the Fas protein (CD95)Signaling through this Fas normally activates apoptosisWith defective apoptosis, cells that should have died do not; results in unchecked proliferation",
                      "Signaling through this Fas normally activates apoptosis",
                      "With defective apoptosis, cells that should have died do not; results in unchecked proliferation"
                    ]
                  },
                  {
                    "text": "Disorders of T-B interactionHyper-IgM syndromePresent with recurrent respiratory infections at 1-2 years of ageExtremely low IgG, IgA, and IgEExtremely elevated IgMNormal number of T and B cellsCaused by mutation in CD154 (CD40L) gene on X chromosomeResults in absence of CD154 on surface of T cellsInteraction of CD154 on T cells with CD40 on B cells is necessary for B cell to class switchX-linked lymphoproliferative syndrome (Duncan Syndrome)Mutation in gene coding for signaling activation molecule associated protein (SAP)SAP gene is on X chromosomeSAP is an intracytoplasmic molecule that links several surface receptors with downstream molecules in T cells, B cells, NK cells, eosinophils, and plateletsAfter exposure to Epstein-Barr virus (EBV) a severe course of infectious mononucleosis occurs and can be fatalDue to impaired killing of EBV-infected cells by T cells and NK cellsMalignant B cell lymphomas frequently follow EBV exposureBurkitt lymphoma is most common type",
                    "sub_points": [
                      "Hyper-IgM syndromePresent with recurrent respiratory infections at 1-2 years of ageExtremely low IgG, IgA, and IgEExtremely elevated IgMNormal number of T and B cellsCaused by mutation in CD154 (CD40L) gene on X chromosomeResults in absence of CD154 on surface of T cellsInteraction of CD154 on T cells with CD40 on B cells is necessary for B cell to class switch",
                      "Present with recurrent respiratory infections at 1-2 years of age",
                      "Extremely low IgG, IgA, and IgE",
                      "Extremely elevated IgM",
                      "Normal number of T and B cells",
                      "Caused by mutation in CD154 (CD40L) gene on X chromosomeResults in absence of CD154 on surface of T cells",
                      "Results in absence of CD154 on surface of T cells",
                      "Interaction of CD154 on T cells with CD40 on B cells is necessary for B cell to class switch",
                      "X-linked lymphoproliferative syndrome (Duncan Syndrome)Mutation in gene coding for signaling activation molecule associated protein (SAP)SAP gene is on X chromosomeSAP is an intracytoplasmic molecule that links several surface receptors with downstream molecules in T cells, B cells, NK cells, eosinophils, and plateletsAfter exposure to Epstein-Barr virus (EBV) a severe course of infectious mononucleosis occurs and can be fatalDue to impaired killing of EBV-infected cells by T cells and NK cellsMalignant B cell lymphomas frequently follow EBV exposureBurkitt lymphoma is most common type",
                      "Mutation in gene coding for signaling activation molecule associated protein (SAP)",
                      "SAP gene is on X chromosome",
                      "SAP is an intracytoplasmic molecule that links several surface receptors with downstream molecules in T cells, B cells, NK cells, eosinophils, and platelets",
                      "After exposure to Epstein-Barr virus (EBV) a severe course of infectious mononucleosis occurs and can be fatalDue to impaired killing of EBV-infected cells by T cells and NK cells",
                      "Due to impaired killing of EBV-infected cells by T cells and NK cells",
                      "Malignant B cell lymphomas frequently follow EBV exposureBurkitt lymphoma is most common type",
                      "Burkitt lymphoma is most common type"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "DiGeorge Syndrome": [
                  {
                    "text": "Absence of thymic shadow on x-ray"
                  },
                  {
                    "text": "Absence of CD3 cells"
                  }
                ],
                "Chronic Mucocutaneous Candidiasis": [
                  {
                    "text": "In vivo stimulation with candida antigen is low to absent"
                  }
                ],
                "Defects in Control": [
                  {
                    "text": "Splenomegaly, lymphadenopathy"
                  },
                  {
                    "text": "High number of double-negative T cells"
                  },
                  {
                    "text": "Apoptosis assays (TUNEL)"
                  },
                  {
                    "text": "Fas and FasL gene abnormalities"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immunodeficiency Disorders Associated With B Cells": {
            "name": "Immunodeficiency Disorders Associated With B Cells",
            "url": "https://app.pathprimer.com/document/a7d9a11d-f0ed-4702-91b8-cc0b5db291ac/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "X-linked agammaglobulinemia"
                  },
                  {
                    "text": "Transient hypogammaglobulinemia"
                  },
                  {
                    "text": "Common variable immunodeficiency disease (CVID)"
                  },
                  {
                    "text": "Selective immunoglobulin deficiencies"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "X-linked agammaglobulinemiaBruton agammaglobulinemia noticed at ≈ 6 months of ageInfant has lost maternally derived IgG that crossed placentaMajor defect seen in inability of pre-B cells to develop into mature B cellsBTKgene (Bruton's tyrosine kinase) is mutatedBTKis required for signal transduction from pre-B cell receptor on developing B cellsNear absence of mature B cells; no tonsilsRecurrent bacterial otitis media, bronchitis, septicemia, pneumonia, meningitis",
                    "sub_points": [
                      "Bruton agammaglobulinemia noticed at ≈ 6 months of ageInfant has lost maternally derived IgG that crossed placenta",
                      "Infant has lost maternally derived IgG that crossed placenta",
                      "Major defect seen in inability of pre-B cells to develop into mature B cells",
                      "BTKgene (Bruton's tyrosine kinase) is mutatedBTKis required for signal transduction from pre-B cell receptor on developing B cells",
                      "BTKis required for signal transduction from pre-B cell receptor on developing B cells",
                      "Near absence of mature B cells; no tonsils",
                      "Recurrent bacterial otitis media, bronchitis, septicemia, pneumonia, meningitis"
                    ]
                  },
                  {
                    "text": "Transient hypogammaglobulinemiaPremature infants may have transient IgG deficiency until they are able to synthesize IgFull-term infants may also fail to synthesize appropriate levels of IgMay persist for a few months up to 2 yearsCause appears to be deficiency in number and function of CD4 cells",
                    "sub_points": [
                      "Premature infants may have transient IgG deficiency until they are able to synthesize Ig",
                      "Full-term infants may also fail to synthesize appropriate levels of Ig",
                      "May persist for a few months up to 2 years",
                      "Cause appears to be deficiency in number and function of CD4 cells"
                    ]
                  },
                  {
                    "text": "Common variable immunodeficiency disease (CVID)Low levels of IgG and IgA but near normal IgMOnset occurs at any age, with peaks at 1-5 years and 15-20 yearsCause is unclear, but probably is not uniformRecurrent respiratory and gastrointestinal infections with pyogenic bacteria",
                    "sub_points": [
                      "Low levels of IgG and IgA but near normal IgM",
                      "Onset occurs at any age, with peaks at 1-5 years and 15-20 years",
                      "Cause is unclear, but probably is not uniform",
                      "Recurrent respiratory and gastrointestinal infections with pyogenic bacteria"
                    ]
                  },
                  {
                    "text": "Selective immunoglobulin deficienciesIgA is the most common immunodeficiency in Western worldOther Ig isotypesIgM patients suffer from infections with polysaccharide-encapsulated organisms, like pneumococci andH. influenzaeIgG subclass deficiencies are extremely rare but have been described",
                    "sub_points": [
                      "IgA is the most common immunodeficiency in Western world",
                      "Other Ig isotypesIgM patients suffer from infections with polysaccharide-encapsulated organisms, like pneumococci andH. influenzaeIgG subclass deficiencies are extremely rare but have been described",
                      "IgM patients suffer from infections with polysaccharide-encapsulated organisms, like pneumococci andH. influenzae",
                      "IgG subclass deficiencies are extremely rare but have been described"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "CD4 and CD8 in HIV Disease": {
            "name": "CD4 and CD8 in HIV Disease",
            "url": "https://app.pathprimer.com/document/7042304e-38dc-4a20-b605-8153e3e57cbd/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Primary reason for immunophenotyping specimens from HIV patients is to determine absolute number of CD4 lymphocytes"
                  },
                  {
                    "text": "For HIV classification purposes, 3 levels of increasing suppression are characterized by CD4 level> 500 cells/μL or > 28%200-500 cells/μL or 14%-28%< 200 cells/μL or < 14%",
                    "sub_points": [
                      "> 500 cells/μL or > 28%",
                      "200-500 cells/μL or 14%-28%",
                      "< 200 cells/μL or < 14%"
                    ]
                  },
                  {
                    "text": "There are 3 phases of HIV infection: Acute phase, chronic latent phase, crisis phase"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Acute phaseViremiaPrecipitous drop in CD4 T cellsSeroconversion to HIV antibody positivityCD4 T cells partially recover",
                    "sub_points": [
                      "Viremia",
                      "Precipitous drop in CD4 T cells",
                      "Seroconversion to HIV antibody positivity",
                      "CD4 T cells partially recover"
                    ]
                  },
                  {
                    "text": "Chronic latent phaseCan last 15 yearsGradual decline in CD4 T cellsEventual involvement of lymph nodesCD4:CD8 ratio begins to reverse from approximate 2:1 ratio seen in healthy individualsReversal of ratio is due to decrease in CD4 numberIn other viral infections, reversal of ratio is due to increase in CD8 numberAs CD4 numbers continue to decrease, patient eventually becomes symptomatic and enters crisis phase",
                    "sub_points": [
                      "Can last 15 years",
                      "Gradual decline in CD4 T cells",
                      "Eventual involvement of lymph nodes",
                      "CD4:CD8 ratio begins to reverse from approximate 2:1 ratio seen in healthy individuals",
                      "Reversal of ratio is due to decrease in CD4 numberIn other viral infections, reversal of ratio is due to increase in CD8 number",
                      "In other viral infections, reversal of ratio is due to increase in CD8 number",
                      "As CD4 numbers continue to decrease, patient eventually becomes symptomatic and enters crisis phase"
                    ]
                  },
                  {
                    "text": "Crisis phaseOpportunistic infectionsUnusual malignanciesGeneral debilitating syndromes",
                    "sub_points": [
                      "Opportunistic infections",
                      "Unusual malignancies",
                      "General debilitating syndromes"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "HIV diseasePrimary reason for immunophenotyping specimens from HIV patients is to determine absolute number of CD4 lymphocytesFor HIV classification purposes, 3 levels of increasing suppression characterized by CD4 level> 500 cells/μL or > 28%200-500 cells/μL or 14%-28%< 200 cells/μL or < 14%CD8 cell determinations may be determined, but practice is inconsistentImmunophenotyping panelCD3 for total T cellsCD4 for total helper cellsCD8 for total cytotoxic cellsCD19 for total B cellsCD16 and CD56 for total natural killer (NK) cellsThree-color immunophenotyping recommends that CD45 be included in tubes containing CD3 and CD4 as well as CD3 and CD8Lymphocytes are identified in these tubes by having low SS and high level of CD45 expressionCheck of replicate CD3 determinations is used to determine consistent sample processing between tubesFour-color immunophenotyping recommends CD3, CD4, CD8, CD45 in single tube",
                    "sub_points": [
                      "Primary reason for immunophenotyping specimens from HIV patients is to determine absolute number of CD4 lymphocytesFor HIV classification purposes, 3 levels of increasing suppression characterized by CD4 level> 500 cells/μL or > 28%200-500 cells/μL or 14%-28%< 200 cells/μL or < 14%",
                      "For HIV classification purposes, 3 levels of increasing suppression characterized by CD4 level> 500 cells/μL or > 28%200-500 cells/μL or 14%-28%< 200 cells/μL or < 14%",
                      "> 500 cells/μL or > 28%",
                      "200-500 cells/μL or 14%-28%",
                      "< 200 cells/μL or < 14%",
                      "CD8 cell determinations may be determined, but practice is inconsistent",
                      "Immunophenotyping panelCD3 for total T cellsCD4 for total helper cellsCD8 for total cytotoxic cellsCD19 for total B cellsCD16 and CD56 for total natural killer (NK) cells",
                      "CD3 for total T cells",
                      "CD4 for total helper cells",
                      "CD8 for total cytotoxic cells",
                      "CD19 for total B cells",
                      "CD16 and CD56 for total natural killer (NK) cells",
                      "Three-color immunophenotyping recommends that CD45 be included in tubes containing CD3 and CD4 as well as CD3 and CD8Lymphocytes are identified in these tubes by having low SS and high level of CD45 expressionCheck of replicate CD3 determinations is used to determine consistent sample processing between tubes",
                      "Lymphocytes are identified in these tubes by having low SS and high level of CD45 expression",
                      "Check of replicate CD3 determinations is used to determine consistent sample processing between tubes",
                      "Four-color immunophenotyping recommends CD3, CD4, CD8, CD45 in single tube"
                    ]
                  }
                ],
                "Methods for Calculation of Absolute Numbers of CD4 Cells": [
                  {
                    "text": "Two-step platformCalculated by multiplying CD4 percentage obtained from flow cytometer by lymphocyte count from hematology instrumentMethod is good and cost-effectiveThere is certain amount of error for each instrument and the calculation multiplies that error",
                    "sub_points": [
                      "Calculated by multiplying CD4 percentage obtained from flow cytometer by lymphocyte count from hematology instrumentMethod is good and cost-effectiveThere is certain amount of error for each instrument and the calculation multiplies that error",
                      "Method is good and cost-effectiveThere is certain amount of error for each instrument and the calculation multiplies that error",
                      "There is certain amount of error for each instrument and the calculation multiplies that error"
                    ]
                  },
                  {
                    "text": "Single-step platformPerform absolute counts directly on flow cytometer by having known number of fluorescent beads in sample tubeMethod is good and with less error but expensive",
                    "sub_points": [
                      "Perform absolute counts directly on flow cytometer by having known number of fluorescent beads in sample tubeMethod is good and with less error but expensive",
                      "Method is good and with less error but expensive"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Phagocytic Dysfunctions": {
            "name": "Phagocytic Dysfunctions",
            "url": "https://app.pathprimer.com/document/7d198990-5884-4cb9-988b-24bb233c88f6/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Leukocyte adhesion deficiencyLAD1: Defective β chain in 3 integrin molecules, LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18), p150,95 (CD11c/CD18)LAD2: Defect in selectin ligandsLAD3: Individuals express CD18, but molecule does not become activated in response to stimuli",
                    "sub_points": [
                      "LAD1: Defective β chain in 3 integrin molecules, LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18), p150,95 (CD11c/CD18)",
                      "LAD2: Defect in selectin ligands",
                      "LAD3: Individuals express CD18, but molecule does not become activated in response to stimuli"
                    ]
                  },
                  {
                    "text": "Chronic granulomatous disease"
                  },
                  {
                    "text": "G6PD deficiency"
                  },
                  {
                    "text": "Myeloperoxidase deficiency"
                  },
                  {
                    "text": "Chédiak-Higashi syndrome"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Classic Clinical Findings": [
                  {
                    "text": "Leukocyte adhesion deficiencyWidespread pyogenic bacterial infectionsLAD1Defective β chain in 3 integrin moleculesLFA-1 (CD11a/CD18)Mac-1 (CD11b/CD18)p150,95 (CD11c/CD18)Results in adhesion and migration of all white blood cells (WBCs)LAD2Defect in selectin ligandsDue to fucose metabolism defectResults in fucosylated ligands being absent so that selectins cannot bindLAD3Clinically similar to LAD1Individuals express CD18, but molecule does not become activated in response to stimuli",
                    "sub_points": [
                      "Widespread pyogenic bacterial infections",
                      "LAD1Defective β chain in 3 integrin moleculesLFA-1 (CD11a/CD18)Mac-1 (CD11b/CD18)p150,95 (CD11c/CD18)Results in adhesion and migration of all white blood cells (WBCs)",
                      "Defective β chain in 3 integrin moleculesLFA-1 (CD11a/CD18)Mac-1 (CD11b/CD18)p150,95 (CD11c/CD18)",
                      "LFA-1 (CD11a/CD18)",
                      "Mac-1 (CD11b/CD18)",
                      "p150,95 (CD11c/CD18)",
                      "Results in adhesion and migration of all white blood cells (WBCs)",
                      "LAD2Defect in selectin ligandsDue to fucose metabolism defectResults in fucosylated ligands being absent so that selectins cannot bind",
                      "Defect in selectin ligands",
                      "Due to fucose metabolism defectResults in fucosylated ligands being absent so that selectins cannot bind",
                      "Results in fucosylated ligands being absent so that selectins cannot bind",
                      "LAD3Clinically similar to LAD1Individuals express CD18, but molecule does not become activated in response to stimuli",
                      "Clinically similar to LAD1",
                      "Individuals express CD18, but molecule does not become activated in response to stimuli"
                    ]
                  },
                  {
                    "text": "Chronic granulomatous diseaseIntracellular and extracellularGranulomasReduced nicotinamide adenine dinucleotide phosphate (NADPH) mutations result in inability to generate hydrogen peroxide and free superoxide radicals",
                    "sub_points": [
                      "Intracellular and extracellular",
                      "Granulomas",
                      "Reduced nicotinamide adenine dinucleotide phosphate (NADPH) mutations result in inability to generate hydrogen peroxide and free superoxide radicals"
                    ]
                  },
                  {
                    "text": "Glucose-6-phosphate dehydrogenase (G6PD) deficiencyDefective respiratory burstChronic infection",
                    "sub_points": [
                      "Defective respiratory burst",
                      "Chronic infection"
                    ]
                  },
                  {
                    "text": "Myeloperoxidase deficiencyDefective intracellular killingChronic infectionDefectiveMPOgene",
                    "sub_points": [
                      "Defective intracellular killing",
                      "Chronic infection",
                      "DefectiveMPOgene"
                    ]
                  },
                  {
                    "text": "Chédiak-Higashi syndromeIntracellular and extracellular infectionGranulomasMutation inLYSTgene responsible for organelle protein trafficking",
                    "sub_points": [
                      "Intracellular and extracellular infection",
                      "Granulomas",
                      "Mutation inLYSTgene responsible for organelle protein trafficking"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Nitroblue tetrazolium (NBT) assay"
                  },
                  {
                    "text": "Chemotaxis assays"
                  },
                  {
                    "text": "Microbicidal assays"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Measure CD18 on surface of WBCs"
                  },
                  {
                    "text": "Oxidative burst assay using delayed hypersensitivity reaction (DHR)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Natural Killer Cell Deficiency": {
            "name": "Natural Killer Cell Deficiency",
            "url": "https://app.pathprimer.com/document/34a4dfde-e943-41e3-89d3-1a3c2768627f/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Natural killer (NK) cells function with T cells to eradicate intracellular organisms"
                  },
                  {
                    "text": "NK cells are LGLs expressing CD16, CD56, CD57"
                  },
                  {
                    "text": "Complete deficiency is rare and is characterized by recurrent herpes infection"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Natural killer (NK) cells function with T cells to eradicate intracellular organisms"
                  },
                  {
                    "text": "Complete deficiency is rare and is characterized by recurrent herpes infection"
                  },
                  {
                    "text": "NK cells are large granular lymphocytes (LGLs) expressing CD16, CD56, CD57"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Flow Cytometry": [
                  {
                    "text": "Quantify CD16, CD56, CD57 LGLs"
                  },
                  {
                    "text": "Functional assaysChromium release assays using K562 tumor as targetFlow cytometry assay using fluorescent labeling techniquesColorimetric substrate techniques to detect granzyme B to detect granule-mediated apoptosis",
                    "sub_points": [
                      "Chromium release assays using K562 tumor as target",
                      "Flow cytometry assay using fluorescent labeling techniques",
                      "Colorimetric substrate techniques to detect granzyme B to detect granule-mediated apoptosis"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Diseases Caused by Abnormalities in Complement": {
            "name": "Diseases Caused by Abnormalities in Complement",
            "url": "https://app.pathprimer.com/document/29345fc8-18e7-4272-a7a3-4850a3ac574e/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Deficiencies of early complement components (C1, C4, C2, C3)Very important in generating opsonin; increased infections with encapsulated organisms (Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae)Increased rheumatoid diseases and SLE due to improper clearance of immune complexes",
                    "sub_points": [
                      "Very important in generating opsonin; increased infections with encapsulated organisms (Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae)",
                      "Increased rheumatoid diseases and SLE due to improper clearance of immune complexes"
                    ]
                  },
                  {
                    "text": "Deficiencies of late complement components (C5-C9)Interfere with generation of the membrane attack complex (MAC); increased susceptibility toNeisseriainfections",
                    "sub_points": [
                      "Interfere with generation of the membrane attack complex (MAC); increased susceptibility toNeisseriainfections"
                    ]
                  },
                  {
                    "text": "Deficiencies in control of complement componentsHereditary angioedemaLack of functional C1 esterase inhibitorGlycosyl phosphatidyl inositol (GPI) protein deficiencyGPI protein deficiency allows granulocytes, platelets, and RBCs to be spontaneously lysed by complementParoxysmal nocturnal hemoglobinuria (PNH)Acquired form caused by an acquired mutation in myeloid stem cell, resulting in deficiency in an enzyme required for production of all GPI proteins",
                    "sub_points": [
                      "Hereditary angioedemaLack of functional C1 esterase inhibitor",
                      "Lack of functional C1 esterase inhibitor",
                      "Glycosyl phosphatidyl inositol (GPI) protein deficiencyGPI protein deficiency allows granulocytes, platelets, and RBCs to be spontaneously lysed by complement",
                      "GPI protein deficiency allows granulocytes, platelets, and RBCs to be spontaneously lysed by complement",
                      "Paroxysmal nocturnal hemoglobinuria (PNH)Acquired form caused by an acquired mutation in myeloid stem cell, resulting in deficiency in an enzyme required for production of all GPI proteins",
                      "Acquired form caused by an acquired mutation in myeloid stem cell, resulting in deficiency in an enzyme required for production of all GPI proteins"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Overview": [
                  {
                    "text": "Complement is important in the opsonization and killing of bacteria, chemotaxis, B-cell activation, and elimination of antigen-antibody complexes"
                  },
                  {
                    "text": "Deficiencies in complement components are inherited as autosomal recessive traitsHeterozygous individuals have half the normal level (this is usually sufficient)",
                    "sub_points": [
                      "Heterozygous individuals have half the normal level (this is usually sufficient)"
                    ]
                  },
                  {
                    "text": "Absence of inhibitors leads to uncontrolled complement activity"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Deficiencies of early complement components (C1, C4, C2, C3)Very important in generating opsoninIncreased infections with encapsulated organisms (Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae)Increased rheumatoid diseases and systemic lupus erythematosus (SLE) due to improper clearance of immune complexesMannose-binding lectin deficiencies also lead to increased rheumatoid diseases and SLE",
                    "sub_points": [
                      "Very important in generating opsonin",
                      "Increased infections with encapsulated organisms (Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae)",
                      "Increased rheumatoid diseases and systemic lupus erythematosus (SLE) due to improper clearance of immune complexes",
                      "Mannose-binding lectin deficiencies also lead to increased rheumatoid diseases and SLE"
                    ]
                  },
                  {
                    "text": "Deficiencies of late complement components (C5-C9)Interfere with generation of the membrane attack complex (MAC)MAC is the primary defense against gram-negative bacteria, especiallyNeisseria meningitidis",
                    "sub_points": [
                      "Interfere with generation of the membrane attack complex (MAC)",
                      "MAC is the primary defense against gram-negative bacteria, especiallyNeisseria meningitidis"
                    ]
                  },
                  {
                    "text": "Deficiencies in control of complement componentsHereditary angioedemaLack of functional C1 esterase inhibitorAction of C1 on C4, C2, and the kallikrein system is uncontrolled, resulting in large amounts of vasoactive peptidesIncreased vascular permeabilityLocal edema can be life threatening when it occurs in the larynxGlycosyl phosphatidyl inositol (GPI) protein deficiencyCD55 (decay accelerating factor, a.k.a. DAF) and CD59 protect cells from spontaneous lysisDeficiencies in GPI proteins allow granulocytes, platelets, and RBCs to be spontaneously lysed by complementRare families have inherited mutations of DAF, CD59, or all the GPI proteinsParoxysmal nocturnal hemoglobinuria (PNH)Acquired form caused by an acquired mutation in myeloid stem cell, resulting in deficiency in an enzyme required for production of all GPI proteinsGranulocytes, platelets, and erythrocytes are affectedIntravascular hemolysis occurs in the kidneys at night, where the acidic environment activates the alternative complement pathway",
                    "sub_points": [
                      "Hereditary angioedemaLack of functional C1 esterase inhibitorAction of C1 on C4, C2, and the kallikrein system is uncontrolled, resulting in large amounts of vasoactive peptidesIncreased vascular permeabilityLocal edema can be life threatening when it occurs in the larynx",
                      "Lack of functional C1 esterase inhibitorAction of C1 on C4, C2, and the kallikrein system is uncontrolled, resulting in large amounts of vasoactive peptidesIncreased vascular permeabilityLocal edema can be life threatening when it occurs in the larynx",
                      "Action of C1 on C4, C2, and the kallikrein system is uncontrolled, resulting in large amounts of vasoactive peptides",
                      "Increased vascular permeability",
                      "Local edema can be life threatening when it occurs in the larynx",
                      "Glycosyl phosphatidyl inositol (GPI) protein deficiencyCD55 (decay accelerating factor, a.k.a. DAF) and CD59 protect cells from spontaneous lysisDeficiencies in GPI proteins allow granulocytes, platelets, and RBCs to be spontaneously lysed by complementRare families have inherited mutations of DAF, CD59, or all the GPI proteinsParoxysmal nocturnal hemoglobinuria (PNH)Acquired form caused by an acquired mutation in myeloid stem cell, resulting in deficiency in an enzyme required for production of all GPI proteinsGranulocytes, platelets, and erythrocytes are affectedIntravascular hemolysis occurs in the kidneys at night, where the acidic environment activates the alternative complement pathway",
                      "CD55 (decay accelerating factor, a.k.a. DAF) and CD59 protect cells from spontaneous lysisDeficiencies in GPI proteins allow granulocytes, platelets, and RBCs to be spontaneously lysed by complementRare families have inherited mutations of DAF, CD59, or all the GPI proteins",
                      "Deficiencies in GPI proteins allow granulocytes, platelets, and RBCs to be spontaneously lysed by complement",
                      "Rare families have inherited mutations of DAF, CD59, or all the GPI proteins",
                      "Paroxysmal nocturnal hemoglobinuria (PNH)Acquired form caused by an acquired mutation in myeloid stem cell, resulting in deficiency in an enzyme required for production of all GPI proteinsGranulocytes, platelets, and erythrocytes are affectedIntravascular hemolysis occurs in the kidneys at night, where the acidic environment activates the alternative complement pathway",
                      "Acquired form caused by an acquired mutation in myeloid stem cell, resulting in deficiency in an enzyme required for production of all GPI proteins",
                      "Granulocytes, platelets, and erythrocytes are affected",
                      "Intravascular hemolysis occurs in the kidneys at night, where the acidic environment activates the alternative complement pathway"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Complement Evaluation": [
                  {
                    "text": "CH50"
                  },
                  {
                    "text": "C2, C3, C4 levels"
                  },
                  {
                    "text": "Other classic and alternative pathway components"
                  },
                  {
                    "text": "Immune complex measurements both C1q and C3d"
                  },
                  {
                    "text": "Level and function of C1 esterase inhibitor"
                  },
                  {
                    "text": "GPI levels"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Measure level of CD55 and CD59 on the cell membranes of granulocytes"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Primary Immunodeficiency Disease Treatment": {
            "name": "Primary Immunodeficiency Disease Treatment",
            "url": "https://app.pathprimer.com/document/1e0e7f18-b2ac-4d31-8dcf-0fdde499971c/lesson/5ac80af6-22df-48fd-9d85-4bcdae83058f",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Defects involving T cells are treated by BMT"
                  },
                  {
                    "text": "Defects involving both T cells and B cells are treated by BMT"
                  },
                  {
                    "text": "Defects involving only B cells are treated prophylactically with wide-spectrum antibiotics and IVIG"
                  },
                  {
                    "text": "Defects involving phagocytic cells are usually treated with wide-spectrum antibiotics, antifungals, and IFN-γ; BMT has been used in extreme cases"
                  },
                  {
                    "text": "Defects involving natural killer cells are treated with antifungals or antivirals when symptomatic"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Severe Combined Immunodeficiency Diseases": [
                  {
                    "text": "TreatmentBone marrow transplantation (BMT) with human leukocyte antigen (HLA)-matched sibling or unrelated donorProphylactic treatment with wide-spectrum antibiotics, antifungals, antivirals, intravenous immune globulin (IVIG)",
                    "sub_points": [
                      "Bone marrow transplantation (BMT) with human leukocyte antigen (HLA)-matched sibling or unrelated donor",
                      "Prophylactic treatment with wide-spectrum antibiotics, antifungals, antivirals, intravenous immune globulin (IVIG)"
                    ]
                  },
                  {
                    "text": "PrognosisGood with successful BMT",
                    "sub_points": [
                      "Good with successful BMT"
                    ]
                  }
                ],
                "DiGeorge Syndrome": [
                  {
                    "text": "TreatmentExperimental thymus transplantsProphylactic treatment with wide-spectrum antibiotics, antifungals, antivirals, IVIGThymic hormones",
                    "sub_points": [
                      "Experimental thymus transplants",
                      "Prophylactic treatment with wide-spectrum antibiotics, antifungals, antivirals, IVIG",
                      "Thymic hormones"
                    ]
                  },
                  {
                    "text": "PrognosisPoor",
                    "sub_points": [
                      "Poor"
                    ]
                  }
                ],
                "B Cell-Associated Immunodeficiency Disorders": [
                  {
                    "text": "TreatmentIVIGProphylactic treatment with antibiotics",
                    "sub_points": [
                      "IVIG",
                      "Prophylactic treatment with antibiotics"
                    ]
                  },
                  {
                    "text": "PrognosisGood",
                    "sub_points": [
                      "Good"
                    ]
                  }
                ],
                "Phagocytic Dysfunction": [
                  {
                    "text": "TreatmentWide-spectrum antibiotics, antifungals, interferon (IFN)-γBMT has been successful but is used only in extreme cases",
                    "sub_points": [
                      "Wide-spectrum antibiotics, antifungals, interferon (IFN)-γ",
                      "BMT has been successful but is used only in extreme cases"
                    ]
                  },
                  {
                    "text": "PrognosisGood except for Chédiak-Higashi syndrome, which is poor",
                    "sub_points": [
                      "Good except for Chédiak-Higashi syndrome, which is poor"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Autoimmune Disorders": {
        "name": "Autoimmune Disorders",
        "url": "https://app.pathprimer.com/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
        "topics": {
          "Autoimmune Diseases: Antibodies and Organ Damage": {
            "name": "Autoimmune Diseases: Antibodies and Organ Damage",
            "url": "https://app.pathprimer.com/document/c92ea72a-e807-410c-b39a-3d728fcc13f6/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Autoimmune hemolytic anemia: Antibodies specific for blood group antigensWarm agglutinins (1) react best at 37⁰C, (2) are primarily IgG, and (3) some are Rh specific and result in phagocytosis and ADCC destruction of RBCsCold agglutinins (1) react best below 37⁰C (in fact, they dissociate at 37⁰C), (2) are primarily IgM, (3) are specific for I or i antigens on RBCs, and (4) are highly efficient in complement activation",
                    "sub_points": [
                      "Warm agglutinins (1) react best at 37⁰C, (2) are primarily IgG, and (3) some are Rh specific and result in phagocytosis and ADCC destruction of RBCs",
                      "Cold agglutinins (1) react best below 37⁰C (in fact, they dissociate at 37⁰C), (2) are primarily IgM, (3) are specific for I or i antigens on RBCs, and (4) are highly efficient in complement activation"
                    ]
                  },
                  {
                    "text": "Enhancing antibody (Graves disease)"
                  },
                  {
                    "text": "Immune-complex mediated (systemic lupus erythematosus)"
                  },
                  {
                    "text": "Blocking antibody (myasthenia gravis, pernicious anemia)"
                  },
                  {
                    "text": "Organ-specific antibody (Hashimoto thyroiditis, Goodpasture syndrome, Sjögren syndrome)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Antibody-Mediated Diseases": [
                  {
                    "text": "Autoimmune hemolytic anemiaAntibodies specific for blood group antigens; destruction of red blood cells (RBC)Complement cascadeOpsonization initiated by antibody and C3bAntibody-dependent cell-mediated cytotoxicity (ADCC) mediated by natural killer cellsTwo groups of antibodiesWarm agglutininsReact best at 37⁰CPrimarily immunoglobulin G (IgG)Some are Rh specific and result in phagocytosis and ADCC destruction of RBCsCold agglutininsReact best below 37⁰C (in fact, they dissociate at 37⁰C)Primarily immunoglobulin M (IgM)Specific for I or i antigens on RBCsHighly efficient in complement activation",
                    "sub_points": [
                      "Antibodies specific for blood group antigens; destruction of red blood cells (RBC)Complement cascadeOpsonization initiated by antibody and C3bAntibody-dependent cell-mediated cytotoxicity (ADCC) mediated by natural killer cells",
                      "Complement cascade",
                      "Opsonization initiated by antibody and C3b",
                      "Antibody-dependent cell-mediated cytotoxicity (ADCC) mediated by natural killer cells",
                      "Two groups of antibodiesWarm agglutininsReact best at 37⁰CPrimarily immunoglobulin G (IgG)Some are Rh specific and result in phagocytosis and ADCC destruction of RBCsCold agglutininsReact best below 37⁰C (in fact, they dissociate at 37⁰C)Primarily immunoglobulin M (IgM)Specific for I or i antigens on RBCsHighly efficient in complement activation",
                      "Warm agglutininsReact best at 37⁰CPrimarily immunoglobulin G (IgG)Some are Rh specific and result in phagocytosis and ADCC destruction of RBCs",
                      "React best at 37⁰C",
                      "Primarily immunoglobulin G (IgG)",
                      "Some are Rh specific and result in phagocytosis and ADCC destruction of RBCs",
                      "Cold agglutininsReact best below 37⁰C (in fact, they dissociate at 37⁰C)Primarily immunoglobulin M (IgM)Specific for I or i antigens on RBCsHighly efficient in complement activation",
                      "React best below 37⁰C (in fact, they dissociate at 37⁰C)",
                      "Primarily immunoglobulin M (IgM)",
                      "Specific for I or i antigens on RBCs",
                      "Highly efficient in complement activation"
                    ]
                  },
                  {
                    "text": "Graves diseaseAntibody is directed against thyroid-stimulating hormone (TSH) receptorActivates receptor in manner similar to TSH itself, resulting in unregulated levels of thyroid hormone",
                    "sub_points": [
                      "Antibody is directed against thyroid-stimulating hormone (TSH) receptor",
                      "Activates receptor in manner similar to TSH itself, resulting in unregulated levels of thyroid hormone"
                    ]
                  },
                  {
                    "text": "Hashimoto thyroiditisAntibodies to both thyroid peroxidase and thyroglobulinThyroid is eventually destroyed, resulting in hypothyroidism",
                    "sub_points": [
                      "Antibodies to both thyroid peroxidase and thyroglobulin",
                      "Thyroid is eventually destroyed, resulting in hypothyroidism"
                    ]
                  },
                  {
                    "text": "Systemic lupus erythematosusAntibodies are directed against nuclear antigens, particularly DNAResults in soluble immune complexes, damaging the kidney",
                    "sub_points": [
                      "Antibodies are directed against nuclear antigens, particularly DNA",
                      "Results in soluble immune complexes, damaging the kidney"
                    ]
                  },
                  {
                    "text": "Myasthenia gravisAntibodies against acetylcholine receptor block ability of acetylcholine to bind and stimulate receptor",
                    "sub_points": [
                      "Antibodies against acetylcholine receptor block ability of acetylcholine to bind and stimulate receptor"
                    ]
                  },
                  {
                    "text": "Pernicious anemiaAntibody against intrinsic factor blocks absorption of B12",
                    "sub_points": [
                      "Antibody against intrinsic factor blocks absorption of B12"
                    ]
                  },
                  {
                    "text": "Goodpasture syndromeAntibody is directed to basement membrane collagen type IV in kidney and lung",
                    "sub_points": [
                      "Antibody is directed to basement membrane collagen type IV in kidney and lung"
                    ]
                  },
                  {
                    "text": "Sjögren syndromeAntibody is directed to salivary duct antigens SS-A and SS-B",
                    "sub_points": [
                      "Antibody is directed to salivary duct antigens SS-A and SS-B"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autoimmune Diseases: T Cells and Organ Damage": {
            "name": "Autoimmune Diseases: T Cells and Organ Damage",
            "url": "https://app.pathprimer.com/document/e7449fdb-cb2c-4578-9d4a-9b8d7c71b1e9/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Multiple sclerosisDemyelination of myelin sheaths surrounding CNS nerve axonsMicroglial cells (APCs) present self-antigen, and T cells secrete inflammatory cytokines (INF-γ and TNF-α), which activate macrophagesInflammatory process induces increased Fas expression on oligodendrocytes, which eventually undergo apoptosis",
                    "sub_points": [
                      "Demyelination of myelin sheaths surrounding CNS nerve axons",
                      "Microglial cells (APCs) present self-antigen, and T cells secrete inflammatory cytokines (INF-γ and TNF-α), which activate macrophages",
                      "Inflammatory process induces increased Fas expression on oligodendrocytes, which eventually undergo apoptosis"
                    ]
                  },
                  {
                    "text": "Type I diabetes mellitusChronic destruction of insulin-producing β cells of the islets of LangerhansCytotoxic CD8 T cells destroy the β cells",
                    "sub_points": [
                      "Chronic destruction of insulin-producing β cells of the islets of Langerhans",
                      "Cytotoxic CD8 T cells destroy the β cells"
                    ]
                  },
                  {
                    "text": "Rheumatoid arthritisComplex pathology involving T cells, B cells, and macrophagesProinflammatory T cells infiltrate the joint; CD4+TH17 cells and their autoinflammatory cytokines cause characteristic bone destruction seen in the joint",
                    "sub_points": [
                      "Complex pathology involving T cells, B cells, and macrophages",
                      "Proinflammatory T cells infiltrate the joint; CD4+TH17 cells and their autoinflammatory cytokines cause characteristic bone destruction seen in the joint"
                    ]
                  },
                  {
                    "text": "PsoriasisBoth CD4 TH1 and TH17 cells involved, along with their cytokines IFN-γ, IL-17 and IL-22",
                    "sub_points": [
                      "Both CD4 TH1 and TH17 cells involved, along with their cytokines IFN-γ, IL-17 and IL-22"
                    ]
                  },
                  {
                    "text": "Hashimoto thyroiditisTH1 cells infiltrate thyroid along with B cells and macrophages, so much so that the thyroid looks like a germinal center",
                    "sub_points": [
                      "TH1 cells infiltrate thyroid along with B cells and macrophages, so much so that the thyroid looks like a germinal center"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "T cell–mediated diseases": [
                  {
                    "text": "Multiple sclerosisDemyelination of myelin sheaths surrounding CNS nerve axonsBlood-brain barrier can be compromised during inflammation from multiple causesAuto-reactive TH1 cells enter brain and encounter self-antigen (mouse models suggest myelin basic protein)Microglial cells (APCs) present self-antigen, and T cells secrete inflammatory cytokines (INF-γ and TNF-α), which activate macrophagesMacrophages release chemokines and cytokines, which attract inflammatory cells into the site, resulting in accumulation of mast cells, neutrophils, macrophages, and lymphocytesInflammatory process induces increased Fas expression on oligodendrocytes, which eventually undergo apoptosis",
                    "sub_points": [
                      "Demyelination of myelin sheaths surrounding CNS nerve axons",
                      "Blood-brain barrier can be compromised during inflammation from multiple causes",
                      "Auto-reactive TH1 cells enter brain and encounter self-antigen (mouse models suggest myelin basic protein)",
                      "Microglial cells (APCs) present self-antigen, and T cells secrete inflammatory cytokines (INF-γ and TNF-α), which activate macrophages",
                      "Macrophages release chemokines and cytokines, which attract inflammatory cells into the site, resulting in accumulation of mast cells, neutrophils, macrophages, and lymphocytes",
                      "Inflammatory process induces increased Fas expression on oligodendrocytes, which eventually undergo apoptosis"
                    ]
                  },
                  {
                    "text": "Type I diabetes mellitusChronic destruction of insulin-producing β cells of the islets of LangerhansCytotoxic CD8 T cells destroy β cellsCD4, macrophages, and CD8 cells infiltrate pancreas and secrete cytokines (IL-1, IL-5, INF-α)Some patients develop autoantibody to insulin, but this is not initial cause of destructionHLA linkage to HLA-DR3/DR4",
                    "sub_points": [
                      "Chronic destruction of insulin-producing β cells of the islets of Langerhans",
                      "Cytotoxic CD8 T cells destroy β cells",
                      "CD4, macrophages, and CD8 cells infiltrate pancreas and secrete cytokines (IL-1, IL-5, INF-α)",
                      "Some patients develop autoantibody to insulin, but this is not initial cause of destruction",
                      "HLA linkage to HLA-DR3/DR4"
                    ]
                  },
                  {
                    "text": "Rheumatoid arthritisCaused by chronic inflammation of jointsComplex pathology involving T cells, B cells, and macrophagesProinflammatory T cells infiltrate the jointCD4+TH17 cells and their autoinflammatory cytokines cause characteristic bone destruction seen in the jointMouse models suggest collagen II is the autoantigen",
                    "sub_points": [
                      "Caused by chronic inflammation of joints",
                      "Complex pathology involving T cells, B cells, and macrophages",
                      "Proinflammatory T cells infiltrate the jointCD4+TH17 cells and their autoinflammatory cytokines cause characteristic bone destruction seen in the joint",
                      "CD4+TH17 cells and their autoinflammatory cytokines cause characteristic bone destruction seen in the joint",
                      "Mouse models suggest collagen II is the autoantigen"
                    ]
                  },
                  {
                    "text": "PsoriasisAutoimmune inflammatory diseaseBoth CD4 TH1 and TH17 cells involved, along with their cytokines IFN-γ, IL-17 and IL-22",
                    "sub_points": [
                      "Autoimmune inflammatory disease",
                      "Both CD4 TH1 and TH17 cells involved, along with their cytokines IFN-γ, IL-17 and IL-22"
                    ]
                  },
                  {
                    "text": "Hashimoto thyroiditisTH1 cells infiltrate thyroid along with B cells and macrophages, so much so that the thyroid looks like a germinal center",
                    "sub_points": [
                      "TH1 cells infiltrate thyroid along with B cells and macrophages, so much so that the thyroid looks like a germinal center"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autoimmune Disease Treatment": {
            "name": "Autoimmune Disease Treatment",
            "url": "https://app.pathprimer.com/document/c2a89a90-320a-4d82-9edd-d2982e2a31f5/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Goals for treatment are (1) reduce symptoms, (2) control autoimmune process, (3) maintain body's ability to fight infections"
                  },
                  {
                    "text": "Treatment depends on specific disease but, in general terms, includes medications to control immune system, disease-modifying antirheumatic drugs, antiinflammatory medications, antimalarial drugs, cytotoxic drugs, biological agents, replacement hormones, and vitamins"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Treatment": [
                  {
                    "text": "Goals for treatmentReduce symptomsControl autoimmune processMaintain body's ability to fight infections",
                    "sub_points": [
                      "Reduce symptoms",
                      "Control autoimmune process",
                      "Maintain body's ability to fight infections"
                    ]
                  },
                  {
                    "text": "Treatment depends on specific diseaseMedications to control immune systemDisease-modifying antirheumatic drugsAntiinflammatory medicationsAntimalarial drugsCytotoxic drugsBiologic agentsReplacement hormonesVitamins",
                    "sub_points": [
                      "Medications to control immune system",
                      "Disease-modifying antirheumatic drugs",
                      "Antiinflammatory medications",
                      "Antimalarial drugs",
                      "Cytotoxic drugs",
                      "Biologic agents",
                      "Replacement hormones",
                      "Vitamins"
                    ]
                  }
                ],
                "Disease": [
                  {
                    "text": "Rheumatoid arthritisDisease-modifying antirheumatic drugsMethotrexateLeflunomideAntiinflammatory drugsIbuprofenNaproxenCelebrexAntimalarial medicationsHydroxychloroquineCorticosteroidsBiologic agentsAbataceptRituximabTumor necrosis factor (TNF) inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab)Interleukin-6 inhibitors (tocilizumab)",
                    "sub_points": [
                      "Disease-modifying antirheumatic drugsMethotrexateLeflunomide",
                      "Methotrexate",
                      "Leflunomide",
                      "Antiinflammatory drugsIbuprofenNaproxenCelebrex",
                      "Ibuprofen",
                      "Naproxen",
                      "Celebrex",
                      "Antimalarial medicationsHydroxychloroquine",
                      "Hydroxychloroquine",
                      "Corticosteroids",
                      "Biologic agentsAbataceptRituximabTumor necrosis factor (TNF) inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab)Interleukin-6 inhibitors (tocilizumab)",
                      "Abatacept",
                      "Rituximab",
                      "Tumor necrosis factor (TNF) inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab)",
                      "Interleukin-6 inhibitors (tocilizumab)"
                    ]
                  },
                  {
                    "text": "Systemic lupus erythematosusAntiinflammatory drugsIbuprofenNaproxenCelebrexAntimalarial medicationsHydroxychloroquineImmunosuppressive medicationsCorticosteroidsCytotoxic drugs",
                    "sub_points": [
                      "Antiinflammatory drugsIbuprofenNaproxenCelebrex",
                      "Ibuprofen",
                      "Naproxen",
                      "Celebrex",
                      "Antimalarial medicationsHydroxychloroquine",
                      "Hydroxychloroquine",
                      "Immunosuppressive medicationsCorticosteroids",
                      "Corticosteroids",
                      "Cytotoxic drugs"
                    ]
                  },
                  {
                    "text": "Multiple sclerosisCorticosteroids",
                    "sub_points": [
                      "Corticosteroids"
                    ]
                  },
                  {
                    "text": "Myasthenia gravisImmunosuppressive medicationsPrednisoneAzathioprineCyclosporineAcetylcholinesterase inhibitorsNeostigiminePyridostigmine",
                    "sub_points": [
                      "Immunosuppressive medicationsPrednisoneAzathioprineCyclosporine",
                      "Prednisone",
                      "Azathioprine",
                      "Cyclosporine",
                      "Acetylcholinesterase inhibitorsNeostigiminePyridostigmine",
                      "Neostigimine",
                      "Pyridostigmine"
                    ]
                  },
                  {
                    "text": "Pernicious anemiaVitamin B12 shot",
                    "sub_points": [
                      "Vitamin B12 shot"
                    ]
                  },
                  {
                    "text": "Graves diseaseβ-blockersAntithyroid medicationsMethimazolePropylthiouracil",
                    "sub_points": [
                      "β-blockers",
                      "Antithyroid medicationsMethimazolePropylthiouracil",
                      "Methimazole",
                      "Propylthiouracil"
                    ]
                  },
                  {
                    "text": "Type I diabetesInsulinIslet cell transplantsEdmonton protocolIslet cells from cadaver pancreases are injected into major liver veinIslet cells home to liver, produce insulin",
                    "sub_points": [
                      "Insulin",
                      "Islet cell transplantsEdmonton protocolIslet cells from cadaver pancreases are injected into major liver veinIslet cells home to liver, produce insulin",
                      "Edmonton protocolIslet cells from cadaver pancreases are injected into major liver veinIslet cells home to liver, produce insulin",
                      "Islet cells from cadaver pancreases are injected into major liver vein",
                      "Islet cells home to liver, produce insulin"
                    ]
                  },
                  {
                    "text": "Hashimoto diseaseThyroid hormone replacement therapyLevothyroxine",
                    "sub_points": [
                      "Thyroid hormone replacement therapyLevothyroxine",
                      "Levothyroxine"
                    ]
                  },
                  {
                    "text": "Sjögren syndromeSymptom reliefEye-lubricating ointmentsCyclosporine liquidDisease-modifying drugsMethotrexateLeflunomideBiological agentsTNF inhibitorsAdalimumabEtanerceptInfliximab",
                    "sub_points": [
                      "Symptom reliefEye-lubricating ointmentsCyclosporine liquid",
                      "Eye-lubricating ointments",
                      "Cyclosporine liquid",
                      "Disease-modifying drugsMethotrexateLeflunomide",
                      "Methotrexate",
                      "Leflunomide",
                      "Biological agentsTNF inhibitorsAdalimumabEtanerceptInfliximab",
                      "TNF inhibitorsAdalimumabEtanerceptInfliximab",
                      "Adalimumab",
                      "Etanercept",
                      "Infliximab"
                    ]
                  },
                  {
                    "text": "DermatomyositisAntiinflammatory drugsCorticosteroidsPrednisone",
                    "sub_points": [
                      "Antiinflammatory drugsCorticosteroidsPrednisone",
                      "Corticosteroids",
                      "Prednisone"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autoimmune Diseases, Target Autoantigens, and Effector Cells": {
            "name": "Autoimmune Diseases, Target Autoantigens, and Effector Cells",
            "url": "https://app.pathprimer.com/document/cde5afc9-c616-4323-b0eb-cd7eb74fb876/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Organ-specific: Chronic inflammation, generally localized in single organ specific for each individual disease"
                  },
                  {
                    "text": "Non-organ-specific: Presence of 1 or more autoantibodies directed against components of the cell surface, cytoplasm, nuclear envelope, or nucleus"
                  },
                  {
                    "text": "Effector cells: Cell-mediated (T cells), antibody-mediated (B cells), both cell-mediated and antibody-mediated"
                  },
                  {
                    "text": "Mechanisms of damage: Immune complexes, complement deficiencies, blocking antibody, enhancing antibody"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Overview of Autoimmune Diseases": [
                  {
                    "text": "Classification can be done in several waysOrgan-specificAntigen is localized to one specific organHashimoto thyroiditisGraves diseaseNon-organ-specificAntigen is ubiquitous; acetylcholine receptorMyasthenia gravisSystemic lupus erythematosus (SLE)Effector cellsT cellsMyelin basic protein (multiple sclerosis)Islet cells (type 1 diabetes)B cellsAutoimmune hemolytic anemiaMechanisms of damageImmune complexSLEDeficiencies in components of complementSLE likely due to deficiencies in early components of complementBlocking antibodyAcetylcholine receptor antibody (AChR)—myasthenia gravisEnhancing antibodyThyroid-stimulating receptor antibody (TSHR)—Graves disease",
                    "sub_points": [
                      "Organ-specificAntigen is localized to one specific organHashimoto thyroiditisGraves disease",
                      "Antigen is localized to one specific organHashimoto thyroiditisGraves disease",
                      "Hashimoto thyroiditis",
                      "Graves disease",
                      "Non-organ-specificAntigen is ubiquitous; acetylcholine receptorMyasthenia gravisSystemic lupus erythematosus (SLE)",
                      "Antigen is ubiquitous; acetylcholine receptorMyasthenia gravisSystemic lupus erythematosus (SLE)",
                      "Myasthenia gravis",
                      "Systemic lupus erythematosus (SLE)",
                      "Effector cellsT cellsMyelin basic protein (multiple sclerosis)Islet cells (type 1 diabetes)B cellsAutoimmune hemolytic anemia",
                      "T cellsMyelin basic protein (multiple sclerosis)Islet cells (type 1 diabetes)",
                      "Myelin basic protein (multiple sclerosis)",
                      "Islet cells (type 1 diabetes)",
                      "B cellsAutoimmune hemolytic anemia",
                      "Autoimmune hemolytic anemia",
                      "Mechanisms of damageImmune complexSLEDeficiencies in components of complementSLE likely due to deficiencies in early components of complementBlocking antibodyAcetylcholine receptor antibody (AChR)—myasthenia gravisEnhancing antibodyThyroid-stimulating receptor antibody (TSHR)—Graves disease",
                      "Immune complexSLE",
                      "SLE",
                      "Deficiencies in components of complementSLE likely due to deficiencies in early components of complement",
                      "SLE likely due to deficiencies in early components of complement",
                      "Blocking antibodyAcetylcholine receptor antibody (AChR)—myasthenia gravis",
                      "Acetylcholine receptor antibody (AChR)—myasthenia gravis",
                      "Enhancing antibodyThyroid-stimulating receptor antibody (TSHR)—Graves disease",
                      "Thyroid-stimulating receptor antibody (TSHR)—Graves disease"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Tolerance and Autoimmunity": {
            "name": "Tolerance and Autoimmunity",
            "url": "https://app.pathprimer.com/document/8c7eba6c-e3d7-449c-ace5-acf647cea8bb/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Central tolerance: Deletion, anergy, and receptor editing"
                  },
                  {
                    "text": "Peripheral tolerance: Anergy, Tregs, and Fas-FasL"
                  },
                  {
                    "text": "Privileged sites: Do not develop immune responses to pathogens, tumors, or transplants"
                  },
                  {
                    "text": "Genetic predisposition: Some have HLA linkage; most involve multiple genes"
                  },
                  {
                    "text": "Treatment: Corticosteroids, cytotoxic drugs, immunosuppressive drugs, anticytokine therapies, and monoclonal antibodies"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Central Tolerance": [
                  {
                    "text": "DeletionDeleting autoreactive T and B cell clones before they develop into immunocompetent cellsOccurs in thymus for T cells; bone marrow for B cellsNegative selection in thymus for cells that have high affinity for self-antigen induces apoptosisSelf-antigens are present in thymus due toEndogenous expressionImportation of antigens from peripheral sites via circulating bloodExpression of proteins of other nonthymic tissues by actions of transcription factor AIRE (autoimmune regulator protein)Deletion of B cells occurs when immature IgM⁺ B cells with BCR specific for self-antigen are deleted in bone marrow",
                    "sub_points": [
                      "Deleting autoreactive T and B cell clones before they develop into immunocompetent cells",
                      "Occurs in thymus for T cells; bone marrow for B cells",
                      "Negative selection in thymus for cells that have high affinity for self-antigen induces apoptosisSelf-antigens are present in thymus due toEndogenous expressionImportation of antigens from peripheral sites via circulating bloodExpression of proteins of other nonthymic tissues by actions of transcription factor AIRE (autoimmune regulator protein)Deletion of B cells occurs when immature IgM⁺ B cells with BCR specific for self-antigen are deleted in bone marrow",
                      "Self-antigens are present in thymus due toEndogenous expressionImportation of antigens from peripheral sites via circulating bloodExpression of proteins of other nonthymic tissues by actions of transcription factor AIRE (autoimmune regulator protein)",
                      "Endogenous expression",
                      "Importation of antigens from peripheral sites via circulating blood",
                      "Expression of proteins of other nonthymic tissues by actions of transcription factor AIRE (autoimmune regulator protein)",
                      "Deletion of B cells occurs when immature IgM⁺ B cells with BCR specific for self-antigen are deleted in bone marrow"
                    ]
                  },
                  {
                    "text": "Anergy: Functional inactivation of B cell after its BCR is cross-linked"
                  },
                  {
                    "text": "Receptor editing: Immature B expressing BCR for self-antigens replaces its BCR with new one that is not directed toward selfOccurs in light chain variable region geneSelf variable region gene is replaced with upstream variable region gene that rearranges to a more downstream J regionThis repeats until new BCR is not autoreactiveIf non-autoreactive BCR cannot be achieved, cell is destroyed by apoptosis",
                    "sub_points": [
                      "Occurs in light chain variable region geneSelf variable region gene is replaced with upstream variable region gene that rearranges to a more downstream J regionThis repeats until new BCR is not autoreactiveIf non-autoreactive BCR cannot be achieved, cell is destroyed by apoptosis",
                      "Self variable region gene is replaced with upstream variable region gene that rearranges to a more downstream J region",
                      "This repeats until new BCR is not autoreactive",
                      "If non-autoreactive BCR cannot be achieved, cell is destroyed by apoptosis"
                    ]
                  }
                ],
                "Peripheral Tolerance": [
                  {
                    "text": "Anergy: Lymphocytes normally require 2 or more signals to become activated; rendered inactive in absence of 2nd signalB cells require CD40L on T cells to interact with CD40 on B cellsT cells require CD80 or CD86 on APC to interact with CD28 on T cells",
                    "sub_points": [
                      "B cells require CD40L on T cells to interact with CD40 on B cells",
                      "T cells require CD80 or CD86 on APC to interact with CD28 on T cells"
                    ]
                  },
                  {
                    "text": "Regulatory T cells (Tregs): CD4 cells that express CD25 (IL-2α chain) and downregulate T-cell activity"
                  },
                  {
                    "text": "Fas-FasL: Fas-mediated apoptosis removes mature autoreactive B and T cells; when Fas binds to FasL, the Fas trimerizes and initiates apoptosis (also see discussion of ALPS in CP PATHPrimer topic Immunodeficiency Disorders Associated with T cells and Cell-Mediated Immunity)"
                  }
                ],
                "Privileged Sites": [
                  {
                    "text": "Sites that do not develop immune responses to pathogens, tumors, or transplantsEye, testis, brain, ovary, placenta",
                    "sub_points": [
                      "Eye, testis, brain, ovary, placenta"
                    ]
                  },
                  {
                    "text": "IL-10, TNF-β, FasL are all in higher concentration"
                  }
                ],
                "Genetic Susceptibility": [
                  {
                    "text": "Genetic predisposition to autoimmune diseaseFamilial tendency; however, most autoimmune diseases involve multiple genes",
                    "sub_points": [
                      "Familial tendency; however, most autoimmune diseases involve multiple genes"
                    ]
                  },
                  {
                    "text": "HLA linkageHLA-B27: Linked to ankylosing spondylitis, Reiter syndrome, and acute anterior uveitisHLA-DR3: Linked to Sjögren syndrome, celiac disease, type I diabetes, myasthenia gravis, systemic lupus erythematosus (SLE)HLA-DR4: Linked to rheumatoid arthritis, pemphigus vulgaris, type I diabetesHLA-DR2: Linked to SLE, multiple sclerosisHLA-B8: Linked to Graves disease",
                    "sub_points": [
                      "HLA-B27: Linked to ankylosing spondylitis, Reiter syndrome, and acute anterior uveitis",
                      "HLA-DR3: Linked to Sjögren syndrome, celiac disease, type I diabetes, myasthenia gravis, systemic lupus erythematosus (SLE)",
                      "HLA-DR4: Linked to rheumatoid arthritis, pemphigus vulgaris, type I diabetes",
                      "HLA-DR2: Linked to SLE, multiple sclerosis",
                      "HLA-B8: Linked to Graves disease"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Corticosteroids"
                  },
                  {
                    "text": "Cytotoxic drugs"
                  },
                  {
                    "text": "Immunosuppressive drugs"
                  },
                  {
                    "text": "Anticytokine therapies"
                  },
                  {
                    "text": "Monoclonal antibodies"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Systemic Lupus Erythematosus (SLE)": {
            "name": "Systemic Lupus Erythematosus (SLE)",
            "url": "https://app.pathprimer.com/document/e1ed6c4a-efcc-4b73-a549-6ec23efa9418/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "SLE is most common immune complex disease"
                  },
                  {
                    "text": "SLE affects 10 times as many female patients as male patients"
                  },
                  {
                    "text": "Small immune complexes tend to be trapped in kidney and joints"
                  },
                  {
                    "text": "Tissue injury is mediated by activation of complement"
                  },
                  {
                    "text": "SLE autoantigens are DNA, histones, and ribosomes snRNP, scRNP"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Immune complex diseaseSubacute bacterial endocarditisMixed essential cryoglobulinemiaSystemic lupus erythematosus (SLE)Affects 10 times as many female patients as male patientsMost common autoantibody is to double-stranded DNA (dsDNA)Phospholipid antibodies also frequent but not as commonSmall immune complexes tend to be trapped in kidney and jointsTissue injury mediated by activation of complement",
                    "sub_points": [
                      "Subacute bacterial endocarditis",
                      "Mixed essential cryoglobulinemia",
                      "Systemic lupus erythematosus (SLE)Affects 10 times as many female patients as male patientsMost common autoantibody is to double-stranded DNA (dsDNA)Phospholipid antibodies also frequent but not as commonSmall immune complexes tend to be trapped in kidney and jointsTissue injury mediated by activation of complement",
                      "Affects 10 times as many female patients as male patients",
                      "Most common autoantibody is to double-stranded DNA (dsDNA)",
                      "Phospholipid antibodies also frequent but not as common",
                      "Small immune complexes tend to be trapped in kidney and joints",
                      "Tissue injury mediated by activation of complement"
                    ]
                  },
                  {
                    "text": "SLE autoantigensDNAHistonesRibosomes small nuclear ribonucleoprotein (snRNP) and small cytoplasmic ribonucleoprotein (scRNP)",
                    "sub_points": [
                      "DNA",
                      "Histones",
                      "Ribosomes small nuclear ribonucleoprotein (snRNP) and small cytoplasmic ribonucleoprotein (scRNP)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Autoantibody Testing": [
                  {
                    "text": "Antinuclear antibody (ANA) by immunofluorescencePerformed properly, negative fluorescent ANA test virtually rules out untreated SLE",
                    "sub_points": [
                      "Performed properly, negative fluorescent ANA test virtually rules out untreated SLE"
                    ]
                  },
                  {
                    "text": "Anti-dsDNA by crithidia immunofluorescence assay (IFA) or enzyme immunoassay (EIA)"
                  },
                  {
                    "text": "Anti-extractable nuclear antibody (ENA) by EIA"
                  }
                ],
                "Other Clinical Laboratory Tests": [
                  {
                    "text": "Coombs test"
                  },
                  {
                    "text": "Complement C3 or C4 and CH50"
                  },
                  {
                    "text": "Immune complex assays (C1q or C3d)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Rheumatoid Arthritis": {
            "name": "Rheumatoid Arthritis",
            "url": "https://app.pathprimer.com/document/885b32c0-6ccc-432a-b85a-dd0a4b17dfdf/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "T cells (CD4TH17) are most common lymphocytes in joints with RA"
                  },
                  {
                    "text": "TH17 T cells secrete IFN-γ and IL-17 cytokines that activate macrophages to secrete proinflammatory TNF-α and IL-1"
                  },
                  {
                    "text": "Patients produce IgM antibody to Fc portion of IgG"
                  },
                  {
                    "text": "Patients produce autoantibodies to CCP and carbamylated protein"
                  },
                  {
                    "text": "HLA linkage to HLA-DR4"
                  },
                  {
                    "text": "Collagen II implemented as important autoantigen"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Chronic inflammation of joints"
                  },
                  {
                    "text": "Synovium inflamed and infiltrated with lymphocytes"
                  },
                  {
                    "text": "Results in destruction of bone and cartilage"
                  },
                  {
                    "text": "Dendritic cells, macrophages, T and B cells, natural killer (NK) cells, plasma cells all invade synoviumT cells (CD4TH17) most common lymphocytes in joints with rheumatoid arthritis (RA)TH17 cytokines interferon (IFN)-γ and interleukin (IL)-17 involved in bone and cartilage destructionTH17 cytokines activate macrophages to secrete proinflammatory tumor necrosis factor (TNF)-α and IL-1",
                    "sub_points": [
                      "T cells (CD4TH17) most common lymphocytes in joints with rheumatoid arthritis (RA)",
                      "TH17 cytokines interferon (IFN)-γ and interleukin (IL)-17 involved in bone and cartilage destructionTH17 cytokines activate macrophages to secrete proinflammatory tumor necrosis factor (TNF)-α and IL-1",
                      "TH17 cytokines activate macrophages to secrete proinflammatory tumor necrosis factor (TNF)-α and IL-1"
                    ]
                  },
                  {
                    "text": "Patients produce IgM antibody to Fc portion of IgGResulting immune complexes are deposited in joints, recruit complement, and begin inflammatory reaction",
                    "sub_points": [
                      "Resulting immune complexes are deposited in joints, recruit complement, and begin inflammatory reaction"
                    ]
                  },
                  {
                    "text": "Patients produce autoantibodies to cyclic citrullinated protein (CCP) and carbamylated protein"
                  },
                  {
                    "text": "HLA linkage to HLA-DR4"
                  },
                  {
                    "text": "Collagen II implemented as important autoantigen"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Measure IgM autoantibodies to Fc portion of IgG"
                  },
                  {
                    "text": "Measure autoantibodies to CCP"
                  },
                  {
                    "text": "Immune complex assays for C1q and C3d complexes"
                  },
                  {
                    "text": "Examine cellular infiltrates of synovium"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Antiphospholipid Antibodies": {
            "name": "Antiphospholipid Antibodies",
            "url": "https://app.pathprimer.com/document/ed68cf4d-23a4-4d6e-81ee-53eac94d36ce/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Alteration in the homeostatic regulation of blood coagulation"
                  },
                  {
                    "text": "Clinical findingsVascular thrombosisArterialVenousSmall-vesselPregnancy morbidity> 10 weeks' gestation spontaneous abortionOne or more premature birthsThree or more spontaneous abortions before 10 weeks' gestationMedium to high levels of IgG or IgM anticardiolipin &/or anti-β₂ glycoprotein",
                    "sub_points": [
                      "Vascular thrombosisArterialVenousSmall-vessel",
                      "Arterial",
                      "Venous",
                      "Small-vessel",
                      "Pregnancy morbidity> 10 weeks' gestation spontaneous abortionOne or more premature birthsThree or more spontaneous abortions before 10 weeks' gestation",
                      "> 10 weeks' gestation spontaneous abortion",
                      "One or more premature births",
                      "Three or more spontaneous abortions before 10 weeks' gestation",
                      "Medium to high levels of IgG or IgM anticardiolipin &/or anti-β₂ glycoprotein"
                    ]
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Anti-β₂ glycoprotein antibody (IgG or IgM)"
                  },
                  {
                    "text": "Anticardiolipin antibody (IgG or IgM)"
                  },
                  {
                    "text": "Antiphosphatidylserine antibody"
                  },
                  {
                    "text": "Serologic test for syphilis (false-positive due to anticardiolipin antibody)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Alteration in the homeostatic regulation of blood coagulationTheoriesDefect in cellular apoptosis leads to phospholipid-protein complexes that result in new epitopes on phospholipids being exposed as a new target for autoantibody productionActivation of platelets to enhance endothelial adherenceActivation of vascular endothelium facilitating the binding of platelets and monocytesEnhanced endothelial adherence of plateletsAntibodies against coagulation factors such as protein C, protein S, and annexins",
                    "sub_points": [
                      "TheoriesDefect in cellular apoptosis leads to phospholipid-protein complexes that result in new epitopes on phospholipids being exposed as a new target for autoantibody productionActivation of platelets to enhance endothelial adherenceActivation of vascular endothelium facilitating the binding of platelets and monocytesEnhanced endothelial adherence of plateletsAntibodies against coagulation factors such as protein C, protein S, and annexins",
                      "Defect in cellular apoptosis leads to phospholipid-protein complexes that result in new epitopes on phospholipids being exposed as a new target for autoantibody production",
                      "Activation of platelets to enhance endothelial adherence",
                      "Activation of vascular endothelium facilitating the binding of platelets and monocytes",
                      "Enhanced endothelial adherence of platelets",
                      "Antibodies against coagulation factors such as protein C, protein S, and annexins"
                    ]
                  },
                  {
                    "text": "Complement activation by antiphospholipid (aPL) antibody plays a significant role"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "1-5% of healthy individuals have aPL antibody"
                  },
                  {
                    "text": "aPL antibody syndrome (APS) estimated at 5 cases per 100,000 persons year"
                  },
                  {
                    "text": "aPL antibodies found in 30-40% of patients with systemic lupus erythematosus (only 10% of these have APS)"
                  },
                  {
                    "text": "50% of patients with APS have no other rheumatic disease"
                  },
                  {
                    "text": "Effects of APS14% of all strokes11% of myocardial infarctions10% of deep thromboses6% of pregnancy morbidity9% of pregnancy losses",
                    "sub_points": [
                      "14% of all strokes",
                      "11% of myocardial infarctions",
                      "10% of deep thromboses",
                      "6% of pregnancy morbidity",
                      "9% of pregnancy losses"
                    ]
                  },
                  {
                    "text": "Familial associationUp to a 33% frequency in relatives with known APS",
                    "sub_points": [
                      "Up to a 33% frequency in relatives with known APS"
                    ]
                  },
                  {
                    "text": "Human leukocyte antigen (HLA) associationHLA-DR4 in white patientsHLA-DR7 in Hispanic patients",
                    "sub_points": [
                      "HLA-DR4 in white patients",
                      "HLA-DR7 in Hispanic patients"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Vascular thrombosisArterialVenousSmall-vessel",
                    "sub_points": [
                      "Arterial",
                      "Venous",
                      "Small-vessel"
                    ]
                  },
                  {
                    "text": "Pregnancy morbidity> 10 weeks' gestation spontaneous abortionOne or more premature birthsThree or more spontaneous abortions before 10 weeks' gestation",
                    "sub_points": [
                      "> 10 weeks' gestation spontaneous abortion",
                      "One or more premature births",
                      "Three or more spontaneous abortions before 10 weeks' gestation"
                    ]
                  },
                  {
                    "text": "Medium to high levels of immunoglobulin G (IgG) or immunoglobulin M (IgM) anticardiolipin &/or anti-β₂ glycoprotein"
                  },
                  {
                    "text": "History of any of the following should raise suspicionThrombosis or strokeMiscarriageHematologic abnormalities: thrombocytopenia or hemolytic anemiaMigraine headachesChoreaSeizuresTransverse myelitisGuillain-Barré syndromeDementia",
                    "sub_points": [
                      "Thrombosis or stroke",
                      "Miscarriage",
                      "Hematologic abnormalities: thrombocytopenia or hemolytic anemia",
                      "Migraine headaches",
                      "Chorea",
                      "Seizures",
                      "Transverse myelitis",
                      "Guillain-Barré syndrome",
                      "Dementia"
                    ]
                  }
                ],
                "Differential Diagnosis": [
                  {
                    "text": "Disseminated intravascular coagulation"
                  },
                  {
                    "text": "Infective endocarditis"
                  },
                  {
                    "text": "Thrombotic thrombocytopenic purpura"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Autoantibody Testing": [
                  {
                    "text": "Anticardiolipin antibody (IgG or IgM)"
                  },
                  {
                    "text": "Antiphosphatidylserine antibody"
                  },
                  {
                    "text": "Anti-β₂ glycoprotein antibody (IgG or IgM)"
                  }
                ],
                "Other Laboratory Tests": [
                  {
                    "text": "Activated partial thromboplastin time"
                  },
                  {
                    "text": "Circulating anticoagulant (lupus anticoagulant)"
                  },
                  {
                    "text": "Serologic test for syphilis (false-positive due to anticardiolipin antibody)"
                  },
                  {
                    "text": "Complete blood count (thrombocytopenia, hemolytic anemia)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Antineutrophil Cytoplasmic Antibodies": {
            "name": "Antineutrophil Cytoplasmic Antibodies",
            "url": "https://app.pathprimer.com/document/17cc42d1-c2e9-45c3-b6f5-c8af1224840a/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "ANCA principal use is in patients with suspected or diagnosed necrotizing small vessel vasculitides (primary vasculitides)"
                  },
                  {
                    "text": "Two main antigens: proteinase 3 (PR3) and myeloperoxidase (MPO)"
                  },
                  {
                    "text": "Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome, rapidly progressing necrotizing glomerulonephritis"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "On ethanol-fixed PMNs: PR3-ANCA produces granular cytoplasmic pattern (cANCA) and MPO-ANCA produces perinuclear pattern (pANCA)"
                  },
                  {
                    "text": "Non-cANCA, non-pANCA patterns usually reported as atypical ANCA and have been found in patients with inflammatory bowel disease"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Antinuclear cytoplasmic antibody (ANCA) principal use is in patients with suspected or diagnosed necrotizing small vessel vasculitides (primary vasculitides)Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome, rapidly progressing necrotizing glomerulonephritis2 main antigensProteinase 3 (PR3)Myeloperoxidase (MPO)",
                    "sub_points": [
                      "Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome, rapidly progressing necrotizing glomerulonephritis",
                      "2 main antigensProteinase 3 (PR3)Myeloperoxidase (MPO)",
                      "Proteinase 3 (PR3)",
                      "Myeloperoxidase (MPO)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Indirect Immunofluorescence": [
                  {
                    "text": "On ethanol-fixed polymorphonuclear neutrophils (PMNs)PR3-ANCA produces granular cytoplasmic pattern (cANCA)MPO-ANCA produces perinuclear pattern (pANCA)",
                    "sub_points": [
                      "PR3-ANCA produces granular cytoplasmic pattern (cANCA)",
                      "MPO-ANCA produces perinuclear pattern (pANCA)"
                    ]
                  },
                  {
                    "text": "On formalin-fixed PMNsPR3-ANCA and MPO-ANCA produce cANCA pattern",
                    "sub_points": [
                      "PR3-ANCA and MPO-ANCA produce cANCA pattern"
                    ]
                  },
                  {
                    "text": "False interpretation of pANCA pattern may occur in patients with positive antinuclear antibody (ANA)Eliminated by examining lymphocytes in field for positive ANA patterns",
                    "sub_points": [
                      "Eliminated by examining lymphocytes in field for positive ANA patterns"
                    ]
                  },
                  {
                    "text": "Non-cANCA, non-pANCA patterns usually reported as atypical ANCAHave been found in patients with inflammatory bowel disease",
                    "sub_points": [
                      "Have been found in patients with inflammatory bowel disease"
                    ]
                  }
                ],
                "Direct PR3 and MPO Enzyme Immunosorbent Assay Testing": [
                  {
                    "text": "PR3 and MPO are main autoantigens in primary vasculitis"
                  },
                  {
                    "text": "Purified PR3 and MPO antigens can be used in routine enzyme immunosorbent assay testing"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autoantibodies in Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome": {
            "name": "Autoantibodies in Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome",
            "url": "https://app.pathprimer.com/document/5b7b9f99-2039-43c3-b933-5d290bb13116/lesson/9d1e7e6d-755d-4f35-873e-3349ec7878cd",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Myasthenia gravisCaused by circulating autoantibody to acetylcholine receptors at postsynaptic neuromuscular junctionAntibodies against acetylcholine receptor seen in 80-95% of patients",
                    "sub_points": [
                      "Caused by circulating autoantibody to acetylcholine receptors at postsynaptic neuromuscular junction",
                      "Antibodies against acetylcholine receptor seen in 80-95% of patients"
                    ]
                  },
                  {
                    "text": "TreatmentAcetylcholinesterase inhibitorsImmunosuppressive drugsPlasmapheresisIVIG",
                    "sub_points": [
                      "Acetylcholinesterase inhibitors",
                      "Immunosuppressive drugs",
                      "Plasmapheresis",
                      "IVIG"
                    ]
                  },
                  {
                    "text": "Lambert-Eaton myasthenic syndromeCaused by circulating autoantibodies to voltage-gated calcium channels (VGCC)60% of patients have an underlying malignancyAntibodies against VGCC found in 85% of patients",
                    "sub_points": [
                      "Caused by circulating autoantibodies to voltage-gated calcium channels (VGCC)",
                      "60% of patients have an underlying malignancy",
                      "Antibodies against VGCC found in 85% of patients"
                    ]
                  },
                  {
                    "text": "TreatmentTreatment of malignancy usually resolves symptomsImmunosuppression is less effectiveIVIG",
                    "sub_points": [
                      "Treatment of malignancy usually resolves symptoms",
                      "Immunosuppression is less effective",
                      "IVIG"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Myasthenia gravisNeuromuscular disease resulting in muscle weakness and fatigue; weakness of eye muscles is commonCaused by circulating autoantibody to acetylcholine receptors at postsynaptic neuromuscular junctionAutoantibody leads to transmission defects in nerve impulses to musclesAutoantigen is usually acetylcholine, but in rare cases the antigen is a muscle-specific kinaseCan be transmitted to infants via IgG to the receptor crossing the placenta (transient neonatal myasthenia)Condition resolves in 3 weeks, as maternal antibodies degradeDiagnosisElectromyographyAntibodies against acetylcholine receptor seen in 80-95% of patientsAntibodies against muscle-specific kinase (MuSK) found in small number of myasthenia gravis patients without acetylcholine receptor antibodiesRule out Lambert-Eaton syndrome (see below)TreatmentAcetylcholinesterase inhibitorsImmunosuppressive drugsPlasmapheresisIntravenous immunoglobulins (IVIG)",
                    "sub_points": [
                      "Neuromuscular disease resulting in muscle weakness and fatigue; weakness of eye muscles is common",
                      "Caused by circulating autoantibody to acetylcholine receptors at postsynaptic neuromuscular junction",
                      "Autoantibody leads to transmission defects in nerve impulses to muscles",
                      "Autoantigen is usually acetylcholine, but in rare cases the antigen is a muscle-specific kinase",
                      "Can be transmitted to infants via IgG to the receptor crossing the placenta (transient neonatal myasthenia)Condition resolves in 3 weeks, as maternal antibodies degrade",
                      "Condition resolves in 3 weeks, as maternal antibodies degrade",
                      "DiagnosisElectromyographyAntibodies against acetylcholine receptor seen in 80-95% of patientsAntibodies against muscle-specific kinase (MuSK) found in small number of myasthenia gravis patients without acetylcholine receptor antibodiesRule out Lambert-Eaton syndrome (see below)",
                      "Electromyography",
                      "Antibodies against acetylcholine receptor seen in 80-95% of patients",
                      "Antibodies against muscle-specific kinase (MuSK) found in small number of myasthenia gravis patients without acetylcholine receptor antibodies",
                      "Rule out Lambert-Eaton syndrome (see below)",
                      "TreatmentAcetylcholinesterase inhibitorsImmunosuppressive drugsPlasmapheresisIntravenous immunoglobulins (IVIG)",
                      "Acetylcholinesterase inhibitors",
                      "Immunosuppressive drugs",
                      "Plasmapheresis",
                      "Intravenous immunoglobulins (IVIG)"
                    ]
                  },
                  {
                    "text": "Lambert-Eaton myasthenic syndromeNeuromuscular disease resulting in muscle weakness of arms and legs; weakness of eye muscles is not commonCaused by circulating autoantibodies to VGCC at neuromuscular junctionNerve impulses lead to opening of VGCC; influx of calcium ions into nerve terminal results in calcium-dependent triggering of synaptic vesicles to release acetylcholine, which stimulates the receptors on muscles, causing them to contractAntigenic domain on VGCC is domain III S5-S6 linker peptideAntibody to VGCC results in decreased amount of calcium resulting in decreased amount of acetylcholine60% of patients have an underlying malignancySmall cell lung cancer (most common)Regarded as a paraneoplastic syndromeAntibody to VGCC thought to be an immune response against tumor cells to slow their growthDiagnosisElectromyographyAntibodies against VGCC found in 85% of patientsTreatmentTreatment of malignancy usually resolves symptomsImmunosuppression is less effectiveIVIG",
                    "sub_points": [
                      "Neuromuscular disease resulting in muscle weakness of arms and legs; weakness of eye muscles is not common",
                      "Caused by circulating autoantibodies to VGCC at neuromuscular junctionNerve impulses lead to opening of VGCC; influx of calcium ions into nerve terminal results in calcium-dependent triggering of synaptic vesicles to release acetylcholine, which stimulates the receptors on muscles, causing them to contractAntigenic domain on VGCC is domain III S5-S6 linker peptide",
                      "Nerve impulses lead to opening of VGCC; influx of calcium ions into nerve terminal results in calcium-dependent triggering of synaptic vesicles to release acetylcholine, which stimulates the receptors on muscles, causing them to contract",
                      "Antigenic domain on VGCC is domain III S5-S6 linker peptide",
                      "Antibody to VGCC results in decreased amount of calcium resulting in decreased amount of acetylcholine",
                      "60% of patients have an underlying malignancySmall cell lung cancer (most common)Regarded as a paraneoplastic syndromeAntibody to VGCC thought to be an immune response against tumor cells to slow their growth",
                      "Small cell lung cancer (most common)",
                      "Regarded as a paraneoplastic syndrome",
                      "Antibody to VGCC thought to be an immune response against tumor cells to slow their growth",
                      "DiagnosisElectromyographyAntibodies against VGCC found in 85% of patients",
                      "Electromyography",
                      "Antibodies against VGCC found in 85% of patients",
                      "TreatmentTreatment of malignancy usually resolves symptomsImmunosuppression is less effectiveIVIG",
                      "Treatment of malignancy usually resolves symptoms",
                      "Immunosuppression is less effective",
                      "IVIG"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      }
    }
  }
}